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Abstract 
Atropisomeric Diaryl Ethers and other Non-Biaryl Atropisomers 
A submission for the degree of Doctor of Philosophy at The University of Manchester, 
Abigail L. Page 2010 
 
Atropisomerism is a property exhibited by molecules where rotation about one or more 
bonds is restricted.  Along with biaryls, which are widely utilised in asymmetric catalysis, 
several other classes of compounds display atropisomerism.  These molecules have 
applications in enantioselective synthesis, asymmetric catalysis and have been used to 
relay stereochemical information.  There are, however, a number of challenges associated 
with their asymmetric synthesis (Chapter 1). 
This thesis describes research carried out on the synthesis and asymmetric synthesis of 
atropisomeric diaryl ethers.  Chapter 2.1 explains how these ethers are synthesised in 
multi-gram quantities and to allow the incorporation of large ortho substituents. 
Having a number of diaryl ethers with suitable substitution patterns to achieve 
atropisomerism, Chapter 2.2 goes on to report two novel and complimentary biocatalytic 
approaches to the enantioselective synthesis of diaryl ethers by desymmetrisation.  This 
chapter also describes a possible route towards the synthesis of a diaryl ether based 
ligand. 
Chapter 2.3 reports the lateral lithiation of meso diaryl ethers to yield diastereomeric 
atropisomers stereoselectively.  Our attempts to use (–)-sparteine in lateral lithiations to 
desymmetrise a diaryl ether enantioselectively is also described.  We go on to determine 
the configurational integrity of our organolithiums and the reaction pathway that exists in 
lithium substitution. 
Finally, the diastereoselective synthesis of both a diaryl ether (via a stereoselective 
reduction of a pro-chiral ketone) and a diaryl sulfide (via an addition reaction) is 
described in chapter 2.4.  This chapter also reports the conformational behaviour of a 
diaryl amide in solution. 
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1. Introduction 
 
During the last few decades almost no other aspect of organic synthesis has 
received as much attention as the preparation of enantiomerically pure compounds.  
From Pasteur’s 1848 separation of tartaric acid into its enantiomerically pure 
components1, novel strategies and methodologies have been sought in order to 
synthesise compounds asymmetrically. 
To this end, atropisomerism – the phenomenon of chirality due to restricted 
rotation about a single bond – has been a widely applicable area of stereochemistry.  
Since the first chiral atropisomeric biaryl2 was resolved in 1922, these complexes have 
seen development as chiral ligands for catalysis and have also been discovered in a 
range of biologically active compounds. 
This thesis is focused on research into the development of new synthetic 
methodologies for the stereoselective syntheses and reactivities of non-biaryl 
atropisomers.   The introduction will therefore discuss the importance and need for 
asymmetric synthesis, before considering the chemical and biological significance of 
atropisomers – in particular the non-biaryls – and the challenges associated with their 
stereoselective synthesis. 
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1.1 Chirality and the Need for Asymmetric Synthesis 
The word chiral comes from the Greek chaire (meaning hand) and is often 
equated to “handedness” with the left and right forms referred to as enantiomers. 
Through an increased understanding of biological processes chemists have 
acknowledged the fact that enantiopurity is related to biological properties.3  Our bodies, 
for example, are a chiral environment (the protein molecules that make up the majority 
of our receptors are made exclusively of L-amino acids) and one in which left- or right-
handedness matters.  Opposite enantiomers interact differently with these chiral 
receptors and can display various activities; these may range from distinguishable smells 
(S-limonene smells like lemons, R-limonene like oranges) and flavours, to different 
clinical effects.4 
In the case of the non-steroidal anti-inflammatory drug Naproxen, only the (S)-
enantiomer 1 has anti-inflammatory activity (Figure 1).  Marketing the drug as a racemic 
mixture would have required patients to take twice as much so its manufactures, Syntex, 
found a route to synthesise the compound in its purely active form. 
More seriously, as in the case of DOPA used in the treatment of Parkinson’s 
disease, one of the forms can have dangerous effects.  The active drug is the achiral 
compound dopamine formed enzymatically from L-DOPA 2, the isomer of which (D-
DOPA), is known to be toxic.  It is therefore essential to administer DOPA as 
enantiomerically pure L-DOPA in order to prevent the build up of D-DOPA in the body, 
which cannot be metabolised by the enzymes.  
 
Figure 1:  Chiral structures of Naproxen 1, DOPA 2 and Thalidomide 3 
Perhaps the most infamous example of the enantiomeric effects in chiral drugs is 
that of Thalidomide.  Between 1958 and 1962, the worldwide use of this racemic drug 
by pregnant women resulted in severe birth defects in approximately 10,000 children. 
Both enantiomers elicited the desired sedative effect, however the lesser sedating 
enantiomer 3 also gave teratogenic side effects.  In hindsight however, even the pure 
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(+)-enantiomer would have caused problems since the two interconvert under 
physiological conditions (Figure 1). 
Drug regulation legislation now include highly restrictive guidelines for the 
marketing of synthetic chiral drugs, requiring as much of the drug as possible to consist 
of the correct form, or enantiomer.  In 2000 40% of all drugs on the market were single 
enantiomers with an estimated 80% of all new drugs entering the market now being 
enantiomerically pure. But separating isomers is difficult; they have the same melting 
point, the same boiling point and are soluble in the same solvents.  
There are therefore three general approaches to an optically active compound;  
(1) use of the chiral pool (R-amino acids, R-hydroxyacids, etc.), (2) separation of 
racemates (classical resolution, direct crystallization, kinetic resolution using an 
enzyme), and (3) asymmetric synthesis (noncatalytic, catalytic, enzyme mediated).    
The large list of examples of manufacturing using chiral pool technology include 
the top-selling ACE inhibitors enalapril, captopril, and lisinopril, which are all derived 
from L-proline.5  However, this methodology is limited by the naturally occurring 
isomer and also by the cost; large quantities of enantiomerically pure starting materials 
can be expensive. There is an even longer list of manufacturing processes incorporating 
a resolution, including the aforementioned NSAID (S)-Naproxen.   The main problem 
with these classical resolution methods is that they are highly wasteful; the maximum 
yield can only be 50% and large quantities of high quality waste must be disposed of.   
The least precedented manufacturing processes to obtain optically active targets 
employ asymmetric synthetic methods.  Examples include catalytic asymmetric 
hydrogenation; a key step in the manufacture of the antiparkinsonian drug L-DOPA, the 
antibiotic stabilizer cilistatin, and the sweetener aspartame.   Such a small but 
compelling list of examples is indicative of the huge need to develop new methodologies 
for the asymmetric synthesis of single enantiomers. 
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1.2 Atropisomers: Discovery and Use 
The name atropisomer (from the Greek a which means not and tropos meaning 
turn) was coined by Kuhn6 in 1933 to describe molecules with a chiral axis maintained 
by hindered rotation about a single bond. This restricted rotation sees the origin of 
chirality come not from a centre or a plane, but an axis,7 and such compounds - in which 
the enantiomers can interconvert without breaking any covalent bonds - are said to 
exhibit conformational chirality, or atropisomerism, where the enantiomers are called 
atropisomers.8  
Predating Kuhn’s name for them, atropisomerism was first detected in 6,6’-
dinitro-2,2’-diphenic acid 4, the enantiomers of which were successfully resolved by 
Christie and Kenner2 in 1922 (Figure 2).  Before this, it was commonly assumed that a 
single bond could have complete free rotation at ambient temperature.  In the 1980’s, 
Oki further delineated the boundary between atropisomers and conformers (and 
therefore between configuration and conformation) with his arbitrary definition that 
atropisomers are conformers, which (at a given temperature), interconvert with a half-
life t1/2 of at least 1000s (16.7 min).9   By this definition, BINAP 5 is atropisomeric up to 
at least 200 °C, 1,1’-binaphthyl 6 ceases to be atropisomeric just below 50 °C,10 and 
butane 7 becomes atropisomeric at temperatures below about –220 °C1 (Figure 3). 
 
Figure 2: 6,6’-dinitro-2,2’-diphenic acid 
 
Figure 3: Barriers to atropisomerism 
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The steric requirements for biphenyls to exist as separable atropisomers were 
investigated by Adams11 who concluded that the ease of racemisation largely depended 
on the size of the ortho groups.   He also demonstrated that restricted bond rotation was 
present in other non-biaryls including terphenyl compounds and binuclear compounds 
such as N-phenylpyrroles.   
Bringman further affirmed the preconditions for axial chirality in his review7 of 
2005, adding that three major factors govern the minimum free energy barrier to 
rotation;  (1) the combined steric demands of substituents close to the axis; (2) the length 
and rigidity of bridges (if present); and (3) the mechanisms involved in isomerisation.  
The past 15 years have since seen specific requirements for chirality based on the C- CO 
bond of amides,42,54,69 the C-N bond of anilides12 and urea derivatives,13 the C-O bond of 
ethers25,26 and the C-S bond of sulfones14,15 be determined. 
 
Figure 4:  Atropisomeric ligands 
A high point in the history of atropisomerism, and the cause of much interest in 
these compounds, was the development of the atropisomeric diphosphine ligand BINAP 
5.  This axially chiral biaryl is used in Ru–catalysed asymmetric hydrogenations of C=O 
and C=C bonds16 and earned Noyori a share of the Nobel Prize for chemistry in 2001.  
Indeed, atropisomers have seen outstanding success as chiral ligands for metals; they 
lend themselves to use in a range of asymmetric reactions because of their ability to 
modify “bite angle” to suit metal and manner of coordination. Other examples include 
QUINAP 8, an axially chiral heteroaromatic used in (among others) Pd catalysed 
asymmetric allylic alkylations and Rh catalysed hydroborations,17 BINOL 9 and 
MeOMOP 10 (Figure 4). 
A number of important biological molecules also exhibit atropisomerism  (Figure 
5).  These include the glycopeptide antibiotic vancomycin 1218,19 which has become the 
last line of defence against methicillin-resistant S. aureus (MRSA) bacterial strains, the 
michellamine / korupensamine family of anti-HIV compounds, the anti-malarial 
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dioncophylline A, the biosynthetically remarkable longithorones 13, and the marine 
bastadins, which have a range of biological activities.20  Some limited degree of 
conformational flexibility is thought to favour binding in biological systems via the 
“induced fit”21 model and in fact a number of recently reported pharmalogically active 
compounds are atropisomeric.22  For example, compound 14 was identified as a NK1 
and NK2 antagonist and advanced as a treatment for depression.23 
In the case of vancomycin - a useful template for the design of future 
antibacterial agents – the ability to recognise and specifically bind to the D-alainine-D-
alanine terminus of bacterial cell-wall peptides is an important characteristic.24 The 
mechanism of complexation has been extensively studied and is known to be due to the 
formation of hydrogen bonds between vancomycin and bacterial dipeptide sequences; 
their formation in such an efficient manner is favoured by the rigid three-dimensional 
architecture of the molecule, brought about by the cross-linking of the constituent amino 
acids by these atropisomeric linkages.24 
 
  
Figure 5: Atropisomeric features in some natural products and pharmaceuticals 
These two respective functions – chemical and biological - can be seen as a result 
of the “adaptability” or “responsiveness” (“softness”) of the stereochemistry of 
atropisomers.  And while the vast majority of atropisomers that have been studied have 
been carbocyclic biaryls, these form only one of dozens of conceivable families of 
atropisomers.  A number of these non-biaryl atropisomers - diaryl ethers, 1825,26 diaryl 
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ureas,27 anilides,15 28,29 benzamides 17 and thioamides,30 styrenes 19 and aryl ketones,31 
N-aryl carbamates, aryl sulfides and sulfones,14,32 N-arylpyrroles 16, indoles and 
carbazoles33 among many more – may offer at least as many benefits in the fields of 
biology or catalysis as the biaryls themselves (Figure 6).   
 
Figure 6: Non-Biaryl Atropisomers 
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1.3 Non-Biaryl Atropisomers: Tools for Stereoselective Synthesis? 
Biaryls are easily the most common atropisomer and only during the last 15 years 
has the chemistry of non-biaryl atropisomers moved beyond simple structural 
observations. Some of the interesting and valuable biological properties34 of non-biaryl 
atropisomers have already been mentioned, yet the properties of abnormally large 
barriers to rotation and labile axes are also introducing a number of new concepts and 
strategies that are proving to be a useful tool in the area of stereoselective synthesis. In 
the quest for stable atropisomeric systems usable as chiral ligands, chemists have tended 
to ignore compounds close to Oki’s boundary9, presumably reasoning that they would be 
too easily racemised for general use in asymmetric reactions.  However, in recent years 
molecules close to this boundary (ie atropisomers which can be induced to isomerise by 
thermal bond rotation) have begun to facilitate insights into mechanisms,35,36,37 
structures,38,39 stereochemistry40 and synthesis. 14,41,42,43  
1.3.1 Amide axis controlled formation of new chial centres 
A central aim of the Clayden group’s research is to understand how to exert 
rational and predictable control over the conformation of acyclic molecules, especially 
those with chiral axes.  In 1998 Clayden outlined in a review44 the remarkable ability of 
rotationally restricted amides to control stereochemistry.  Here it was demonstrated that 
steric (bulky NR2) and electronic (electron rich O) contrast about a stereogenic axis 
provided a powerful stereocontrolling influence over the formation of new chiral 
centres. For example, the addition of benzaldehyde to ortho-lithiated benzamide 20 
created a new chiral centre and produced two separable diastereoisomers syn-21 and 
anti-21 with regard to the OH and the carbonyl oxygen (Scheme 1). 
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Scheme 1: Products from the addition of aldehydes to lithiated 20 
  (a) i. secBuLi, THF -78 °C; (b) R2CHO, –78 °C 
A variety of aldehyde quenches were explored with most exhibiting reasonable 
levels of diastereoselectivity in favour of the syn-conformation.   
The significant feature of this chemistry was that the stereochemistry of the non-
biaryl atropisomer was able to govern the formation of a new stereogenic centre, and a 
few research groups around the world have also demonstrated similar atroposelective 
reactions.45  
1.3.2 Utilising conformational interplay to control stereoselectivity 
The term “chiral relay” was coined by Davies46 in reference to chiral auxiliary 
controlled reactions that employ a stereogenic centre to both relay and amplify the 
stereochemical information of an existing stereocentre.  Their approach towards the 
asymmetric synthesis of α-amino acids utilised the conformationally flexible N-benzyl 
groups of 22 inserted between a stereogenic centre and a prochiral reacting site.  
Deprotonation and quenching with iodomethane yielded anti-23 in 93 % ee (Scheme 2). 
 
Scheme 2: Alkylation of amino acid derived diazines via a chiral relay                                           
(a) i. LHMDS, THF, –78 °C; ii. MeI 
During their own chiral-relay work, Clayden utilised the fact that when 
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condensed with aromatic aldehydes, (−)-ephedrine imposes a preferred orientation on 
the adjacent amide axis, which adjusts its conformation to ensure that the oxygen atoms 
of the oxazolidine and carbonyl group (and likewise their bulky substituted nitrogen 
atoms) lay on opposing faces of the ring69a (Figure 7). This control over conformation 
can then be exploited either by trapping the favoured conformer as an atropisomer (as in 
their enantioselective syntheses of atropisomers – see section x) or by using it to relay 
information about the stereochemistry of the controlling centre in order to exert control 
over the formation of a new chiral centre. 
	  
Figure 7: Predferred conformation of (–)-ephedrine adjacent to an amide axis 
Condensation of 25 with (–)-ephedrine gave 26 as a single diastereomer both at 
the new chiral centre and at the amide axis, which preferentially adopted the 
conformation shown in scheme 3.   This amide was able to retain its conformation 
through both the formylation and addition reactions, eventually leading to 28. The  
stereoselectivity of Grignard additions is governed by amide conformation and the 
reaction of 27 with PhMgBr was fully diastereoselective (Scheme 3).  
Scheme 3: 1,5-stereocontrol by stereochemical relay from an oxazolidine 
(a) (–)-ephedrine, toluene, heat 
(b) i. s-Buli ii. DMF 
(c) PhMgBr 
The operation of this stereochemical relay (also termed “chiral relay”) effect has 
also been deduced in other contexts, for example in asymmetric Diels Alder reactions.47   
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1.3.3 Non-Biaryl Atropisomers as Molecular Machines? 
Biological systems commonly transmit information on a molecular scale through 
conformational changes.  For instance, ligand-linked conformational changes in the 
allosteric protein haemoglobin affect the molecule’s binding affinity to further ligands 
thus regulating gaseous exchange and oxygen delivery in the body.  In analogous 
chemical systems, stereocontrol is the mode of communicating chemical information 
through space, where the shape or configuration of a molecule governs the reactivity and 
selectivity of reactions occurring elsewhere on the molecule.  Remote stereocontrol is of 
interest to chemists as it provides us with a model to mimic biology and enables us to 
develop a chemical method to transmit information. 
The Clayden group, who have done much work on the conformational interplay 
of aromatic amides, observed that the adjacent amides in aromatic dicarboxamides 29 
adopted a preferential conformation (lieing anti with respect to one another), suggesting 
that they were in communication despite their remoteness.   
	  
Figure 8: Conformational preference of Xanthene  
Given that Clayden could also control the conformation of an amide using the 
oxazolidine, this gave the group the ideal opportunity to combine both respective 
features of the conformational preferences of amides and perform an ultra-remote 1,23 
stereocontrol.  Trisxanthene 30 was therefore synthesised by employing a sequence of 
ortholithiation and palladium-catalysed coupling reactions followed by the addition of 
an oxazolidine (scheme 4). 
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Scheme 4: 1,23 remote stereocontrol in trisxanthene  
 (a) PhMgBr, THF, –78 °C 
As expected, the conformational preference imposed by the oxazolidine was 
propagated through the chain of amide groups and the terminal amide was then able to 
control the attack of a nucleophile at the aldehyde to afford 31 as a single diastereomer.  
Here the oxazolidine ring is shown to be transmitting conformational control by a series 
of amide-amide interactions through 23 bond lengths, a record at the time.40  So far the 
“output” of the conformational change has been a stereoselective reaction, detectable 
chromatographically or spectroscopically.  Other inputs and outputs can be envisaged, 
though: for example, the possibility that the synthetic methodology of remote 
stereocontrol might be applied to a challenge in nanotechnology – signal transduction 
and processing – is intriguing, and it is clear that the future in this area is very bright.48  
There are huge opportunities for the combination of various types of conformational 
control elements to lead not just to systems capable of relaying information but of 
processing and storing that information as well. 
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1.3.4 Non-biaryl atropisomers in catalysis and synthesis 
Atropisomeric biaryls are well established as one of the most important classes of 
ligands for asymmetric catalysis by metals,49 some of which have been mentioned in the 
previous section.  The angled aromatic rings serve as a useful scaffold for the attachment 
of metal-coordinating heteroatoms, and biaryl-complexed transition metals provide 
modern chemistry with some of its most powerful asymmetric catalysts.50   
 
Figure 9: Diarylether based ligands 
The use of non-biaryl atropisomers in catalytic applications has to date been 
limited.51  Diarylether bisphosphines (Figure 9) such as DPEPhos 32, Xantphos 33, and 
their analogues52 are wide bite angle ligands which have been used to promote metal-
catalysed hydroformylation52a and more recently also for C-H insertions,52b 
carboetherificaions52c and aminations.52e  With few exceptions,53 chiral analogues of 
these ligands are unknown and only within last decade have some useful chiral metal 
ligands based on non-biaryl atropisomers been reported by the Clayden group54 and 
others.55  In the first ever instance of a non-biaryl atropisomeric chiral ligand, Clayden54 
reported that atropisomeric amide 35 was effectively used for the asymmetric allylic 
substitution of 34 to yield 36 in 90% enantiomeric excess, ee (Scheme 5). 
 
Scheme 5: First non-biaryl atropisomeric chiral ligand 
 (a) dimethyl propanedioate, [PdCl(C3H5)]2, MeC(OSiMe3)=NSiMe3, CH2Cl2 
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However work with these types of ligands has so far been limited, perhaps due to 
the difficulty of their enantioselective synthesis and the trial and error procedure of 
matching their suitability to a reaction type. 
The field of organocatalysis is a rapidly growing area of research and currently a 
focus of several groups.56 To date most of these organoctalysts are biomolecules such as 
proline and cinchona alkaloids or derivatives of these, such as Macmillan’s 
imidazolidinones.  Other organocatalysts are related to thioureas.  Atropisomeric biaryl 
examples in this area of catalysis include NOBIN 37, a derivative of BINOL. 
 
Figure 10: Atropisomeric organocatalyst NOBIN 
Recently, JØrgensen51a reported the use of non-biaryl atropisomers as 
organocatalysts.  The catalysts, which are 6’-hydroxy cinchona alkaloids 40, feature 
atropisomeric functionalisation at position 5’ of the quinoline core.  These molecules are 
organocatalysts for the Michael addition of β-keto esters to acrolein and methyl vinyl 
ketone as well as for the asymmetric Friedel-Crafts amination of a range of 2-naphthols 
(Scheme 6). 
	  
 
Scheme 6: Non-biaryl atropisomeric organocatalysis 
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Enantioselective synthesis using non-biaryls, especially anilides and their 
derivatives, has been the research interest of numerous groups.  The group of Taguchi 
has generated many examples in this area, and he recently utilized an enantioselective N-
arylation57 of 42 to synthesise atropisomeric anilide derivatives which were then used in 
the enantioselective synthesis of NET inhibitors (Scheme 7).58 
 
Scheme 7: Taguchi’s enentioselective synthesis of a NET inhibitor 
(a) Pd(OAc)2, (S)-BINAP, Cs2CO3, toluene, 80 °C 
(b) i. Li-TMP; ii. Allyl-Br 
(c) i. 9-BBN; ii. NaOH, H2O2 
(d) AlCl3, C6H6, 80 °C 
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1.4 Asymmetric Synthesis of Atropisomers 
The asymmetric synthesis of atropisomers (of any sort) is a field which has been 
remarkably slow to develop, principally because of the difficulty of combining the 
formation of necessarily hindered biaryl couplings with stereochemical control.59,60  
While there are an increasing number of asymmetric methods for the construction of 
atropisomeric biaryls by asymmetric coupling methods, almost all practical syntheses of 
ligands rely on resolution.61,62 
1.4.1 Asymmetric coupling methods 
Asymmetric coupling methods involve the simultaneous joining of the two 
aromatic portions with asymmetric induction.  This can either be diastereoselectivly – 
using a chiral tether / auxillary / or other traceless agent whose source of asymmetry is 
incorporated into the coupling and then removed – or enantioselectively via the use of a 
metal catalysed cross coupling reaction with a chiral ligand. 
1.4.1.1 Use of a chiral tether 
Lin used a tartaric acid derived chiral bridging unit in the total synthesis of (+)-kotanin 
50 (Scheme 8).35 The origin of the selectivity observed in this oxidative coupling 
reaction was proposed by Sargent,36  who suggested that the cyano cuprate intermediate 
49 adopts  gauche conformation 49a rather than a diaxial conformation, 49b. 
  
Scheme 8: Key step in the synthesis of (+)-kotanin35 
 (a) i. tertBuLi; ii. CuCN; iii. O2, THF -78 °C 
O
O
MeO
Br
Br
MeO
Me
OBn
OBn
a OBn
OBn
O
O
MeO
MeO
MeMe
Me
48
50
H
CH2OBnO
H
O CH2OBn
CH2OBn
O H
CH2OBn
HO
49a 49b
Vs.
O
O
O
OMeO
Me OMe
Me OMe
MeO
(+)-kotanin 51
 35 
1.4.1.2 Chiral auxilliaries 
The use of chiral auxiliaries on one of the aromatic components, rather than a 
chiral link, in a biaryl coupling allows much more freedom of the substituents on the 
second aromatic unit.  Better transfer of stereochemical information is achieved when 
the auxiliary is placed ortho to the coupling site.7 
The first highly selective biaryl coupling using a non-bridging chiral auxiliary 
was reported by Meyers in 1982,38 whereby an oxazoline derived from (+)-1-methoxy-2-
amino-3-phenyl-3-hydroxypropanol activated an ortho methoxy group to nucleophilic 
aromatic substitution by a naphthyl Grignard reagent.  This generated binaphthyl 54 with 
92:8 dr and in 65 % yield (Scheme 9).38   
 
Scheme 9: Meyers’ oxazoline auxiliary in diastereoselective synthesis of binaphthyl38 
The major disadvantages of using chiral auxiliaries are the added steps in 
synthesis required to introduce and remove the auxiliary.  Also, as can be seen above, 
the auxiliary limits the substitution pattern in the ortho positions.  
Transition metal – arene complexes, in which the metal is bound to the aromatic 
ring by η6 coordination, have planar chirality.  Uemura et al. exploited this in the 
synthesis of biphenyls by coupling planar-chiral bromoarenes 56 with boronic acids in a 
Suzuki coupling reaction (scheme 10).  Cross coupling of the planar-chiral aryl bromides 
with aryl boronic acids was highly diastereoselective, achieveing at least 97: 3 
selectivity for either the syn or anti atropisomer 57, depending on the substitution 
pattern.44 
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Scheme 10: Diastereoselective Suzuki cross coupling of planar chiral aryl bromides with boronic acids43 
(a) [Pd(PPh4)], Na2CO3, MeOH / H2O 
1.4.1.3 Metal-catalysed asymmetric cross-coupling 
Hayashi pioneered the use of chiral ligands in asymmetric cross coupling 
reactions. A nickel-catalyzed coupling of naphthyl Grignard reagents with naphthyl 
bromides (Kumada cross coupling) in the presence of the ligand 60 was achieved with 
enantiomeric ratios of up to 98:2 and excellent yields (Scheme 11, Table 1).56 
 
Scheme 11: Asymmetric Kumada cross coupling in the enantioselective synthesis of binaphthyls56 
(a) 60 (4-10 mol% ), NiBr2 (2-5 mol%), Et2O/toluene, -10 °C 
R Ligand (R’) Yield er 
H H 81 % 51:49 
H OMe 92 % 91.5:8.5 
Me OMe 69 % 97.5:2.5 
Table 1: Asymmetric Kumada cross coupling in the enantioselective synthesis of binaphthyls56 
The most successful asymmetric synthesis of atropisomeric biaryls so far using a 
Suzuki coupling was published by Buchwald et al. (Scheme 12, Table 2).60 
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Scheme 12: Suzuki coupling in the asymmetric synthesis of biaryls.60  
                     [*] configuration at axis unknown. 
 (a) 64 (0.8 – 3.3 mol%), [Pd2(dba)2] (0.5 – 0.2 mol%), K3PO4, toluene, 60-80 °C 
R R’ Yield er 
Me Et 98% 95.5:6.5 
Et Et 96% 96:4 
i-Pr Et 89% 92.5:7.5 
Ph Et 74% 87:13 
Me Me 91% 92:8 
Me Me 95% 93:7 
Table 2: Yields and enantioselectivities for the asymmetric synthesis of Suzuki coupled biaryls.60  
                      
As little as 0.2 mol % of the catalyst can be used without any loss of 
enantiomeric excess in the products.  The presence of the phosphonate group is not 
essential to achieve the high levels of enantioselectivity but it can be converted into a 
PPh2 group thus allowing the synthesis of axially chiral monodentate ligands.60 
1.4.2 Classic resolution 
The enantiomeric synthesis of BINAP 4 employs a resolution of bis-phosphine oxide 66.  
One enantiomer of the compound forms a much more crystalline 1:1 complex with di-O-
benzoyl tartrate than the other, leading to the fortuitous synthesis of both the R and S 
forms 61 (Scheme 13). 
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Scheme 13: Synthesis of BINAP by Classic Resolution 
(a) i..(–)-di-O-benzoyl-L-tartrate or (+)-di-O-benzoyl-D-tartrate; ii. Fractional crystallisation, 
iii. Base; iv. HSiCl3, Et3N 
Classical resolution methods have also been utilised to publish the first total 
synthesis of Murrastifoline-F,63 a naturally occurring member of the carbazole alkaloids, 
while Malkov and Kokovsky’s technique of co-crystalising with S-(-)-BINOL afforded 
them their catalyst64 for the asymmetric allylation of aromatic aldehydes.  
Despite their common utility, however, there exist a number of drawbacks with 
the above-described methods, namely; (1) The acidic or basic groups required for 
resolution are rarely present in a final target ligand, placing constraints on the choice of 
synthetic route and therefore the ability to vary a single route to provide a range of 
ligands; and (2) often only one enantiomer of a particular syntheses is required, leading 
to a maximum 50% yield. 
Recent approaches towards the synthesis of atropisomers have aimed to exploit 
the potential dynamic nature of axial chemistry and indeed progress has been made 
towards the synthesis of atropisomers via kinetic resolution65,66 and dynamic resolution 
under kinetic67,68 or thermodynamic42,43,54,69,70 control.  
 
1.4.3 Kinetic resolution methods 
Kinetic resolution methods make use of the fact that when two enantiomers show 
different reaction rates, one enantiomer is converted while an excess of the less reactive 
enantiomer can be recovered in an enantioenriched form.  Clayden recently employed 
such a strategy during the first asymmetric synthesis of an atropisomeric urea (Scheme 
14). 65  
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Scheme 14: Asymmetric Synthesis of an Atropisomeric Urea by Kinetic Resolution 
(a) H2O2, VO(acac)2,  ligand 68 
This method for KR employed an asymmetric oxidation of 67 in the presence of 
a ligand to generate anti-69 in good enantiomeric excess (86:14).  The reaction reached 
no further than 50% completion, with the remaining sulfide (+)-67 isolated in 30% yield 
and with 97:3 er. 
 
1.4.4 Dynamic Kinetic resolution 
Dynamic resolution methods tackle the obvious drawbacks of the above-
described system, namely that the maximum conversion in the reaction is only 50% and 
that the product has to be separated from the reactants.   The inherent kinetic lability of 
atropisomers makes them especially suited to this process.  
 If a chirally labile substrate can interconvert faster than it can react, the reaction 
proceeds with one enantiomer reacting faster than the other but the equilibrium 
continually shifting to obtain a 50:50 mixture of the remaining starting material; the 
faster-reacting enantiomer is therefore continually replenished at the expense of the 
slower-reacting enantiomer, making it theoretically possible to convert the achiral 
reactant with 100% completion. 
Both the Clayden67 group and others68 have exploited its use in synthesis, with 
Bringmann et al.68a utilising a DKR to yield either enantiomer of the natural product 
Mastigophorene.  
 In a simple example shown in scheme 15, two lactones 70a and 70b are 
enantiomeric conformers even at 240 °C, and interconvert rapidly on the timescale of 
their reduction by the BINAL reagent 71. One of them (70a) reacts faster than the other, 
and generates a product 72a which, because it lacks the bridging lactone linkage, is 
atropisomeric up to ambient temperature and beyond. As 70a reacts, equilibrium with 
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70b is continually restored, and eventually a product 72a is formed in good yield (80%) 
and with good enantioselectivity (88:12). 
 
Scheme 15: Bringmann’s method for dynamic kinetic resolution 
 
1.4.5 Thermodynamic Resolutions 
Thermodynamic control is particularly suited to compounds for which 
stereoisomeric interconversion can be achieved via a simple mechanism — thermally 
induced bond rotation in the case of atropisomers. This concept has been realised by 
Meyers who demonstrated that thermodynamic control can be used in the asymmetric 
synthesis of chiral biaryls 7471 via copper mediated Ullmann coupling of o-
bromoaryloxazolines 73 (Scheme 16).  
 
Scheme 16: Meyers thermodynamic resolution of  o-bromoaryloxazolines 
(a) Cu, solvent, heat 
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Thermodynamic resolution was also the method of choice for the 
enantioselective synthesis of the atropisomeric chiral amide ligand 35, the application of 
which was seen in section 1.3.4.  Moreover, the procedure became the first instance of 
an amide being made enantioselectively (Scheme 17). 
 
Scheme 17: Thermodynamic resolution in the synthesis of ligand 35 
(a) i. s-BuLi, (–)-sparteine; ii. Me3SiCl  
(b) (a) i. s-BuLi; ii. Ph2PCl  
(c) TBAF 
A stereogenic centre was constructed enantioselectively adjacent to an otherwise 
freely rotating (i.e. kinetically unconstrained) axis, leading to the synthesis of 76.  The 
benzamide, which prefers to adopt principally conformation syn-76 has only a low 
kinetic barrier to rotational interconversion between its conformers, but this changes 
when the major conformer is trapped as a major atropisomer by increasing the steric 
hindrance to rotation about the axis. Lithiation and substitution of 76 introduces a kinetic 
barrier to conformer (now atropisomer) interconversion, thus allowing the major 
atropisomer syn-35 to be obtained, after purification, enantiomerically and  
diastereoisomerically pure.  
Finally, removal of the stereogenic centre (by desilylation in this case) provides a 
single atropisomeric enantiomer of the phosphine (S)-77, which, despite the loss of a 
thermodynamic preference for one atropisomer over the other, was unable to relax to 
thermodynamic equilibrium with (R)-77 because of the residual kinetic barrier to 
rotation provided by the Et and PPh2 groups.  
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1.4.5.1 Thermodynamic resolution: application to the first asymmetric synthesis of 
Vancomycin 
 Vancomycin 1218,19 (the biological benefits of which were discussed in section 
1.2), remains the only natural product thus far published where the atropisomeric diaryl 
ethers contained within its framework are synthesised asymmetrically. Its aglycon is 
considered to consist of three interlocking cyclic tripeptides that collectively give rise to 
a conformationally rigid cup-shaped structure; these are usually referred to as the AB, C-
O-D and D-O-E ring systems (Figure 11).  Construction of each of the constituent 
macrocycles must be carried out in such a way that this skeleton is produced in only one 
of eight possible atropdiastereomers; the magnitude of this challenge is testified by the 
fact that more than 40 years passed between the first isolation of vancomycin and its first 
successful total synthesis.18a 
 
Figure 11: Structure of Vancomycin aglycon 
Much literature has delved into the diversity of synthetic approaches that can be 
applied to its synthesis, most notably the review by Nicolaou,18 however for the 
purposes of this report only the synthesis of the diaryl ether containing rings will be 
discussed. 
Of the three reported syntheses, that of Evans19b is chronologically the first. 
Here, Evans found that SNAr ether formation (and subsequent macrocylisation) with a 
nitro group meta to the chlorine in 78 afforded the desired atropisomer as a 5:1 mixture, 
although no explanation for the observed selectivity was given (scheme 18).   It was then 
a simple task to diazotise the nitro group followed by reduction to yield the desired 
monochloride in enantiomerically enriched form. 
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Scheme 18:  Selective ring closing of C-O-D ring system 
(a) Na2CO3, DMSO, rt, 1.5h 
 
 The substitution pattern of the aromatic ring was found to play a key role in 
determining the atropisomer bias in the C-O-D macrocycle in 79; if a non-chlorinated 
analogue of 78 was cyclised in the same way - via SNAr - the predominant product 
became the undesired atropisomer in a ratio of 10:1.  Evans therefore utilised this 
strategy in the similar intramolecular SNAr ring closing of the D-O-E cycle by placing a 
single nitro group on the ring, which preferentially sat on the back face of 81 and was 
then later converted to the naturally present chloro derivative (scheme 19). 
 
 
Scheme 19: Selective ring closing of D-O-E ring system 
 (a) CsF, DMSO, rt, 1.5h  
 (b) i. Zn(0), HOAc, EtOH, 40 °C; ii. NaNO2, H3PO2, cat. Cu2O, THF/H2O, 0 °C; iii. CuCl,  
CuCl2 
 Nicolaou et al.18b published a rather more elegant synthesis employing a bulky 
auxiliary designed to direct the chlorines into the desired orientation by minimising 
unfavourable steric interactions.  The strategy relied on attaching a bulky substituent 
onto ring “C” ring of 82 that would cause an unfavourable interaction with the hydroxyl 
moiety on the neighbouring amino acid as in 83a (Scheme 20).  Rotation of the aromatic 
ring to 83b to reduce steric clashes coupled with a chelating group on the hydroxyl of 
central ring D, ensured stereoselective ring formation.  Metal triazine mediated ring 
closure then formed the macrocyclised product 84 as a single atropisomer in excellent 
yield. 
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Scheme 20:  Nicolaou’s Asymmetric synthesis of the C-O-D ring system of Vancomycin 
 
 Boger’s synthesis19 utilised similar SNAr ether formation to that used by Evans 
for ring closure of both the C-O-D and D-O-E macrocycles.  However, while Evans 
controlled the conformation of the ether axis during the formation of the linkage, Boger 
formed the ring systems in racemic form, separated the diastereoisomers, equilibrated 
the “wrong” isomer back to the equilibrium mixture and then repeated the steps in order 
to afford the desired atropisomer in enriched form.   
1.4.6 Dynamic Thermodynamic Resolutions 
Dynamic thermodynamic resolution is a practically more straightforward method 
than described above, and makes use of the potential thermal lability of the 
atropisomeric axis. In the example illustrated in scheme 21 - the first enantioselective 
synthesis of an atropisomeric diaryl ether – the synthesis began with racemic 
atropisomer 85. This compound was converted to a diastereomeric (and therefore 
energetically non-equivalent) mixture of atropisomers, each enantiomerically pure, by 
reaction with an enantiomerically pure “resolving agent”.  In this case a sulfoxide (68) 
was used, although centres such as proline-derived aminals and ephedrine derived 
oxazolidines have been utilised in similar chiral syntheses. 
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Resolution is then achieved not by discarding 50% of the material, but simply by 
heating.  The “near atropisomers” are equilibrated to gain the thermodynamically 
favoured conformation, which can itself be isolated in enantioenriched form by means of 
addition of a bulky substituent to prevent rotation, followed by removal of the auxiliary. 
In this case, the chirality of the sulfoxide was destroyed by oxidation to the 
corresponding sulfone to provide atropisomer 88 in up to 95:5 er.43 
 
Scheme 21: Synthesis of enantiomerically enriched atropisomeric diaryl ethers by dynamic thermodynamic 
resolution using an ortho sulfoxide auxiliary 
(a) nBuLi, THF, -78 °C, 1 min 
(b) sulfoxide 86 , -78 °C to +20 °C, 16h 
(c) mCPBA, CH2Cl2, 0 °C 
 The observed stereochemical control in the diaryl ether series is proposed to arise 
from a combination of steric and electronic effects. Dipole repulsion between the S-O 
bond and the proximal Ar-O bond of the ether, in combination with steric repulsion 
between the aryl and alkyl substituents of the sulfoxide group, favors conformations in 
which a lone pair of electrons of the sulfoxide group eclipses, or lies gauche to, the 
proximal Ar-O bond (Figure 12).  
 
Figure 12: Conformational preference in sulfinyl ethers 
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Steric repulsion between the ether substituents (the upper ring) and the alkyl 
substituent on the sulfoxide group then favor Ar-O-Ar’ conformer A over conformer B. 
Such a rationale is in accordance with the observed increased selectivity afforded by 
bulkier substituents α and ortho to the sulfoxide group (Table 3). 
Entry R2’ R6 R3 R Ratio 87a:87b 
1 tBu CN H iPr 57:43 
2 tBu CN Et iPr 66:34 
3 tBu CH2OMe H tBu 86:14 
4 tBu CH2OMe Me tBu 95:5 
5 tBu CH2OMe Me C(Me)(CH2)5 94:6 
6 tBu CH2OMe Et C(Me)(CH2)5 93:7 
7 iPr CH2OMe H tBu 98:2 
8 iPr CH2OMe H iPr 83:17 
Table 3: Diastereoselectivities in ortho sulfoxide substituted biaryl ethers 
Overall, resolution is achieved dynamically (no material is wasted) and under 
thermodynamic and not kinetic control.  Using this highly versatile procedure, Clayden 
et al. have enantioselectively synthesised a variety of atropisomers including 
atropisomeric amides,42,54,69 ethers,43 sulfones, and even the binapthyl ligand QUINAP70 
5. 
1.4.7 Aromatic ring construction 
A fundamentally new strategy has recently emerged in the construction of chiral 
biaryl compounds in which a preformed aryl-C bond is transformed atropselectively into 
the biaryl axis upon construction of the second aromatic ring. 
The groups of Gutnov and of Heller synthesised axially chiral 2-aryl pyridines by 
a catalytic asymmetric [2+2+2] cycloaddition.72  The reaction of the 1-naphthyl diyne 89 
with alkyl or aryl nitriles in the presence of the cobalt catalyst 90 gave the pyridines 91 
in good yields and up to 88% ee (Scheme 22). 
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Scheme 22: Asymmetric synthesis of a biaryl by construction of an aromatic ring 
 (a) 1 mol % 90, hv (wavelength = 420 nm), THF, 3 °C 
This work has recently been extended by Tanaka et al. who have developed 
hindered, axially chiral anilides73 94 in >99% ee using Rh(I)-catalysed cycloaddition of 
1,6-diynes 92 with trimethylsilylynamides 93 to control the conformation of the chiral 
axis during the ring closing step (Scheme 23).  
 
Scheme 23: Atroposelective formation of anilides by construction of an aromatic ring 
(a) 10 mol% [Rh(COD)2]BF4, (S)-xyl BINAP, DCM, rt, 16h 
                      X = NSO2(4-BrC6H4 
1.4.8 Desymmetrisation methods 
The desymmetrisation of symmetric compounds consists of a modification that 
eliminates one or more elements of symmetry from the starting compound. In the case of 
the biaryls, desymmetrisation introduces asymmetry to the molecule and leads to an 
axially chiral product. 
1.4.8.1 Chemical Desymmetrisation 
Raston et al.83b (scheme 24) performed an enantioselective dilithiation of the 
axially prostereogenic tetra-ortho-methylated biphenyl 95 in the presence of the chiral 
ligand (–)-sparteine.  An electrophilic quench with carbon dioxide followed, and lead to 
the synthesis of diacid 96 with moderate stereocontrol (40% ee).  
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Scheme 24: Desymmetrisation via enantioselective dilithiation 
 (a) i. nBuli, (–)-sparteine; ii. CO2 
As with the biaryls, axial chemistry in atropisomeric amides may be introduced 
by stereochemical control in the atroposelective reactions of planar chiral complexes. 74	  	   
Enantioselective lithiation was reported in this context by Uemura75 who showed that 
the achiral complex 97 could be enantioselectively deprotonated by treatment with a 
chiral lithiumamide base 98 (Scheme 25).  The stereogenic C-C and C-N axes in these 
compounds were orientated such that the larger NR2 and acyl groups were directed away 
from the chromium, and after decomplexation returned atropisomer 99 in excellent yield 
and enantioselectivity.  
 
Scheme 25: Atroposelective reactions of planar chiral complexes 
 (a) i. 98, THF, -78 °C to -30 °C; ii. MeI; iii. hv, O2 
Harada83d desymmetrised tetra-ortho-hydroxybiphenyl through a 
diastereoselective formation of an eight-membered diether bridge while, more recently, 
Hayashi83c has developed a remarkable enantio-differentiating cross coupling reaction of 
ditriflates.  Here he used Grignard reagents in the presence of an enantiomerically pure 
palladium complex 101 to form desymmetrised axially chiral biaryl 102 in good yield 
with high enantioselectivities (Scheme 26, Table 4). 
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Scheme 26: Enantioselective desymmetrisation of ditriflates by Palladium catalysed cross coupling  
 (a) LiBr or LiI, 5 mol % 101 
R R’ X Yield / % er 
Benzo Benzo Ph 92 % 97:3 
Benzo Benzo m-tol 90 % 97.5:2.5 
Benzo Benzo 
 
88 % 96:4 
Ph H Ph 80 % 97:3 
Ph H 
 
88 % >99:1 
Me H Ph 85 % 97.5:2.5 
Me H 
 
87 % 92.5:7.5 
Table 4: Yields and enantioselectivities for desymmetrisation of ditriflates 
The triflate group remaining in the product can be subjected to a further cross 
coupling reaction allowing the synthesis of a wide range of biaryls, including 
monophosphine 104 (Scheme 27) which was demonstrated to be useful as a ligand in the 
hydro silylation reaction of styrene giving 85 % yield and 95:5 er. 67 
 
Scheme 27: Further manipulation to desymmetrised triflate, synthesis of atropisomeric phosphine67 
 (a) i. Ph2P(O)H, Pd (OAc)2/dppp, i-Pr2NEt; ii. HSiCl3, MeOH 
1.4.8.2 Atroposelective Enzymatic Desymmetrisation 
The Enzyme Commisson has classified enzymes in six main groups according to 
the type of reaction they catalyse76:  (1) Oxidoreductases; (2) Transferases; (3) 
Hydrolases; (4) Lyases; (5) Isomerases; (6) Ligases. Enzymes from groups 1 through 4, 
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especially hydrolytic enzymes, have found broad application in organic 
transformations.77 
In an approach by Matsumoto et al.78, the enzymes Candida antarctica lipase 
(CAL) and Pseudomonas cepacia lipase (PCL) were used to enantiselectively 
monohydrolyse (and therefore desymmetrise) the prochiral diacetoxy biaryls 105.  The 
axially chiral 2-acetoxy-6-hydroxy biaryls 106 were obtained in moderate to high yields 
(51-94%) and excellent enantioselectivities (≥96% ee), even for derivatives bearing 
small substituents (e.g. R=Me).  In all cases, the M atropisomer predominated, although 
no stereochemical rationale was given (Scheme 28, Table 5). 
 
Scheme 28: Enzymatic desymmetrisation of axially chiral biaryl 105  
 (a) Lipase, phosphate buffer (pH = 7), 30-35 °C, 1-7 days 
 R Me Et CH2OBn 2,3-benzo 
Lipase Yield  er Yield  er Yield  er Yield  er 
Candida antarctica 80 % 98:2 57 % >99:1 68 % >99:1 72 % 98:2 
Pseudomonas cepacia 86 % >99:1 67 % 98:2 51 % 99:1 94 % 99:1 
Pseudomonas fluorescens       82 % 89:11 
Table 5: Yields and enantioselectivities for the enzymatic desymmetrisation of axially chiral biaryl 105 
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1.5 Aims of the Project 
Members of the diaryl ether family of compounds79 have diverse functions as 
mammalian hormones (thyroxine),80 powerful antibiotics (vancomycin, teicoplanin, 
ristocetin),18,81 and ligands for transition-metal-promoted hydroformylation (bis(2-
diphenylphosphinophenyl)ether; DPEphos).52  They are also present in a range of natural 
products including the bastadins, perottetines, riccardin B, and cyclic peptide K3.20,82 
Their synthetic utility is limited however, until these compounds can be 
synthesised efficiently in a stereoselective fashion.  Unfortunately (with the notable 
exception of vancomycin) this has been an area that has seen relatively little success.  
The main obstacle preventing their development seems to be the difficulty of combining 
the formation of necessarily hindered biaryl couplings with an aspect of stereocontrol. 
 Although the synthesis of enantiomerically enriched diaryl ethers based on a tert-
butyl substituted aryl ring was successful (as described in the enantioselective synthesis 
in section 1.4.1), the barrier to rotation was still slightly lower than would be desirable 
for stable chirality.  Synthesis of sulfoxides based on the bulkier i-propyl-methyl 
substituted ring were attempted, however the yields were extremely poor compared with 
the singly substituted analogues (Scheme 29, Table 6). 
 
Scheme 29: Increasing the barrier to rotation in the diaryl ethers 
(a) nBuLi, -78 °C, THF, 1 min, then 86 
Substitution 
108 R R1 R2 Yield / % 
a iPr iPr Me 0 
b Cychex iPr Me 4 
c Tol iPr Me 4 
d CycHex tBu H 66 
Table 6: Increasing the barrier to rotation in the diaryl ethers 
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An alternative and relatively undeveloped approach towards the asymmetric 
synthesis of diaryl ether atropisomers would be to use desymmetrisation methods. As 
discussed in section 1.4.8, if at least one of the two aromatic rings is symmetrically 
substituted, then an enantioposition-differentiating transformation of one substituent will 
reduce the symmetry and lead to an axially chiral compound.    
The main strategies; those of enantioselective lithiations and enantioselective 
enzymatic reactions, have proved to work well with biaryl atropisomers and with 
organic molecules in general, but few examples exist as to their utilisation in non-biaryl 
systems and the use of desymmetrisation for the synthesis of single atropisomers is 
rare.83 
It is therefore the aim of this report to utilise the methodologies outlined above in 
order to synthesise enantiomerically enriched diaryl ethers.  Their requirements for 
chirality have recently been established, so it is envisaged that once a method for their 
enantioselective synthesis is in hand, further evaluations into their synthetic utility 
(either as ligands or as units in natural product synthesise) can be made. 
Previous work carried out by the Clayden group has already established that the 
diaryl ether and diaryl sulfide linkage can form a chiral axis, and that the 
stereochemistry of this axis can be controlled by a neighbouring chiral auxiliary such as 
a sulfoxide (see section 1.4.6).  However, this work did not investigate the ability of 
achieving stereocontrol via the controlling influence of the axis.  Utilising similar 
strategies to those discussed in section 1.3  for the benzamide class of atropisomers, we 
also aimed to explore the stereoselectivity of the reactions of atropisomers based on this 
Ar-X-Ar framework. 
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2. Results and Discussion 
 
2.1 Synthesis of Diaryl Ethers 
Multi-gram quantities of diaryl ether linked compounds were required for use in 
a number of the stereoselective reactions and investigations contained within this thesis.  
A synthetic strategy was therefore sought in which to sythesise analogues of these 
compounds on a large scale. 
 
2.1.1 Diaryl ether synthesis and requirements for chirality 
The preconditions for axial stability in the diaryl ethers were fully elucidated by 
Clayden et al.26 in 2006, where it was observed that atropisomerism in this class of 
compound can be exhibited provided certain structural conditions are fulfilled (Table 7).  
A comprehensive investigation into the mechanism of interconversion suggested that the 
potential for chirality depended less on the number of substituents than the substitution 
pattern.26 Atropisomerism was exhibited when one of the substituents was as large as a t-
butyl and when there were at least 3 substituents ortho to the ether axis. Ethers based on 
this framework were therefore the targets for synthesis. 
 
 
 
 
Table 7: Barriers to rotation in diaryl ethers 
The classic approach to diaryl ether synthesis is the metal catalysed Ullman 
coupling reaction.  Initial synthetic work done by Boger19c during the synthesis of 
O R2
R1
109
HO OH
R3 R4
Entry R1 R2 R3 R4 ΔG≠kJmol-1 t½25°C 
1 iPr H Me H epimerisation < 1 µS 
2 iPr iPr H H < 37 < 1 µS 
3 iPr iPr Me Me < 37 < 1 µS 
4 iPr H Me Me 90.9 8 mins 
5 tBu H Me H 105 20h 
6 tBu H Me Me 113.5 50 days 
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vancomycin utilised an Ullman macrocyclisation to form the diaryl ether linkages of the 
final product.  However, the harsh conditions of the traditional Ullmann coupling are not 
applicable to a wide variety of functional groups and so the search for a milder method 
of forming diaryl ethers has taken many forms.  
Ullmann couplings of phenols and aryl halides under milder conditions have 
been reported by Cristau et al.84 who reported high yielding reactions of aryl halides 
with phenols in acetonitrile using Cs2CO3 and catalytic copper (I) oxide in the presence 
of ligand 110 (Table 8).  
 
Entry R1 R2 X Time / h T /°C Yield / % 
1 H H Br 90 110 100 
2 H H I 24 82 100 
3 H 2-Me I 40 82 93 
4 2-Me 2-Me I 35 110 98 
Table 8: Ullmann coupling results published by Cristau84 
Although yields for the couplings were excellent the most hindered ether 
synthesised was di-ortho-methyl (entry 4), making this approach inappropriate for 
installing the large degree of hindrance around the axis required to observe 
atropisomerism. 
The Buchwald group has also developed a series of ligands that promote the 
coupling of phenols with aryl halides, and have recently reported85 the use of ligand 111 
to aid the formation of a variety of ortho-substituted diaryl ethers in excellent yield 
(Table 9). 
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Entry R1 R2 X T / °C Yield / % 
1 4-CN H Br 100 94 
2 4-CN 2-iPr Br 100 84 
3 3-NMe2 2-tBu Cl 100 88 
4 2-CO2Me 2-iPr Br 100 78 
5 2,5-di-Me 2-Me Br 100 92 
6 2-Me 2-iPr Br 100 84 
Table 9: Pd-catalysed coupling results published by Buchwald 
Again, although Buchwald and co-workers managed to install a greater degree of 
steric hindrance ortho to the axis than in the corresponding Ullmann coupling, it can still 
be seen that as substituent size in this position increases, yields for the etherification 
invariably decrease.  The publication also reported that it was not possible to synthesise 
ethers with greater than two ortho-substituents thus making this method inappropriate 
for the installation of high degrees of steric hindrance. 
An alternative approach to the formation of hindered diaryls is the employment 
of an SNAr reaction.  Simple aryl halides do not undergo SN1 or SN2 reactions however 
the installation of strongly electron-withdrawing substituents in the ortho and/or para 
positions can promote SNAr.  The electron withdrawing groups (EWG) of compound 
112 reduces the electron density of the π-system and allows the nucleophile (Nu-) to 
approach the ring and form a negatively charged sigma complex, stabilised by de-
localisation of the negative charge onto the electron withdrawing groups.  The forward 
reaction then eliminates the chloride anion and reforms the aromatic ring (Scheme 30). 
 
Scheme 30:  SNAr facilitated by ortho-electron withdrawing groups 
Mazzocchi et al.86 reported forming diaryl ethers by substitution of aryl bromides 
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with Group I metal phenoxides.  They synthesised a range of diaryl ethers as models of 
thyroid hormones for conformational studies.  Both sodium and potassium stabilised 
phenoxides were utilised as reacting partners for the aryl bromides.  This method avoids 
the requirement for expensive catalysts and was thought to be versatile enough to be 
used for the desired application. 
SNAr is generally less sensitive to steric hindrance than the metal catalysed 
coupling reactions and was therefore the method selected for the construction of the 
diaryl ethers described in this work. 
2.1.2 Synthetic Strategy 
Krizan and co-workers87 reported the selective lithiation and subsequent 
chlorination of isophthalonitrile 115 to yield 116 in excellent yield (Scheme 31), thus 
providing a reliable route to an activated aryl chloride partner that could undergo the 
required SNAr.  
 
Scheme 31: Chlorination of isophthalonitrile as reported by Krizan 
(a) i) LDA, THF, –95 °C, 1 h. ii) Cl3CCCl3, –78 ºC - 20 °C, 16 h 
These methods were therefore selected to afford a viable route to a range of pro-
atropisomeric diaryl ethers, as outlined in Scheme 32.  
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Scheme 32:  Synthetic route towards potentially atropisomeric diaryl ethers 
(a) i. LDA, THF, –95 °C, 1 h; ii. Cl3CCCl3, –78 ºC - 20 °C, 16 h 
(b) i. DiBAL-H, –78 °C ,16 h; ii. HCl, H2O, 1 h 
(c) NaBH4, THF, 16 h 
The chlorinated compound 116, prepared via selective lithiation with LDA at -98 
°C followed by a Cl3CCCl3 quench, can be coupled with an appropriate phenoxide to 
give the dinitrile ether 117. Reduction to the di-imine with DiBAl-H followed by acid 
hydrolysis will yield dialdehyde 118, which on treatment with NaBH4 will generate the 
final synthetic target 119. 
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2.1.3 Chlorination 
Directed lithiation of 1,3-dicyanobenzene 115 using LDA at -95°C followed by a 
hexachloroethane quench yielded the desired chloride 116 in up to 89% yield (Table 10). 
 
Entry Temp
[a] 
/ oC Scale
[c] Temp
[b] of 
C2Cl6 / °C 
Solvent Yield / % 
1 –78 5g RT THF 15 
2 –95 5g RT THF 70-89 
3 -95 5g RT Toluene 49 
4 –95 10g RT THF 48 
5 -95 10g -5  THF 70 
6 -95 20g RT THF 69[d] 
7 -95 20g 10  THF 36 
Table 10:  Yields and conditions of chlorination 
[a] Temperature of reaction taken as the temperature of the solution of LDA before and 
during the addition of 115 and C2Cl6 [b] Taken as the temperature of the dissolved C2Cl6 
before addition to deprotonated 115 [c] Scale based on the amount of 115 used in the 
reaction [d] Reaction carried out in a completely sealed reaction vessel with slow, 
controlled addition of reagents under vacuum 
The reaction was seen to be extremely temperature dependent: lithiation and 
quench at -78°C resulted in only a 15% conversion to the product (entry 1).  
Furthermore, increasing quantities of starting materials above a 5g scale resulted in the 
mass recovery of 116 remaining the same (entries 2  4).  Thus in order to obtain the 
quantities required for bulk synthesis, we were required to synthesise 116 in batches. 
It was envisaged that a scale up of the reaction could be achieved by cooling both 
substrate 115 and the C2Cl6 quench to -95°C before the addition to LDA.  However, 
attempts at cooling 115 were completely unsuccessful owing to its insolubility in THF 
below rt. Attempts to find a suitable solvent in which 115 could show improved 
solubility were also unsuccesful. 
Improved success was observed on cooling the hexachloroethane quench, which 
remained in solution at -10°C when adequately diluted.  Unfortunately, on a scale of 30g 
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it was not possible (owing to the limiting size of the reactant cooling vessel) to achieve 
the necessary dilution at lower temperatures, and precipitation occurred.   
Greater success was achieved by conducting the experiment using Schlenk 
apparatus and by using a vacuum assisted dropwise addition of both 115 and the 
hexachloroethane quench (entry 6). 
The importance of purification was also highlighted during this synthesis: both 
flash column chromatography (where elution of 116 from its close running impurities 
was slow) and crystalisation of 116 from IPA appeared to provide similar levels of 
purification by 1H NMR analysis.  However, excess C2Cl6 (not visible on 1H NMR) was 
found to crystallise out in IPA and contaminate large batches of product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 60 
2.1.4 Diaryl ether formation  
Formation of the ortho-substituted ethers was initially conducted via a two-step 
procedure (Method A).  The reaction of phenol with KOH in toluene under Dean-Stark 
conditions followed by refluxing the formed phenoxide salt (after solvent removal) in 
DMF with 116 for 16 hours yielded 117 with varying success (Table 11). 
 
 Substituent 
Entry 
117 R1 R2 R3 
Temp 
°C Solvent Base Method 
Yield[c] 
% 
1 a iPr H H 130 DMF KOH A 23 
2     reflux DMF KOH A 80-86 
3 b tBu H H 130 DMF KOH A 61 
4     reflux DMF KOH A 83 
5     reflux DMF NaH B 82 
6 c iPr Me H reflux DMF KOH A 69-71 
7 d tBu Me H 130 DMF KOH A 0 
8     reflux DMF KOH A 28[d]-52 
9     reflux MEG KOH A 0 
10     reflux DMF KOH B 7 + [b] 
11     reflux DMF NaH B 51 
12      DMF K2CO3 B[a] 54 
13      DMSO K2CO3 B[a] 0 
14 e tBu Me Me reflux DMF KOH A 49-62 
15      DMF K2CO3 B[a] 51 
Table 11: Yields and conditions of diaryl ether formation 
Method A: Phenol refluxed in toluene with KOH under Dean-stark conditions, 
toluene removed and replaced with DMF, then 116 added. Method B: Base added 
directly to phenol in solvent, stirred for 30 mins then 116 added 
[a] Reaction carried out in the presence of 3 Å mol. sieves [b] Impurity 121 
observed, yield not determined [c] Yield based on the scale of the reaction 
using ≤ 0.5g of 116, unless otherwise stated [d] Yield carried out on a large 
scale based on using > 0.5g of 116 
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Attempts at non-refluxing temperatures gave back either starting material or low 
yields of the desired product (entries 1, 3 and 7).    
As expected, yields were found to be highly dependent on the nature of the ortho 
substituents; increased steric bulk resulted in decreased yields (entry 3  entry 8).  
Given the seemingly high dependance of the reaction on temperature, attempts at 
refluxing in the higher boiling point solvent ethylene glycol were made.  However this 
resulted in only the starting phenol being returned, possibly due to the hygroscopic 
nature of the solvent. An attempt at employing DMSO as the reaction solvent returned 
large quantities of DMS under the harsh and long reaction times (entry 13).  
Isolation and analysis of some of the major impurities of the reaction mixture 
provided some useful insights into the possible reasons behind the low yielding 
couplings of sterically encoumbered 117d.  Amino benzene 121 was thought to have 
been isolated due to the decomposition of DMF to Me2NH or by the mechanism outlined 
in Scheme 33. In the case of biaryl impurity 120, placing a substituent in the para 
position of the starting phenol led to an increased conversion to the ether (compare 
yields of 117d with 117e, entries 8  14).  
 
Scheme 33: Possible reaction mechanisms for the formation of impurities 120 and 121 
With respect to reducing reaction times and thus the possibility of solvent 
degradtion products, a microwave assisted coupling reaction was attempted.  However, 
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complete return of starting materials coupled with the limited capabilities regarding the 
scales achievable resulted in this method being abandoned. 
Atempts at combining phenoxide formation with the coupling step and negating 
the need to change reaction conditions succesfully reduced a step in the procedure with 
comparable results in yield, and for a range of bases (Method B, entries 5, 10-13 and 15 
in Table 11). 
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2.1.5 DiBAl-H reduction 
Addition of an excess (2.5 equivalents) of DiBAl-H in either toluene or DCM to 
117 at various temperatures for between 12 and 16 hours followed by acid hydrolysis of 
the intermediate imine, yielded dialdehyde 118 (Table 12). 
 
Substitution Entry 118 
R1 R2 R3 
Temp 
(°C) Solvent 
Yield 
(%) 
1 a iPr H H -78 Toluene 62 
2     -40 Toluene 47 
3     0 Toluene 42 
4     RT Toluene 63 
5 b tBu H H -78 Toluene 67 
6     -40 Toluene 45[a] 
7     -40 Toluene [b] 
8     RT Toluene 54 
9 c iPr Me H RT Toluene 25 
10     50 Toluene 9.4 
11     -78 Toluene 75 
12 d tBu Me H RT Toluene 33-64 
13     -40 Toluene 52-74[c] 
14     -40 DCM 44-72[c] 
15 e tBu Me Me -40 Toluene 65 
16     50 Toluene 62 
Table 12: Yields and conditions of DiBAL-H reduction 
[a] DiBAL-H added dropwise through pressure equalised dropping funnel [b] Methanol quench 
before acid hydrolysis resulted in mainly acetal product [c] Addition of 6M HCl after work-up 
Optimum reaction temperatures appear to be between -40 °C and -78 °C, 
employing either toluene or DCM as the solvent.  A large excess of the hydride reagent 
is also required to ensure formation of the di-aldehyde (the mono-aldehyde is almost 
inseparable from the desired di-aldehyde by column chromatography).  In an attempt at 
reducing the exothermic nature of the acid hydrolysis, methanol was employed as a 
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DiBAl-H quench before addition of HCl.  However this resulted in acetal formation, 
presumably via nucleophilic attack of the methanol.    
The main problem regarding scale-up of the reaction seemed to be the formation 
of a large amount of insoluble sticky filtrate produced in the hydrolysis step.  This 
filtrate was difficult to break down using various methods.  A number of attempts were 
made to reduce its prevalence; slowing the addition of DiBAl-H, diluting the reaction 
mixture, reducing the temperature at the hydrolysis step and changing the reaction 
solvent to DCM.  However, none were successful.   It was eventually discovered that the 
addition of 6M HCl dissolved the filtrate after work-up, and after further work-up and 
purification, yields increased by as much as 63% (entries 13 and 14). 
 
2.1.6 Borohydride reduction  
Addition of a large excess of sodium borohydride to dialdehyde 118 at room 
temperature for 12-16 hours led to the formation of 119 with excellent reliability. The 
substituent patterns did not appear to have any effect on the yields of 119 and proceeded 
in up to 95%  (Table 13). 
 
Substitution 119 
R1 R2 R3 
Yield 
(%) 
a iPr H H 81 
b tBu H H 92 
c iPr Me H 88 
d tBu Me H 95 
e tBu Me Me 81 
Table 13: Yields of NaBH4 reduction 
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2.1.7 Routes to the commercially unavailable phenol  
Of the four starting phenols utilised in the diaryl ether formation outlined in 
section 2.1.4, all but one, 2-iso-propyl-6-methylphenol, were commercially available.  
Given that the analogous aniline 122 was commercially available, it was proposed that a 
transformation to the diazonium salt by the method of Jones88 followed by a Shine89 
transformation to the alcohol would yield the desired product 123. 
 
Scheme 34: Synthesis of phenol 123 via its diazonium salt 
(a) i. conc. HCl, H2O, dioxane, NaNO2; ii. H2SO4, 50 °C 
By the method of Jones,88 122 was dissolved in conc. HCl and dioxane and 
treated with sodium nitrite to form the diazonium salt.  By the method of Shine89 the 
diazonium salt was then added to conc. H2SO4 and heated for 16 h to yield 123 in 
overall 62% yield.  However, having performed the reaction on a small scale the 
commercially available aniline became unavailable to repurchase for large-scale 
throughput. 
A new method for the synthesis of a 2-iso-propyl-6-methyl substituted phenol 
123 was therefore sought.  As discussed in section 2.1.4, the para-substituted phenol 
ether used in the coupling of 117e increased yields in the step by up to 10% compared to 
its 2,6-disubstituted analogue 117d (entries 8  14, table 11, section 2.1.4).  Given the 
difficulty outlined above in forming 123, an alternative synthesis of a trisubstituted (2-
iso-propyl-4-6-dimethyl) phenol 129 was planned in order to afford a para-substituted 
analogue of 123.  This could then be utilised in the SNAr coupling step to effect higher 
yields than the 2-iso-propyl-6-methyl analogue 117c.  
A 1936 patent90 reported the iso-propyl alkylation of a number of substituted 
phenols utilising Fridel Crafts chemistry.  One example included the conversion of m-
cresol 124 into thymol 126 in 34% yield (Scheme 35). It was therefore envisaged that 
iso-propyl choride could react at the ortho position of commercially available 2,4-
dimethyl xylene 127 in a similar fashion, to afford the required phenol 129. 
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Scheme 35: Reported synthesis of ortho-substituted phenol via Friedel Crafts chemistry90 
(a) AlCl3, 1,2-DCE 
The commercially available xylene 127 was added to a solution of AlCl3, before 
cooling to -10°C and adding isopropyl chloride 128 (Scheme 36).  
 
Scheme 36: Attempted synthesis of 129 via Friedel Crafts chemistry 
(a) AlCl3, 1,2-DCE 
However, the desired product 129 was not formed. The 1H NMR appeared to 
show formation of a number of products that were not cleanly isolable either by flash 
column chromatography or distillation. 
A new method was therefore derived from a method by James et al.91 and is 
shown in Scheme 37. 
 
Scheme 37: New route to commercially unavailable phenol 12791 
(a) i. NaH; ii. MEMCl 
(b) i. nBuLi; ii. MeI; iii. H+ deprotection 
 Where James et al.91 used methoxymethyl (MOM) chloride to protect the phenol, 
it was proposed to use methoxyethoxymethyl (MEM) chloride as a less toxic and more 
readily available protecting group.  However, Moskowitz92 reported the difficulty of 
using MEM as a protecting group for phenolic hydroxyl, as ortho-lithiation can lead to 
an intramolecular attack on the MEM group instead of the desired condensation 
(Scheme 38).   
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 Scheme 38: Difficulty of ortholithiating in the presence of MEM 
(a) nBuLi 
Consequently, an alternative protecting group in the form of a 2-tetrapyranal 
(THP) ether was employed.  A viable route to the commercially unavailable phenol 123 
was therefore developed (Scheme 39). 
 
Scheme 39: Synthetic strategy towards commercially unavailable phenol 
(a) H2SO4 on SiO2, C2CL6 
(b) i. nBuLi; ii. MeI 
(c) AcOH deprotection 
THP ether protected compound 136 was prepared via sulphuric acid adsorbed 
SiO2 catalysis with phenol 130 (39-90%).  This was then ortho-lithiated with nBuLi and 
quenched with MeI to afford 137.  Deprotection in AcOH/H2O/THF afforded the final 
product 123 (18-56%). 
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2.1.7.1 THP ether protection 
THP ether protected compound 136 was prepared via sulphuric acid adsorbed 
SiO2 catalysis93 with phenol 130 (Table 14).  
 
Entry Scale (based on 130) / cm3 Yield / % 
1 1 89 
2 20 57-90 
3 30 39 
Table 14: Yields and conditions of THP ether protection 
The decline in yield (entries 1  3) was attributed in part to a loss in activity 
over time of the acidified silica gel.  
2.1.7.2 Ortho-lithiation, quench and deprotection 
Formation of the doubly ortho-substituted phenol was conducted via addition of 
the mono alkylated THP ether 136 to a stirring suspension of nBuLi and TMEDA in an 
ice bath, followed by an electrophile quench and then a deprotection in AcOH to yield 
123 (Table 15).   
 
Entry Scale (based on 136) / g Conditions Quench Yield[a] / % 
1 1 [b] MeI 56 
2 27.5 [b] MeI 28 
3 1.45  MeI 18 
4 10  MeI 12[c] 
5 9.5  Me2SO4 - 
Table 15: Yields and conditions of ortho-lithiation and methylation 
[a] yield calculated from 136 [b] 136 added slowly to a stirring suspension of nBuLi/TMEDA 
through a pressure equalised dropping funnel [c] calculated yield was an inseperable mixture 
of 123 and 130 
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Isolated yields of 137 were unavailable due to the product being inseparable 
from the starting material 136.  The crude mixtures were therefore reacted without 
further purification to yield 123.  Eventual purification of 123 also proved to be 
problematic, thought in part to be attributable to phenols 123 and 130 (from the 
deprotection of unreacted 136) being soluble in one another.  A number of purification 
techniques were attempted; separation on acidified silica, recrystallisation of the 
phenoxide salts of the compounds and distillation - all of which were unsuccessful.   
An NMR study of a deuterated quench of the lithiated species of 136 with MeOD 
demonstrated that there was a 75% conversion to product, indicating that the 
electrophilic quench and not ortho-lithiation was the problematic step.  To this end, a 
different form of electrophilic methyl was sought in the form of Me2SO4.  However, this 
was seen to give a complex reaction mixture on deprotection (entry 5).  Consequently, 
the highest yields were obtained by adding the substrate slowly to nBuLi/TMEDA via a 
pressure-equalising dropping funnel up to a 1g scale (entry 1). 
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2.2 Biocatalytic Desymmetrisation of Diaryl Ethers 
With large quantities of pro-atropisomeric compounds 118 and 119 now available, 
we turned our attention towards a strategy for desymmetrisation.  As previously 
mentioned, Matsumoto78 had employed an enzyme to effect an enantiopos-
differentiating transformation of a biaryl with excellent success (section 1.4.8.2), and the 
added ecological benefit of such a process seemed appealing.  
 
Scheme 40: Desymmetrisation of an atropisomeric achiral ether 
From a synthetic viewpoint, one of the most appealing features of enzymes is 
their specificity; they only touch the functional group corresponding to their active site 
and in most cases will only react with or produce a single enantiomer of a given 
compound.  Indeed, by far the best asymmetric syntheses are achieved in nature by 
enzymes and their ability as chiral host molecules to discriminate between enantiomers 
of a racemic substrate is of well-recognised preparative value.  For example, the 
resolution of racemic mandelate by pig liver esterase was published by Dakin94 as early 
as 1903.  
Against this background, we decided to investigate a biocatalytic approach to the 
enantioselective synthesis of atropisomeric diaryl ethers, based on the desymmetrisation 
of appropriately achiral substrates containing a pair of enantiotopic functional groups 
(Scheme 40). 
2.2.1 Enantioselective acylation and deacylation 
The selective enzymatic acylation and deacylation of alcohols has become a 
powerful technique for the preparation of optically enriched compounds and is practiced 
both in laboratory and large-scale production.95,96 Initial screens of our compounds were 
therefore undertaken with the readily available enzymes shown to be effective by 
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Matsumoto;78 Pseudomonas fluorescens lipase (PFL) and Pseudomonas cepacia lipase  
(PCL).   
A racemic reference was first synthesised in order to effectively measure the 
enantioselectivity of the reaction by HPLC.  Dialdehyde 118d was selectively reduced 
with 0.25 equivalent of LiBH4 (68% yield) before acylating via an NaH deprotonation 
followed by an acetic anhydride quench in refluxing diethyl ether (74%).  Further 
reduction in NaBH4 afforded the mono acylated product 142 in 92% yield (Scheme 41).  
 
Scheme 41: Synthesis of a mono-acylated racemic reference  
(a) 0.25 eq. LiBH4, 0 °C, EtOH 
(b) i. NaH; ii. Acetic anhydride 
(c) NaBH4, THF 
The results of the incubation of our substrates with both PCL and PFL are shown 
in Table 16, where unfortunately very little activity was displayed towards the ethers and 
the selectivity in all cases was nil.97  
 
Substitution Yield / % 
Entry R1 R2 Enzyme Temp Time 143 142 er 
1 iPr H PCL 40 °C 10 d 100 0 - 
2 iPr H PFL 40 °C 10 d 47 30 - 
3 tBu H PFL RT 4 wk 100 0 - 
4 tBu H PCL 40 °C 7 wk 100 0 - 
5 tBu H PFL 40 °C 7 wk 82 12 - 
6 tBu Me PCL 40 °C 7 wk 100 0 - 
7 tBu Me PFL 40 °C 7 wk 100 0 - 
8 tBu Me PFL 50 °C 22 d 100 0 - 
Table 16: Activity and selectivity of deacylation with lipase enzymes 
(a) Lipase, 1:2 acetone:0.1 M phosphate buffer solution (pH 7) in water 
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An enantioselective acylation was therefore undertaken using Candida antartica 
lipase B and vinyl acetate (Scheme 42).  
 
Scheme 42: Acylation with CAL-B and vinyl acetate 
(a) CAL-B, vinyl acetate 
In this case slow acylation of 118d was observed with approximately 50% 
conversion after 24 hours and modest enantioselectivity of 80:20 er.  Consequently, our 
attention turned towards the application of a different class of enzyme.  
2.2.2 Kinetic resolution by enantioselective oxidation 
Kinetic resolutions of atropisomers offer the added benefit of being able to 
recover, racemise and recycle the unreactive enantiomer.  Despite this, their application 
in synthesis is rare,65,98 and the enzymatic kinetic resolutions of both biaryl78,99 and non-
biaryl atropisomers100 are a relatively recent development.  
Galactose Oxidase (GOase) is a soluble, copper-dependent enzyme that catalyses 
the O2 dependent oxidation of the C6-OH of D-galactose 144 to the corresponding 
aldehyde 145 (Scheme 43). Turner et al101 successfully changed this specificity from a 
1º to a 2º alcohol oxidase capable of enantioselective oxidation and with the ability to 
bind nonpolar, rather than polar substrates.  The groups directed evolution approach 
through random mutagenesis and screening identified a varient of the enzyme, GOase 
M3-5, which possessed good activity towards a range of 1-phenylethanol templates, and 
with high enantioselectivity (99% ee). We therefore hoped to apply this 
enantiodiscriminating oxidase enzyme to our diols. 
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Scheme 43: Directed evolution of GOase 
2.2.2.1 Initial screening and method development 
Our initial focus was to investigate what, if any, effect the substitution pattern of 
our diaryl ethers had on the oxidative ability of the GOase M3-5 enzyme.  In 
collaboration with Bo Yuan and Prof. Nick Turner102 at the Manchester Interdisciplinary 
Biocentre, diaryl ethers 118a-d (synthesis described in section 2.1) were screened for 
their activity using a peroxidase based assay.  Oxidase-catalysed H2O2 formation 
(intrinsically linked to the enzmes activity) was used in conjunction with a peroxidase 
enzyme and the substrate ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) 
to produce a green pigment (Figure 13).  The reaction kinetics were then indirectly 
measured by following the absorbance increase at 420 nm (Figure 14). 
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c i-Pr Me 
d t-Bu Me 
 
 
 
 
Figure 13: ABTS peroxidase assay to measure activity of GOase towards substrates 119a-d        
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Figure 14: Activity screening of diols 119a-d with GOase M3-5 
Despite the insolubility of the diols in the assay mixture, it was possible to 
measure activity for compounds 119b-d.  The highest activity was observed for 
compounds 119b and 119c with some activity observable for 119d.  However no 
activity was observed for compound 119a.   
The most promising diols 119c and 119d (based both on their activity and their 
potential for being stable chiral atropisomers) were then taken through for 
enantioselective studies with the enzyme.  As a result, racemic references for their 
monoreduced analogues were synthesised (Scheme 44). 
 
Scheme 44: Synthesis of racemic references for GOase M3-5 enzyme study 
(a) 0.25 equivalent LiBH4, 0 °C, EtOH 
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Diadehydes 118c and 118d were treated with 0.25 equivalents of lithium 
borohydride at 0 ºC for 1 hour in ethanol to yield the monoaldehydes 140 and 149 in up 
to 72% yield.  HPLC analyses were then taken of the monoreduced products in order to 
find suitable conditions and retention time references for their enantiomer seperation.   
The inherent insolubility of diols 119a-d under the aqueous conditions of the 
study lead us to screen a number of water-miscible solvents.  It was found that MBTE 
and DMSO gave the largest degree of solubility while still remaining compatible with 
the enzyme’s activity.  However, a large degree of variation between the selectivity of 
GOase M3-5 towards our substrates in MTBE under seemingly identical conditions made 
the low volatility of the solvent an unsuitable choice.  Although the initial screens were 
undertaken in an assay mixture of 10%, the enzyme was found to tolerate assay mixtures 
of up to 30%, overcoming our solubility issue. 
Initial method development was undertaken on quantities of  monoaldehyde 140 
by Bo Yuan (Table 17).  The preferential oxidation of one monoaldehyde enantiomer 
was monitored by HPLC, and found largely to depend on enzyme quantity (entries 1  
3) and assay component  (entries 3  5). 
Entry Assay component Enzyme Quantity Reaction Time 
er 
1 30% MTBE (aq) 28.9 µl 3 hours 50:50 
2 30% MTBE (aq) 28.9 µl 6 hours 51:49 
3 30% MTBE (aq) 57.8 µl 3 hours 65:35 
4 30% MTBE (aq) 57.8 µl 21 hours 61:39 
5 30% DMSO (aq) 57.8 µl 3 hours 98:2 
Table 17: Selectivity enhancement of GOase M3-5 
2.2.2.2 Results of incubating 119 c and 119d with GOase M3-5 
Diols 119c and 119d were incubated with the GOase M3-5 enzyme under the 
optimised conditions and the course of the reaction followed by HPLC analysis (Scheme 
45, Figure 15).  Unfortunately, the attempted kinetic resolution of the less hindered diol 
119c (with an ortho isopropyl in place of the ortho tert-butyl of 119d) returned a 
racemic compound.  This was thought to be most likely as a result of racemisation of the 
compound on the timescale of the reaction.  Although 119c is resolvable by HPLC, our 
 76 
work with related compounds26 featuring similarly low barriers to racemisation seems to 
corroborate this theory. 
 
Scheme 45: Enantioselective oxidation of pro-atropisomeric diarl ethers 
 
Figure 15: Enantioselective desymmetrisation of 119d using GOase M3-5 variant 
 
Incubation of diol 119d with the enzyme rapidly produced the oxidised P-140 
(see section 2.2.2.3 for assignment of configuration) in approximately 88% ee after just 1 
hour.  This was followed by a seemingly slower increase to a maximum ee of 94% after 
24 hours.   
 This increase in ee, along with the formation of dialdehyde 118d (14% after 24h), 
suggests that the minor enantiomer M-140 produced in the enantioselective oxidation of 
119d is preferentially being removed by a secondary oxidation process to the dialdehyde 
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118d.  Thus the final enantiomeric purity of P-140 is determined by a combination of 
enantioselective desymmetrisation and kinetic resolution, as has been noted before in 
other systems.77 
2.2.2.3 Assignment of configuration 
The absolute sense of the enantioselective oxidation was established by 
comparing the experimental and modelled circular dichroism spectra of the remaining 
starting material from the kinetic resolution, (+)-P-140 (Figure 16).  
The modelled spectra was obtained by Dr. J. McDouall using density functional 
calculations at the B3LYP/6-311G(d,p) level, with the Gaussian suite of programs.103 
Favoured conformations of 140 were identified by taking the X-ray crystal structure of 
118d104 and modelling the replacement of firstly the pro-M and secondly the pro-P 
formyl group with a CH2OH group. Minimization of these starting structures led to two 
diastereoisomeric conformations differing in energy by 2 kJ mol–1.  
Taking the enantiomer of the lower energy conformation having P 
stereochemistry at the stereogenic axis, time-dependent density functional (TD-DFT) 
calculations of the lowest 100 electronically excited states were obtained. These data 
were then used to simulate the CD spectra of both conformations with the GaussSum 
package.105  
The CD spectra are simulated by overlapping Gaussian functions for each 
transition using the excitation energies and rotatory strengths (using the dipole length 
representation).106 The quality of the fit may be controlled by specifying the width of the 
bands and we found that a width of 0.4 eV produced the CD spectrum of P-140 
illustrated by the pink line (Figure 16). 
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Figure 16:  CD spectra of (+)-P-140: (blue line) observed for the slower reacting enantiomer of 140;  
(pink line) modelled for the lowest energy conformer of P-140 
 The modelled spectrum matches the experimental CD spectrum (Figure 16, blue 
line) very closely, with positive maxima aligning at 234 (observed) and 235 (modelled) 
nm and at 348 (observed) and 353 (modelled) nm.  A negative maximum at 313 
(observed) and 316 nm (modelled) nm also practically align, while a shoulder in both 
observed and modelled spectra appear at 280 nm.  The match confirmed that the slower 
reacting enantiomer of 140, and hence also the product of the desymmetrisation of 119d, 
has P stereochemistry (Scheme 45). 
Further confirmation of our assignment of configuration came from modelling 
the active site of GOase, which is characterised by a bowl-shaped cleft near the surface 
of the protein.107  The M3-5 variant contains a mutation at position 330 compared to the 
wild-type (Lys Met) and this residue has previously been identified as important in 
controlling substrate recognition.  A homology model of the GOase M3-5 was therefore 
created using the crystal structure of the E1 mutant (PDB code ZWQ8) as a template, 
which consists of two amino acid changes from the M3-5 mutant.  Docking the two 
enantiomers of 140 into the binding site of GOase using the CHARMm forcefield 
implemented in Accelrys Discovery Studio 2.5, revealed that the bulky tert-butyl group 
of the substrate is forced to occupy a position in which it is pointing away from the cleft 
and towards the surface of the protein. In such a binding mode, the hydroxymethyl 
group of M-140 is placed close to the copper-containing reactive centre poised for 
oxidation to the aldehyde (Figure 17).  
O
OHC
OH
(+)-(P)-140
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Figure 17: Docking model of the faster reacting enantiomer (M)-140 into the active site of GAose M3-5 
This model therefore predicts that M-140 is the faster reacting enantiomer in the 
kinetic resolution process and thus the opposite enantiomer to the enantioenriched 
sample left behind by the enzyme.  This observation is in agreement with the assignment 
of absolute configuration based on circular dichroism.  
2.2.2.4 Determining the enantioselectivity and E-value 
As kinetic resolutions invariably involve a trade-off between yield and 
enantiomeric excess, their reactions are best characterised by an enantioselectivity factor 
(E).  This value quantifies the treatment of biochemical data and allows the synthetic 
chemist to make useful predictions by relating the parameters of conversion (c) and 
optical purity (ee). 
To investigate the enantioselectivity of the kinetic resolution process, racemic 
monoaldehyde (±)-140 was incubated with the GOase M3-5 variant resulting in 89% 
conversion after 24h (Figure 18).  
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Figure 18: Kinetic resolution of (±)-140 using GOase M3-5 variant: Composition ■ = monoaldehyde 140; ♦ 
= ee%. 
As expected, the remaining atropisomer was of P-configuration with an ee of 
99%.  This also confirmed that the resolution process proceeds more slowly than the 
desymmetrisation reaction (incubation of the diol returned an 88% ee within an hour). 
 
Entry Time / h Conversion / % ee / % E 
1 0.5 34 24 3.54 
2 1 53 49 3.95 
3 2 68 79 4.89 
4 3 80 84 3.47 
5 6 83 90 3.60 
6 24 89 99 4.54 
Table 18: Kinetic resolution of GOase M3-5 and determination of E number 
The relationship between the extent of conversion (c) and the enantiomeric excess 
of the recovered substrate fraction (ee(S)) for various values (E) was calculated using: 
E =ln[(1−c)(1−ee(S))]/ln[(1−c)(1+ee(S))]108 
The kinetic resolution under these conditions has a selectivity (E) value of 
approximately 4 (Table 18).109  
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2.2.2.5 Determining the the configurational stability 
The half-life to racemisation and thus the barrier to rotation about the chiral axis 
of the enantiomerically enriched (+)-(P)-140 (obtained from the kinetic resolution) was 
established by incubation in heptane at 90 °C, with the decay in ee measured by HPLC 
(R,R-whelk-o1) as a chiral stationary phase, eluting with hexane: IPA 97:3 at 0.5 ml/min.  
The relative concentration of the enantiomers was measured regularly (Table 19). 
Time / mins % A % B ee / % 
0 19 81 62 
690 19 81 62 
1440 21 79 58 
3335 23 77 54 
4895 32 68 36 
6735 33 67 34 
Table 19: Racemisation of monoaldehyde (+)-P-140 by incubation in heptane at 90 °C 
 
Figure 19: HPLC trace of monoaldehyde  (+)-P-140 (Chiralcel R,R-Whelk column running 97:3 
hexane:IPA at  0.5 ml/min) 
A slow first order decay in the ee value from 62 to 34% was observed over a 
period of several days. Fitting to the equation ee = ee(t=0) • e-kt gave the first order rate 
constant, k = 1.605 x 10-6 s. 
The Half-life for racemisation was then calculated using the equation: t½ = ln 2/ k  
from which we deduced the half-life for racemisation at this temperature to be 120 h. 
This in turn gives an estimation of a barrier to enantiomerisation greater than 130 kJ mol–
1 at 90 °C.110 
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2.2.3 Desymmetrisation with Ketoreductases 
We also examined an alternative approach to the synthesis of enantiomerically 
enriched monoaldehyde 140, via asymmetric reduction of the symmetrical dialdehyde 
118d using ketoreductases (KREDs).  
KREDs have been widely applied to the asymmetric reduction of ketones, 
particularly benzylic ones,111 but to our knowledge had not previously been used for the 
desymmetrisation of pro-atropisomeric substrates. A panel of 17 different KREDs112  
were therefore screened and the conversions and ee value of the product determined after 
24 hours (Scheme 46, Table 15).  
 
Scheme 46: Reduction of 118d with ketoreductases (KREDs) 
Entry Enzyme Conversion[b] / % ee / % Configuration[c] R / S[a] 
1 KRED101 53 24 P R 
2 KRED103 6 22 P - 
3 KRED104 3 75 M - 
4 KRED105 2 99 M - 
5 KRED106 3 11 P - 
6 KRED108 39 78 M S 
7 KRED109 3 54 M - 
8 KRED110 1 99 M - 
9 KRED114 95 40 M - 
10 KRED115 33 9 M R 
11 KRED116 23 79 M - 
12 KRED117 7 79 M - 
13 KRED118 91 77 P S 
14 KRED119 99 71 P S 
15 KRED120 22 87 M S 
16 KRED121 84 61 M R 
17 KRED124 3 99 M R 
Table 20: Reduction of 118d with ketoreductases (KREDs) 
[a] The typical selectivity of the KRED in the reduction of nonsymmetrical diaryl ketones is 
shown (when known).111 [b] Conversion after 24 h. [c] Major enantiomer produced by reduction 
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All of the enzymes showed activity and often high enantioselectivity (Entries 4, 8 
and 17) although some with low conversion. Notable successes were achieved with 
KRED118 (91% conv., 77% ee P-enantiomer) and KRED121 (84% conv., 61% ee M-
enantiomer). These KREDs have previously been classified as either (S)- or (R)-
selective based upon their stereoselectivity in the reduction of non-symmetrical diaryl 
ketones.111 
 Interestingly, this trend is not always followed for the reduction of 118d, i.e. 
enantiomerically enriched P-140 was obtained from both an (R)-selective KRED101 and 
(S)-selective KRED118. Similarly, M-140 was obtained from both (R)- (KRED121) and 
(S)- (KRED108) selective enzymes. These results suggest that dialdehyde 118d binds at 
the active site of the ketoreductases in a different mode to that adopted by more 
conventional benzylic ketones. 
2.2.3.1 Towards the desymmetrisation of a diketone 
In order to assess the KRED activity against a ketone analogue of our compound, 
diketone 152 became a target for synthesis.  It was envisaged that the diketone could be 
synthesised by a double Grignard addition to dialdehyde 118d, owing to the large stocks 
of this compound, followed by an oxidation to afford 152 (Scheme 47).  
 
Scheme 47: Synthetic strategy towards diketone 150 from aldehyde 118d 
However, attempts to make the diol 150 from dialdehyde 118d with this 
organometallic species were low yielding at the second addition (Table 21). The main 
products of the reaction were the monoaddition product 150 and an unidentified 
impurity, X.  Sequential addition: taking the mono addition product and resubjecting it 
to the same reaction conditions also failed.  
Bartoli113 reported enhancing the electrophilicity of carbonyl groups (and 
therefore the subsequent addition of the organomagnesium reagent), by carrying out the 
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addition in the presence of an organocerium reagent.  However, although addition of this 
product suppressed the formation of the unidentified side product (entries 10 and 11), 
neither monoaddition 151 or product formation 150 occurred.  The diol was eventually 
reached however by addition of 6 equivalents of (non-coordinating) PhLi at -78 ºC in 
ether (entry 14). 
Yield / % 
Entry Conditionsa RLi / RMgBr Eq 
118d 151 X 150 
1 -78 ºC, 4 h  RT 12 h MeMgBr 3 82 9 3 5 
2 0 ºC, 4 h  RT 12 h MeMgBr 10 - 20 50 13 
3 0 ºC, 4 h  RT 12 h PhMgBr 4 - 31 - 4 
4 Benzene, -78 ºC, 8 h MeMgBr 6 - 53 14 20 
5 RT, 12 h MeMgBr 3 34 42 7 12 
6 RT, 16 h MeMgBr 6 34 42 7 12 
7 65 ºC 7 h MeMgBr 3 15 51 7 15 
8 65 °C 7 h MeMgBr 10 - 4 38 28 
9 65 ºC, 12 h, 1:1Benzene:THF MeMgBr 3 7 68 / / 
10 0 ºC, 4 h MeMgBr + CeCl3 3 90 2 - - 
11 0ºC, 4h MeMgBr + CeCl3 6 84 8 - 1 
12 -78 ºC, 4 h PhLi 3 55 38 2 5 
13 -78 ºC, 4 hrs  RT 12 h PhLi 3 26 56 5 11 
14 -78 ºC, 4 h  RT 12 h, ether PhLi 6 - 15 - 62 
Table 21: Attempted alkylation of 118d with organometallic reagents 
 [a] All reactions carried out in anhydrous THF unless otherwise stated 
Formation of the diketone was also directly reached from dinitrile compound 
117d (Scheme 48, Table 22).  Grignard addition again failed (entries 1 and 2) although 
the addition of 6 equivalents of MeLi at -78 °C in ether afforded 152a in 72% yield 
(entry 4).  As expected, the racemic reference mono reduced product 154 was then 
reached via a reduction of 152a with LiBH4 in EtOH at 0 ºC for 1 hour (68%) to afford 
the product as mixture of diastereomers (70:30).   
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Scheme 48: Synthesis of diketone 152a and racemic reference 154 from dinitrile 117d  
(a) 0.25 equivalent LiBH4, EtOH, 1 h 
Yield / % 
Entry Conditions MeLi / MeMgBr Eq.  
117d 153 152a 
1 0 ºC  60 ºC 12 hours, THF MeMgBr 3 10 56 - 
2 0 ºC  60 ºC 12 hours, THF MeMgBr 5 - 70  
3 -78 ºC 4 hrs, ether MeLi 3 72 2 - 
4 -78 °C, 90 mins, ether MeLi 6 - - 72 
Table 22: Diketone synthesis from 117d  
Study of the activity of the KREDS towards our benzyl ketones is currently 
ongoing.  However, our results so far suggest that biocatalytic redox reactions may be 
more widely applicable to the asymmetric synthesis of atropisomers by 
desymmetrisation. 
2.2.4 Ongoing and future work: Toward ligand synthesis 
The large impact of phosphine ligands became evident by the important 
discovery of the Wilkinson hydrogenation catalyst, RhCl(PPh3)3.114 Substitution at the 
aromatic ring of the ligand revealed an electronic effect on the reaction rate, illustrating 
the distinct ligand effect on the reactivity of a transition metal complex. Since then, an 
impressive number of phosphine and phosphite ligands have been applied in many 
catalytic reactions, and it became obvious that the steric and electronic properties of the 
ligands have an enormous effect on the reactivity of metal complexes.  
The capability for our diaryl ethers to demonstrate potential as hemi-labile 
ligands in catalytic applications has been alluded to in section 1.3.4, where the 
application of DPEPhos and Xantphos in (non-asymmetric) catalysis was discussed. In 
this case, the potential to combine the architecture and reactivity profile of DPEPhos 
with the stereochemical opportunities offered by atropisomeric ligands might be realised 
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if we can make the bisphosphines more heavily encumbered and thus able to exhibit 
atropisomerism.  Similarly, although no diaryl ether P,N-donor ligands are known, other 
axially chiral bidenate ligands have drawn attention due to their high efficiency in 
catalytic asymmetric synthesis (Figure 20).   The non-biaryl wide bite-angle P,N-ligand 
157 was used in the enantioselective hydroboration of vinylarenes in up to 94% ee.115 A 
route towards being able to incorporate phosphine and/or nitrogen into our ligands in 
order to assist metal chelation was therefore investigated. 
 
Figure 20: Examples of P,N-ligands and their use in synthesis,115,116 
2.2.4.1 Transaminases 
The emergence of transaminases, which catalyse the direct amination of ketones 
to chiral amines using ammonia, are providing an alternative and highly attractive 
additional option towards the synthesis of chiral amines.117 Such a process was recently 
employed in the asymmetric synthesis of Sitagliptin118 160 (an anti-diabetic drug) where 
the chiral amine present in its struture was biocatalytically transformed from ketone 158 
(Scheme 49).   
 
Scheme 49: Synthesis of Sitagliptin phosphate via a transamination  
This could prove a feasible route towards the synthesis of the “N” part of a chiral 
P,N ligand. Consequently, a racemic reference was synthesised in order to screen our 
original dicarbonyl compounds for selectivity against these enzymes (Scheme 50).   
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Scheme 50: Synthesis of monoaminated diaryl ether 
(a) 0.25 equivalent LiBH4, EtOH, 1h 
(b) SOCl2, reflux 
(c) NH4OH, reflux 
Attempts to selectively reduce one of the two functional groups present in either 
the dinitrile 117d (via a selective reduction with LiAlH4) or the dialdehyde 118d (via a 
selective reductive amination) both failed under a number of conditions.  Therefore 
dialdehyde 118d was monoreduced with 0.25 equivalents of LiBH4 before being treated 
with SOCl2 at reflux to afford the chlorinated analogue 161 in good yield.  161 was then 
refluxed in NH4OH to afford the monoaminated product 162 in 70% yield. 
Dialdehyde 118d was incubated with Transaminase-113 in DMSO and the 
reaction followed by HPLC over the course of 24 h (Figure 21 and Figure 22). 
 
Figure 21: HPLC trace of transaminase reaction mixture after 24 h 
  Chiralcel ASH column running 97:3 hexane:IPA at 1.0 ml/min 
The Initial results from incubation with TA113 shows the formation of a new 
peak at 4.56 (Figure 21) that increases during the course of the reaction over a period of 
24 h (Figure 22), although a cross-reference with racemic compound 162 is yet to be 
performed.  This peak was not found in the control reaction (run without the presence of 
transaminase-113). 
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Figure 22: Increase of product over time for the transamination of 118d with TA-113 
Reaction conditions: 118d 5 mM in DMSO, TA113 5 g/l, GDH 1 g/l, LDH 1 g/l, NAD+ 1g/l, 
PLP 0.5 g/l, D/L-alanine 45 g/l, glucose 10 g/l, potassium phosphate buffer (pH 8-8.5) 100 
mM 
 
However the control reaction also showed a reduction in 118d along with the 
formation of monaldehyde 140, suggesting that LDH in the assay mixture could be 
responsible for the reduction.  Synthesis of a diaminated analogue is currently underway, 
and further optimisation with this class of enzyme is ongoing. 
2.2.4.2 Incorporation of an iodine substituent 
Phosphination of a potential diaryl ether based ligand could be carried out by 
iodine-lithium exchange followed by trapping with chlorodiphenylphosphine (or a 
phosphite derivative) (Scheme 51).  This method has previously seen success in the 
synthesis of phosphinophenyl ethers.119 
 
Scheme 51: Synthesis of a phosphinophenyl ethers based ligand 
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As such, a phenol incorporating an iodine substituent in the 2-position and a tert-
buytl group in the 6-position was synthesised.   
The group of G.-Choghamarin has published an efficient method for the 
mononitration of a variety of phenols.120  Their procedure included the nitration of 
commercially available phenol 168 which displayed a nitro in position-6 and a tert-butyl 
group in position-2  (Scheme 52). 
 
Scheme 52: Nitration of phenol 168 
(a) SiO2-OSO3H, Al(NO3).9H2O, wet SiO2, CH2Cl2,  
Based on this observation, and utilising the diaryl ether synthesis described in 
section 2.1, a route towards the iodine substituted d  iaryl ether 172 was undertaken 
(Scheme 53). 
  
 
Scheme 53: Synthesis of a potential ligand  
(a) SiO2-OSO3H, Al(NO3).9H2O, wet SiO2, CH2Cl2, rt 
(b) Fe powder, HCl 
(c) i. conc. H2SO4, NaNO2; ii. KI 
(d) K2CO3, DMF, 3Å mol sieves, 156 ºC, 116 
Nitrated phenol 169 was prepared via the literature described procedure120 in 
53% yield.  Attempted coupling with 116 failed, returning only starting material and 
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suspected degradation products.  This is most likely due to the strongly deactivating 
nature of the nitro group in position-6 of the aryl ring.  169 was therefore reduced to the 
corresponding aniline 170 with Fe powder and HCl  (67 %) before being converted to a 
diazonium salt and quenching with KI to afford iodo-phenol 171 in 23% overall yield.  
The coupling of 171 and 116 then proceeded in moderate yield (54 %).  An attempt to 
couple the aniline compound 170 to 116 produced compound 173 (tentatively assigned 
as the amine shown) in 31 % yield. 
With 172 in hand, this compound will be converted to the dialdehyde 167 and 
either screened for activity against the above described transaminase (in the hope of 
achieving an enantioenriched species that can be transformed into a P,N-ligand), or 
treated with either of the GAOase M3-5 (after converting to a diol) or the KRED enzymes 
that have previously worked well (sections 2.2.2 and 2.2.3). 
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2.3 Enantiopos-Differentiatiation and Stereoselectivity of Laterally   
Lithiated Diaryl Ethers 
Much work has been done within the Clayden group on the ability of tertiary 
aromatic amides to direct lateral lithiation i.e to deprotonate at the more acidic benzylic 
sites of alkyl groups located ortho to an amide axis.   
Complexation of the butyllithium coupled with the strong acidifying effect of the 
electron withdrawing carbonyl group are thought to account for the regioselecective 
nature of these lithiation reactions, and their stereoselectivity has also been extensively 
studied.  For example, lateral lithiation of amide 174 gave organolithium 175 which, on 
addition to an imine, generated only a single diastereoisomer of the amine 176 (an 
intermediate in a synthesis of corydalic acid methyl ester) (Scheme 54).121 
Scheme 54: Diastereoselective lateral lithiations of amides  
(a) LDA 
(b) ArCH=NMe 
Similar reactions lead to enantiomerically enriched products in the presence of 
sparteine.122 Lateral lithiation of 177 gave organolithium 178 which was 
configurationally labile at the lithium-bearing centre but which reacted 
enantioselectively in the presence of (–)-sparteine to produce laterally functionalised 
products 179 in up to 92% ee (scheme 55).123,124  
 
Scheme 55: Absolute stereocontrol via lateral lithiations of amides 
(a)  secBuLi 
(b) E+, (–)-sparteine  
 A chiral lithium amide base also governed the selective desymmetrising lateral 
lithiation of one of the pair of enantiotopic methyl groups of 180, leading to the 
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enantiomerically enriched atropisomers of 181 (Scheme 56). 125 
 
Scheme 56: Desymmetrising lateral lithiation of a benzamide 
(a) i. -78 °C, THF; ii.TMSCl 
 Lateral lithiation in the diaryl ethers, however, remains relatively unexplored.  
We therefore aimed to explore the possibility that, when quenched with a bulky 
substituent, the chiral centre at the lateral position could be efficient at controlling the 
conformation of the diaryl ether axis.  An initial investigation126 thus looked at the 
ability of this class of compound to undergo directed metallation and simple 
unsymmetrical compound 182, left over from a previous study, was subjected to the 
lateral lithiation conditions outlined in Scheme 57.   
 
Scheme 57: Lateral lithiation of non-symmetrical diaryl ether 182 
(a) i. nBuLi, (–)-sparteine, -78 / 0 °C, ether; ii. MeI  
Diaryl ether 182 (in ether) was added to a stirred solution of nBuLi, both with 
and without (–)-sparteine, at –78 °C or 0 °C, stirred for 1 hr and then quenched with 
MeI.  The results from these reactions are summarised in Table 23, and show good 
yields and moderate diastereoselectivity (entries 2-4).  The enantioselectivity of the 
reaction was unable to be measured on chiral HPLC owing to the low barrier to rotation.  
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Yield / % 
Entry Conditions 182 183 dr 
1 –78 °C 92 0 - 
2 –78 °C / (–)-sparteine 38 49 66:34 
3 0 °C 0 88 66:34 
4 0 °C / (–)-sparteine 5 80 66:34 
Table 23: Results from the lateral lithiation of 182 with nBuLi 
The consistent ratio of diastereomers in this case suggests that the dr is controlled 
through a thermal equilibration of the products 183, and is not a result of   a 
stereoselective deprotonation / reaction of the intermediate organolithium. 
However, with the success of these lithiations, and with quantities of diols 119 in 
hand, it was envisaged that our substrate could be employed as a precursor for the 
enantiopos-differentiating lateral lithiation strategies outlined in Scheme 58 (section 
2.3.1).  The pro-atropisomeric compounds 184 and 187 were therefore our initial targets 
for synthesis, and it was hoped that we could obtain high kinetic selectivity in the lateral 
lithiation of our ethers with bulkier compounds. 
2.3.1 Strategy and synthesis of pro-atropisomers 
 
Scheme 58: Lateral lithiation strategy 
(a) i. NaH; ii. MeI 
(b) i. R-BuLi, ii. E+ 
(c) H2, PdC 
(d) i. R-BuLi, (–)-sparteine; ii. E+ 
For our initial studies, the singly ortho-substituted 119b was chosen given the far 
greater ease of its synthesis compared to its 2,6-substituted analogue (see diaryl ether 
synthesis, section 2.1).  Therefore, diol 119b was reacted with a large excess of NaH 
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followed by an electrophile quench with MeI.  This gave 184, a candidate for lateral 
lithiation investigations, in 79% yield. 
Similarly, one analogue of 187 was made by hydrolysing the diol 119b with 10% 
Pd/C on a continuous flow system. The reaction to generate 187 was carried out on the 
H-cube in ethanol at a concentration of 0.02M, a temperature of 25°C, a pressure of 1 
ATM and in 68% yield.  Although the yield appears to only be moderate, the sole by-
product in the reaction mixture was starting 119b.  It is therefore believed that higher 
yields might be reached by conducting another cycle on the H-cube. 
2.3.2 Lateral lithiation of meso-dimethoxy analogues 
Initial studies of 184 sought to assess the diastereoselectivity of its reaction with 
a range of electrophiles, and thus lateral lithiations of 184 followed by an electrophile 
quench were attempted utilising the same conditions found to be successful in the 
deprotonation of the analogous but unsymmetrical 182 (Scheme 59, Table 24).  
 
Scheme 59:  Lateral lithiation of dimethoxy compound 184 
(a) i. R-BuLi; ii. E = TMSCl or MeI 
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Entry RLi Eq[f] 
Temp 
(°C) 
Solvent Addition[d] 
Colour 
change[e] 
 Time to 
Quench 
E+ 
Yield 
/ % 
1 sBu 1.5 -78 THF RLi to 184 None 1 hr MeI [a] 
2 nBu 1.5 -78 THF RLi to 184 None 4 hr MeI - 
3 nBu 1.5 0 THF RLi to 184 None 1 hr MeI - 
4 nBu 1.5 0 THF 184 to RLi None 1 hr TMSCl - 
5 nBu 1.5 0 THF 184 to RLi Green 1 hr TMSCl - 
6 nBu 1.5 0 Ether 184 to RLi Green 1 min MeI - 
7 nBu 1.5 0 Ether 184 to RLi Green 1 hr MeI - 
8 nBu 1.5 0 Ether 184 to RLi Green 1 hr TMSCl - 
9 nBu 1.5 0 Ether 184 to RLi * None 1 hr MeI - 
10 nBu 1.5 0 Ether 184 to RLi Green 1 min MeI [b] 
11 tBu 1.5 0 Ether 184 to RLi None 1 hr MeI - 
12 nBu 4 0 Ether 184 to RLi Green 1 min MeI [c] 
Table 24: Conditions for attempted lateral lithiation of 184 
* reaction carried out in the presence of (–)-sparteine 
[a] small amount of monoaldehyde by-product on NMR, yield not determined [b] minium amount 
of desymmetrised product on crude NMR, purification unsuccesful [c]  small amount of 
dimethylated product seen on 1H NMR, yield not determined [d] order of addition in the reaction 
taken as either adding dissolved 184 to a solution of cooled RLi (184 RLi) or adding RLi  to a 
cooled solution of 184 (RLi184) [e] colour change observed immediately after addition of RLi 
to 184 / 184 to RLi [f] Equivalents taken as the excess of RLi compared to 184  
However, despite a number of attempts a route towards desymmetrised 190 was 
unsuccessful. 
A number of reaction conditions were explored but unfortunately varying solvent, 
temperature, order of addition, reaction times and the electrophile did not yield 190 in 
any isolable form.  More powerful bases in the form of both tert and sec-BuLi were 
employed in the hope that the acidity of the benzylic protons was the problem.  
Unfortunately, neither were successful at yielding 190. 
It was noted that a number of attempts at deprotonation led to the observance of a 
colour change, usually indicative that a lithiation is occuring.  Furthermore, under 
certain conditions it was seen that 184 appeared to have undergone an electrophilic 
quench with atmospheric oxygen, resulting in the formation of the monoaldehyde 
product 192 (Scheme 60).  This in itself is a desymmetrisation reaction, and with further 
optimisation could prove synthetically useful. 
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Scheme 60: Possible mechanism for mono-aldehyde biproduct formation 192 
 In order to ascertain if any lithiation was indeed possible, the methods thought to 
be most effective were employed to try and force the lithiation of 184. Ether 184 was 
therefore added to a large excess of nBuLi (entry 12) at 0 °C followed by the addition of 
MeI as the electrophile.  The crude 1H NMR showed a small amount of conversion, with 
two quartets corresponding to a double lithiation and quench, indicating that 
desymmetrisation in this set of compounds is not a viable strategy.  
2.3.3 Lateral lithiation of meso-dimethyl analogues 
The attempted lithiation of 187 with 1.5 equivalents of R-BuLi at varying 
temperatures to yield desymmetrised 193 also failed. (Scheme 61, Table 25). 
 
Scheme 61: Lateral lithiation of dimethyl compound 187 
(a) i. R-BuLi; ii. E = TMSCl or MeI 
Entry RLi Temp (°C) Solvent Yield 
1  secBu -78 THF - 
2 tertBu -78 THF - 
3 nBu 0 Ether - 
Table 25: Conditions for attempted lateral lithiation of 187 
(a) i.R-BuLi, ii. TMSCl or MeI 
These results are perhaps unsurprising given our failed attempts at lithiating 184.   
Work with this type of compound was therefore abandoned in favour of incorporating a 
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directing group on the benzylic carbon known to favour coordination to Li, such as 
MEM or carbamate.  The benefit here would be two fold; firstly, these groups have a 
larger coordinating power to lithium and would therefore direct lateral lithiation to a 
greater extent, and secondly they would be much easier to cleave than an OMe group 
once desymmetrisation occurs. 
2.3.4 Synthesis and lateral lithiation of meso-carbamate analogues 
The search for a strongly coordinating protecting group in order to complex the 
lithium and direct lateral deprotonations led us in the obvious direction of the widely 
available MEM and diisopropyl-carbamate protecting groups. 
 
Scheme 62: Protection of diol 119 with MEM or diisoptopylcarbamate 
(a) i. Base; ii. MEMCl or diisoprpylcarbamoylCl 
Diol 119 was therefore dissolved in solvent at various temperatures and then 
subjected to the addition of a protecting group, P, utilising a number of bases in order to 
reach the protected compounds 194-197, candidates for further lithiation studies 
(Scheme 62, Table 26).   
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b R1 = t-Butyl, R2 = H
d R1 = t-Butyl, R2 = Me
194 R1 = t-Butyl, R2 = H,    P=Cb
195 R1 = t-Butyl, R2 = Me,  P=Cb
196 R1 = t-Butyl, R2 = H,    P=MEM
197 R1 = t-Butyl, R2 = Me,  P=MEM
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Entry  
Protecting 
Group (Eq.) 
Base (Eq.) Temp (°C) Solvent Yield / % 
1 196 MEM (2 eq) Hunigs (2.5eq) RT DCM - 
2 196 MEM (3 eq) Hunigs (4eq) Reflux DCM - 
3 196 MEM (3 eq) NaH (6eq) RT THF - 
4 197 MEM (3 eq) NaH (4 eq) Reflux THF - 
5 194 Cb (3 eq) Net3 (5eq) RT DCM - 
6 194 Cb (3 eq) NEt3(5eq)/DMAP RT DCM - 
7 194 Cb (3 eq) NEt3(5eq)/DMAP Reflux DCM - 
8 194 Cb (5 eq) NEt3(5eq)/DMAP RT DCM - 
9 194 Cb (10 eq) NEt3(5eq)/DMAP RT DCM - 
10 194 Cb (20 eq) NEt3(5eq)/DMAP RT DCM [a] 
11 194 Cb (4 eq) Pyridine Reflux Pyridine 67 
12 194 Cb (20 eq) NaH (6 eq) RT THF 38 
13 194 Cb (4 eq) NaH (4 eq) Reflux DCM[b] 47 
14 194 Cb (4 eq) NaH (4 eq) Reflux DMF - 
15 194 Cb (4 eq) NaH (4 eq) Reflux Toluene 33 
16 194 Cb (4 eq) NaH (6 eq) 80 Toluene[c] 37 
17 194 Cb (4 eq) NaH (4 eq) Reflux THF 35 
18 194 Cb (4 eq) NaH (6 eq) 80 THF[c] 61 
19 194 Cb (4 eq) NaH (6 eq) Reflux Ether 8 
20 194 Cb (4 eq) NaH (6 eq) Reflux Ether[c] 98 
21 195 Cb (4 eq) NaH (6 eq) Reflux Ether[c] 75 
22 195 Cb (4 eq) NaH (6 eq)  Reflux Ether[d] 72 
23 194 Cb (4 eq) NaH (6 eq)  Reflux Ether[d] 87 
Table 26:  Conditions for attempted protection of diol 119 
[a] Minimal conversion to product by crude 1H NMR, yield not determined [b] Cb added 
instantaneously after NaH to avoid any radical reactions in DCM [c] Products of reaction 
left for 1 week open to the air before work-up [c] Product intentionally left open to air for 
16 h before work-up [d] catalytic amount of 18-crown-6 ether added to reaction mixture 
An unexpected difficulty occurred during the attempted protection of diols 119, 
with a propensity for the diols to only monoprotect, if at all, even with large excesses of 
electrophile.  NaH deprotonation of 119b followed by a carbamate protection of the diol 
in refluxing ether was only found to proceed in a high yield after a fortuitous discovery 
that complete evaporation of the volatile ether solvent from the reaction vessel over a 
period of 16 hours led to the reaction yield increasing from 8  75% (entries 19  21). 
 This seemed to imply that the Na+ counter ion was complexing to the 
deprotonated substrate in solution and affecting its nucleophilicity towards the 
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carbamoylCl electrophile.  Thus addition of a catalytic amount of 18-crown-6 ether was 
added to the reaction vessel in order to chelate the problematic Na+ counter ion, and the 
reaction proceeded in up to 87% yield (entries 22 and 23).  
With the pro-atropisomeric protected compounds 194 and 195 now in hand, it 
was decided that before any enantioselective or diastereoselective lithiations could take 
place, a working set of reaction conditions should be found. Carbamate 194 was 
therefore subjected to a lithiation followed by quench under a number of conditions 
(Scheme 63, Table 27). 
 
Scheme 63: Conditions for attempted lateral lithiation of carbamate protected 194 
(a) i. R-BuLi in ether; ii Electrophilic quench 
Entry RLi Eq. Temp (°C) Conditions 
Time to 
Quench E
+ Yield / % d.r.
[d] 
1 nBu 1.5 0 [a] 5 mins MeI - - 
2 secBu 2.4 -78 to 0 [b]  [b] (CH3)2CO - - 
3 secBu 1.1 -78 [c] 1 h PhCHO - - 
4 secBu 1.1 -78 to 0 [b] [b] PhCHO - - 
5 secBu 1.6 -78 [c] 0.5 h (CH3)2CO 63 >95:5 
6 secBu 1.6 -78 [c] 5 mins (CH3)2CO 43 >95:5 
Table 27: Conditions for attempted lateral lithiation of 194 
[a] 194 added to RLi [b] RLi added to 194 at -78 °C for 1 hr, warmed to 0 ºC for 1 hr, then 
cooled to -78 ºC and electrophile added [c] RLi added to 194 [d] Taken as the ratio of 
diatereomers seen by 1H NMR 
The most favoured conditions were those described by Beak37 for analogous 
diisopropylcarbamate protected compounds.  Therefore, secBuLi (1.6 eq) was added to a 
stirring suspension of 194 in ether at -78 ºC, stirred for half an hour and then quenched 
with acetone and warmed to RT over night, yielding up to 63% of 198. However, the 
reaction proved to be highly capricious with seemingly identical reaction conditions 
often proceeding to fail.   
This, coupled with the observation that the yields of 198 and its analogues 
appeared to decrease the longer they were left in solution (ie longer times before 
O
O O
a
see tableN
O O
N
O
O ON
O O
N
194 198
E
 100
quench), led us to switch our inert atmosphere from nitrogen to argon.  All subsequent 
lithiation reactions were carried out with freshly distilled (no longer than 2 hours old) 
electrophiles and freshly redistilled (–)-sparteine (also obtained commercially as 
reported 99% purity).  The solvents, substrates and (–)-sparteine were also freeze-thaw 
degassed in order to avoid the problems of oxidation and reprotonation. 
Additionally, all future lithiation strategies utilised the doubly ortho substituted  2-
tert-butyl,6-methyl analogue 195, the atropisomers of which (owing to the results from 
our enzyme studies) were expected to show a higher propensity for being chiral at useful 
temperatures, and for longer periods of time. 
2.3.5 Desymmetrisiation and stereoselectivity of laterally lithiated diaryl-
ethers 
With quantities of 195 in hand, and with the conditions required for lateral 
lithiations established, the next step was to investigate if this class of compound could 
exert control over the formation of a new chiral centres via lateral lithiation. 
Carbamate protected diaryl ether 195 was therefore dissolved in ether, subjected 
to a freeze–thaw degass technique and cooled to -78 °C. 1.6 equivalents of secBuLi was 
added dropwise and the lithioderivative was allowed to stir for half an hour before being 
quenched with a variety of electrophiles (Scheme 64, Table 28).  
 
Scheme 64: Lateral lithiation and electrophilic quench of carbamate protected 195 
(a) i. secBuLi , -78 °C, ether; ii. Electrophilic quench 
Entry  E+ Yield / % d.r.[a] 
1 199 (CH3)2CO 75  95:5 
2 200 Cyclobutanone 56 85:15 
3 201 TMS-Cl 70 95:5 
4 202 (CH3CO)2O 69 85:15 
Table 28: Diastereoisomeric ratios of laterally lithiated 195 with a variety of electrophiles 
[a] Taken as the ratio of diastereomers seen by 1H NMR 
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The diastereo-controlling ability of the axis appears to be very good, with one 
main diastereomer being evidenced in the 1H NMR in each case, regardless of whether E 
is an alcohol (as in the addition of acetone and cyclobutanone, entries 1 and 2), a 
carbonyl (when E = acetic anhydride, entry 4) or a silyl (entry 3).  A number of other 
quenches were attempted including DMF, benzaldehyde, acetaldehyde, DIAD, and 
propionaldehyde.  However, despite a number of attempts all returned starting material 
or a mixture of unidentifiable products. 
The next stage was to see if this control could be extended to the 
enantioposelective desymmetrisation technique we had intended from the outset.  195 
was therefore subjected to the same conditions but in the presence of the chiral ligand, 
(−)-sparteine.  It was hoped that this would bias the formation / reaction of the 
organolithium itself, which when combined with the diastereocontrol demonstrated 
above could (after removal of the unwanted chiral centre) instill asymmetry at the axis 
and offer a route to atropisomerically pure diaryl ethers.  
Diaryl ether 195 in ether, and (–)-sparteine were subjected to a freeze–thaw 
degass technique, before cooling the mixture to -78 °C and adding secBuLi.  The 
reaction was then allowed to stir for half an hour before being quenched with a variety 
of electrophiles (Scheme 65, Table 29).  
 
Scheme 65: Lateral lithiation of daryl ether 195 in the presence of (–)-sparteine 
(a) i. secBuLi , -78 °C, (–)-sparteine, ether; ii Electrophilic quench 
Entry  E+ Yield / % dr[a] er[b] 
1 199 (CH3)2CO 86 >97:3 75:25 
2 200 Cyclobutanone 26 >97:3 73:27 
3 201 TMS-Cl 72 95:5 78:22 
4 202 (CH3CO)2O 66 95:5 81:19 
Table 29: Lateral lithiation of 195 with attempted absolute stereocontrol 
[a] Taken as the ratio of diastereomers seen by 1H NMR [b] Taken as the ratio of enantiomers 
measured on chiral HPLC, first eluted peak reported first 
O
O O
a
see table
N
O O
N
O
O ON
O O
N
195 199 - 202
E
(!)-sparteine
 102
The enantioselective lithiations in each case afforded desymmetrised 199-202 
with uniformally moderate e.r.’s, and  (−)-sparteine improved diastereoselectivity in the 
case of 200 and 202 (entries 2 and 4).  This might imply that (–)-sparteine accelerates 
the reaction, and that if left to react for longer, the d.r.’s of entries 2 and 4 from Table 28 
could improve. 
2.3.5.1 Stereoselectivity with the electrophile SnBu3Cl 
An interesting case occurred when 195 was subjected to the lateral lithiation 
conditions already described, with or without (–)-sparteine, and quenched with SnBu3Cl 
(Scheme 66).  It appeared in this case to be the first example of a non-diastereoselective 
reaction of 195 depending on the reation conditions (Scheme 67, Table 30). 
 
Scheme 66: Lateral lithiation and quench of daryl ether 195 with SnBu3Cl 
(a) i. secBuLi , -78 °C, (–)-sparteine / no (-)-sparteine, ether; ii Electrophilic quench 
 
Entry (–)-sparteine 
Reaction time of 
organolithium with SnBu3Cl 
Yield / % dr[a] er[b] 
1 No 90 mins 9 2:1 - 
2 No 6 hrs 42 5:1 - 
3 No 16 hrs 58 9:1 - 
4 Yes 16 hrs 62 95:5 20:80 
5 Yes 26 hrs 59 95:5 20:80 
Table 30: Lateral lithiation of 195 followed by quench with SnBu3Cl 
[a] dr’s measured as a ratio of of diastereotopic signals in 1H NMR [b] er’s measured as a ratio 
of signals  on chiral HPLC, first eluted peak reported first 
Revealingly, the enantiomeric ratio of the reaction while remaining similar in 
value to the previous examples, appears to have been reversed (compare each entry 4 in 
Tables 29 and 30) and the favoured diastereomer now elutes second on HPLC, 
compared to the favoured diastereomers of 201 and 202 which elute first. The CH2Ph 
AB system of the more prevalent diastereomer of 203 has a chemical shift that appears 
further downfield in 1H NMR compared to the CH2Ph AB system of the less prevalent 
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diastereomer 203, and compared to the CH2Ph AB system of 199 – 202.  In the case of 
the enantioenriched products, 203 rotates circular polarised light in the opposite sense to 
199 - 202. This suggests that the opposite diastereomer has been formed, and given our 
experience with trialkyl tin compounds, that the mechanism of the reaction has switched 
from one of retention to one of inversion (discussed in section 2.3.6).  However, as each 
compound is not structurally identical we cannot presume to know which diastereomer 
is favoured, and this theory is completely speculative. 
Diastereomeric ratios in the case of 203 heavily depend on the incubation time of 
the organolithium with the electrophile, and on whether (–)-sparteine is used.   Longer 
reaction times (90 minutes compared with 16 hours) increases the dr from 2:1 to 9:1, 
(entries 1  3) and the presence of (–)-sparteine improves the ratio from 9:1 to 95:5 for 
the same reaction times (entries 3  4).  In each case the prevalence of what we assume 
to be the inversion product diastereomer is increased. The favoured diastereomer in this 
case was proven not to be under thermodynamic control as heating the 2:1 mixture at 55 
ºC for 24 hours afforded no change in the diastereomeric ratio.   
 
Scheme 67: Proposed reaction mechanism leading to the diastereotopic ratios of 203 
 
The appearance of the lowest diastereomeric ratio (2:1) occurring with the least 
amount of conversion (9%, entry 1) is thought to be more indicative of what is occurring 
during the reaction.  This theory, as illustrated in Scheme 67, proposes that the d.r. is a 
reflection of the respective reaction rates between SnBu3Cl and the intermediate 
organolithiums 204A and 204B.  Organolithium A is the more prevalent diastereomer, 
but reacts slower than the less prevalent diastereomer B.  Therefore, at low conversions, 
203B appears to be more highly represented in the ratio of diastereomers. 
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If this is the case, it would imply a configurational stability of the intermediate 
organolithium species, and this hypothesis could be investigated utilising a tin-lithium 
exchange,127 which will be discussed in section 2.3.6.1. 
2.3.6 Configurational stability and stereoselectivity in the reaction and 
synthesis of laterally lithiated diaryl ethers 
We went on to investigate the mechanism of the stereoselective reaction of the 
lateral lithiation – electrophilic quench of diaryl ether 195 and, given that the 
stereochemistry of organolithiums is intimately associated with the configurational 
stability of the lithium-bearing centre, to study the configurational stability of the 
intermediate organolithium.  
Figure 23 shows the stereochemical possibilities available to the organolithium 
after deprotonation.  Once formed, any epimerisation of the C-Li bond would lead to 
equilibration of the diastereomeric intermediates, whereas racemisation would require an 
unlikely rotation of the sterically hindered O-Ar axis and Li migration.  The 
stereochemical outcome of the product can then be further influenced by the 
stereoselectivity of its reaction with electrophiles. 
 
Figure 23: Stereoisomers of intermediate organolithium and pathways of epimerisation or racemisation 
The group of Hoppe have placed huge significance on the origin of the 
electrophile in determining the mechanism of the reaction of benzylic organolithiums.  
Unlike the general reaction of organolithiums with electrophiles, which proceed with 
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retention of configuration*, stabilised organolithiums – compounds in which the lithium 
finds itself in an allylic or benzylic position – can react with either retention or inversion 
of configuration. The adjacent π-system of these conjugated organolithiums gives the C-
Li bond more p-character, increasing the planarity of the organolithium and making the 
rear lobe of the C-Li σ-bond more susceptible to attack.  Gawley128 has proposed the 
terms SE2ret and SE2inv to distinguish between the two possibilities (Figure 24).    
 
Figure 24: Reaction mechanism of organolithiums – SE2ret or SE2inv 
It is now well known that the stereospecificity of the reaction of a number of 
organolithiums with electrophiles is erratic, with many reported examples of 
organolithiums reacting with some electrophiles with retention and with others with 
inversion.  Hoppe studied the stereochemical course of some reactions of a benzylic 
organolithium 210 with a variety of electrophiles. Retention of configuration was 
observed where the leaving group of the electrophile was able to coordinate to the 
lithium, for example MeOH (MeO-) 211 and MeCO2COMe (MeCO2-) 212 whereas 
halide leaving groups gave inversion (Scheme 68). 
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Scheme 68: Stereospecificity in the electrophilic substitution of benzylic organolithium 200 
We intended to investigate whether there would be any bias towards the 
formation of a new chiral centre when E was the same group but the source of the 
electrophile differed.  Attempts were made to synthesise 215 via a lateral lithiation 
followed by quench with both MeI and MeOTf (Scheme 69).  However, the reaction 
product was not reached. 
 
Scheme 69: Lateral lithiation and quench of diaryl ether 195 with MeI or MeOTf 
(a) i. secBuLi , -78 °C, (–)-sparteine / no (–)-sparteine, ether; ii Electrophilic quench 
Consequently, we turned our attention towards investigating the possible 
retentive / invertive mechanism by utilising tin-lithium exchange chemistry. We also 
aimed to use a tin-lithium exchange in order to determine the configuational stability of 
the intermediate organolithiums 204.  
2.3.6.1 Tin-lithium exchange 
The conversion of C-Sn to C-Li bonds by electrophilic substitution (tin-lithium  
exchange) is the most important general way of making configurationally defined 
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organolithiums.127  These transmetallations are always assumed to proceed with reliable 
retention of configuration, although the Clayden group have presented a tin-lithium 
exchange that did not proceed stereospecifically.35   
The first demonstration of this specificity was put forward by Stille in 1980, 
where his sequence of reactions started with stannane (±)217 formed from the 
nucleophilic addition of of Bu3SnLi to aldehyde 216. The stannane transmetalates 
stereospecifically to an organolithium presumed to be (±) 218 which reacts 
stereospecifically with electrophiles, and the overall course of the reaction was proved to 
proceed with retention by re-stannylation with Bu3SnI (Scheme 70). 
 
Scheme 70: Stereospecificity in tin-lithium excahnge 
(a)  i. Bu3SnLi; ii. MeOCH2Cl; iii. Separate 
(b) nBuLi, -78 °C, THF 
From the results we obtained in section 2.3.5, we suspected our organolithium to 
be reacting via an invertive process with the SnBu3Cl electrophile and with retention 
when TMSCl was used.   In order to ascertain if indeed our compounds were reacting by 
retentive and invertive mechanisms, we synthesised 201 by two different routes.  The 
first by deprotonation of 195 followed by a quench with TMSCl and the second by tin-
lithium exchange of stannane 203 and a quench with TMSCl (Scheme 71).    
 
Scheme 71: Complimentary syntheses of 201 
(a) secBuLi, -78 °C, ether, 0.5 h 
(b)  nBuLi, -78 °C, ether, 2 h 
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It was hoped that the different origin of organolithiums of 204 would be reflected 
in the different stereochemical properties of 201.  The deprotonation of 195 followed by 
direct addition of TMSCl led to the synthesis of 201 as a single diastereomer.  Synthesis 
of 201 via the tin-lithium exchange of 203 also formed a single diastereomer of identical 
stereochemistry.  This result suggests that either the intermediate organolithium is not 
configurationally stable and epimerises to > 95:5 of the favoured diastereomer (see 
Figure 23), or that trialkyl tin chlorides also react with our organolithiums via a retentive 
mechanism.  Each scenario would lead to the products of 201 having identical 
stereochemistry.   
We therefore synthesised 199 and 203, each by the two different routes, and 
analysed the stereochemical outcome of each product (Scheme 72). 
 
Scheme 72: Complimentary synthesese of 199 and 203 
(a) secBuLi, -78 °C, ether, 0.5 h, E+ = (CH3)2CO or SnBu3Cl 
(b) nBuLi, -78 °C, ether, 2 h, E+ = (CH3)2CO or SnBu3Cl 
 Again, reaction of both 195 and 203 with BuLi and acetone led to products 199 
with identical stereochemistry.  Attempts to synthesise a “double inversion” product by 
reacting 203 with a further equivalent of SnBu3Cl after tin-lithium exchange was also 
made. Unfortunately, the loss of colour associated with our transmetallations after 
addition of nBuLi to the substrate indicated that the transmetallation and quench of 203 
failed, and returned only starting material.  In this instance, we could not rely on the 
stereochemical outcome of our attempts at a double stannylation although our results so 
far suggested that trialkyl-tin compounds, despite our initial reasoning, also react with 
retention. 
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 Given Schemes 71 and 72, it was also likely that the intermediate organolithium 
formed after deprotonation was not configurationally stable, although the results from 
section 2.3.5.1 indicated otherwise. We therefore additionally exploited tin-lithium 
exchange chemistry to establish which was the case.  The reaction of carbamate 
protected 195 with SnBu3Cl in section 2.3.5.1 had produced stannanes 203 with 
differing ratios of diastereomers. If we assume that tin-lithium exchange proceeds with 
reliable retention, the stability of the intermediate organolithium (if indeed it is 
configurationally stable) should reflect the original ratio of stannanes in the new product. 
We therefore treated different diastereomeric ratios of stannane 203 with nBuli in 
ether at -78 ºC followed by addition of TMSCl (Scheme 73, Table 31).   
 
Scheme 73: Configurational stability study with Sn-Li exchange 
(a) nBuLi, -78 °C, ether, 2 h, then quench 
Entry 
203 
d.r. [a] 
Transmetallation Conditions Yield / % 
201  
dr [a] 
1 5:1 -78 °C, 2 hours 22 7.6:1 
2 9:1 -78 °C, 2 hours 28 94:6 
3 9:1 -78 °C, 6 hours 32 94:6 
Table 31: Tin-Lithium exchange of 203 followed by quench with TMSCl 
[a] dr’s measured as a ratio of of diastereotopic signals in 1H NMR 
While not delivering the exact ratio of diastereomers of starting stannane 203, the 
outcome of 201 did differ depending on the ratio of starting diastereomers (compare 
entry 1 with entry 2) suggesting that the organolithium at least has some degree of 
configurational stability under these conditions. The low conversion further indicates 
that the observed reduction in d.r. could be a consequence of the reaction rates of each 
intermediate.  We also treated enantioenriched stannane 203 with with nBuli in ether at -
78 ºC followed by addition of TMS-Cl (Scheme 74).   
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Scheme 74: Configurational stability study using Sn-Li exchange 
(a) nBuLi, -78 °C, ether, 2 h, then quench, er = first eluted enantiomer reported first 
The product 201 was enantioenriched consistent with substantial stability to O-
Ar bond rotation under these reaction conditions. 
2.3.6.1.1 Non stereospecificity in tin-lithium exchange 
 It is, however, possible that tin-lithium exchange is not reliably 
stereospecific and great care should be taken in interpreting stereochemical results which 
rely upon the assumption that it is.129  Clayden reported what they believed to be the first 
example of a non-stereospecific tin-lithium exchange in 1997 (Scheme 75, Table 32).122 
 
Scheme 75: Transmetallation of stannanes 219a and 219b 
(a) nBuLi,  
(b) excess EtI, -78 °C 
Entry 219a:219b Transmetallation Conditions Yield / % 221a:221b 
1 100:0 -78 °C, 2 hours 97 99:1 
2 6:94 -78 °C, 2 hours 87 60:40 
3 100:0 -40 °C, 2 hours 94 98:2 
4 5:95 -40 °C, 2 hours 83 60:40 
5 5:95 -78 °C, 30 min  -25 °C, 5 min  -78 °C, 100 min 83 64:36 
Table 32: Stereospecificity in the transmetallation of stannanes 219a and 219b 
 Transmetallation and alkylation of each diastereomer of 219 provided evidence 
for lack of stereospecificity in a tin-lithium exchange.  Stannane 219a reacted entirely as 
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expected, giving, after transmetallation and alkylation at -78 °C or at -40 °C, essentially a 
single diastereomer of the product 221a (entries 1 and 3).  However, when a sample 
containing 95% of stannane 219b was transmetallated and alkylated under either of 
these conditions, the product contained a mixture of 60:40 219a:219b (entries 2 and 4).  
Entries 3-5 show how the product ratios are invariant even when the intermediate 
organolithium is kept at -40 °C for 2 h or even warmed briefly to -25 °C.  These 
selectivities are therefore not snapshots of a slowly equilibrating mixture of 
organolithiums130 and organolithiums 220 must be configurationally stable. Given this 
configurational stability, the loss of stereospecificity could be occurring in either of the 
two seps in the sequence.  NMR studies indicated that there was in fact a lack of 
stereospecificity in both the formation and reaction of organolithiums 220, and their 
overall conclusions are summarised in Scheme 76. 
 
Scheme 76: Non-stereospecificity in the transmetalation of 219b and reactions of 220b 
It might therefore be possible that our own stannanes are reacting without 
stereospecificity, or in fact with inversion, although this is unlikely taking into 
consideration the α-oxygenated structure of our compound. 
Typically, in a tin-lithium exchange, we would expect an intermediate ate 
complex 224 (Scheme 77).  For the exchange to be retentive, 224 must collapse with 
retention to give 225.  Presumably the organolithium 225 must form a very short-lived 
ion pair, and the stereochemistry of the organolithium is dictated by the stereoselectivity 
of the attack of Li+ on the carbanion.  Even if an ion pair is not an intermediate, retentive 
and invertive electrophilic substitutions of organotin compounds are both known.131  The 
reaction is so generally retentive because the exchange is only thermodynamically 
N
O SnBu3
219a
N
O SnBu3
219b
n-BuLi
SE2ret
N
O Li
220a
n-BuLi
65% SE2ret
N
O Li
220a
35
%
 S
E
2in
v
E = RI
60% SE2ret
40
%
 S
E
2i
nv
E = RI, R3SiX, 
ROD
SE2ret
N
O E
222a
N
O E
222a
E = 
R3SnX
SE2inv
 112
favourable when the product organolithium is stabilised in some way, and there is 
almost always a lithium-coordinating heteroatom X involved in the ion pair collapse.  
The effect of the heterostom will be to anchor the lithium cation during the collapse of 
the ion pair, leading to overall retention.  Retention might be much rarer in the formation 
of non-heteroatom-stabilised organolithiums. 
 
Scheme 77: Mechanism of tin-lithium exchange via ate complex 224 
 If the lithium is not sufficienty anchored by the α-oxygen, the transmetallation of 
203 could possibly proceed via a stannate intermediate 226, which may collapse to give 
either diastereomeric organolithium depending on the direction of attack on the C-Sn 
bond by Li+ (Scheme 78).  The hypothetical conformation of the ate complex derived 
from 203 can exist as diastereomers 226a or 226b.  In 226a, delivery of either RLi or Li+ 
(by coordination to the carbamate carbonyl) can take place in such a way that invertive 
transmetallation is preferred.  The case of a diastereomer where 203 has the preferred 
conformation shown in stannante complex 226b is less clear-cut.  Either the tin or the 
carbamate substituent must lie close to the bulky Ar group on the axis, and population of 
either the syn or the anti conformer could lead to retentive or invertive organolithium 
204.   
 
 
Scheme 78: Possible invertive and non-stereospecific tin-lithium exchange mechanisms  
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If in fact transmetallation is invertive then a possible mechanism to explain the 
identical sterechemical outcome of ether 195 and stannane 203 with acetone and silyl 
electrophiles to produce products with identical stereochemistry is shown below 
(Scheme 79). 
 
Scheme 79: Possible invertive transmetallation to explain the stereochemical outcome of 199 and 201 
(a) secBuLi, -78 °C, ether, 0.5 h 
(b)  nBuLi, -78 °C, ether, 2 h 
 Of course the most likely explanation is that organolithium 204 reacts retentively 
with trialkyl tin halides to produce products of identical stereochemistry even after 
transmetallation.  The retention times and chemical shift properties of the supposedly 
“opposite” diastereomer when compared to products 199 – 202 could simply be 
misleading.  As no X-ray crystallographic studies were possible due to the products 
being oils or gums, we cannot assume that 203 is the opposite diastereomer to 199-202. 
2.3.6.2 Reaction pathways in lithium substitution 
Hoppe has shown that lithiated secondary O-benzyl N,N-diisopropylcarbamate 
228132 (Figure 25) belongs to only a small group of benzyllithium compounds that 
exhibit configurational stability in solution at low temperatures.  His most closely related 
compound to ether 195, lithiated benzyl carbamates 229133, although configurationally 
stable in the Hoffmann test,134 exhibit configurational lability at -78 °C.  
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Figure 25: Configurationally stable and configurationally labile benzyl lithium complexes 
The racemisation of Hoppes chiral secondary benzyl alkali-metal derivatives 229 
probably proceeds via a planar transition state (Scheme 80); therefore, the chiral 
information introduced during their generation is lost, and the final substitution product 
is formed with poor or even no enantioselectivity.133 
	  
Scheme 80: Possible racemisation mechanism of metallated benzylic carbanions 229	  
Configurational stability plays an important role in the asymmetric organolithium 
reaction, and configurational stability is closely linked to the mechanism by which the 
reaction takes place.  For an enantioselective reaction, the enantiodetermining step can 
be the lithiation, as an asymmetric deprotonation, or a postdeprotonation step, as an 
asymmetric substitution. A chiral ligand complexed to lithium can create the necessary 
diastereomeric environment in either step.  
In an asymmetric deprotonation, the organolithium reagent complexed to the 
chiral ligand is a chiral base which selectively abstracts an enantiotopic proton from the 
prochiral substrate 230. The enantioenriched organolithium intermediate 231 or 231-L* 
is configurationally stable and reacts stereoselectively with an electrophile, providing the 
enantioenriched product 232 (Scheme 81).135  
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Scheme 81: Enantioselective reaction pathways 
In an asymmetric substitution, the enantiodetermining step occurs after 
deprotonation. The racemic organolithium 231 can afford enantioenriched product 232 
under the influence of the chiral ligand by different pathways depending on whether 231 
is slowly or rapidly epimerising with respect to its rate of reaction with the electrophile. 
Most of Beak’s work has investigated the reaction pathways of lithium 
substitution reactions and probed the stereochemical integrity of the organolithiums. 
Configurationally stable organolithiums generally promote the formation of an 
organolithium, while configurationally unstable organolithiums allow the chiral ligand 
to direct the course of the reaction. 
For example, Beak concluded that the enantioselectivity in the synthesis of 
aromatic amide 235 was a result of a simple asymmetric deprotonation.  The complex of 
secBuLi with (–)-sparteine selectively removes the pro-R proton in 233.  The chiral, 
configurationally stable organolithium 234 then reacts with the alkylating reagent to give 
the product with an er of 75:25 (Scheme 82).136 
 
Scheme 82: Asymmetric deprotonation of aromatic amide 233 
(a) s-BuLi, (–)-sparteine, -78 °C, ether 
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For an asymmetric substitution reaction, the intermediate organolithium must 
usually be configurationally unstable, or the ligand will be unable to direct the course of 
the reaction (an exception might be a hypothetical reaction in which the ligand allows 
the two organolithium enantiomers to react with opposite stereospecificity).  These 
diastereomeric organolithium intermediates can epimerise regardless of the 
stereoselectivity of the deprotonation step.  If this epimerisation is slower than the rate at 
which the intermediate reacts with the electrophile then the product ratio reflects the 
ratio of the diastereomeric organolithium complexes in the reaction mixture (dynamic 
thermodynamic resolution) (Scheme 83).  Alternatively, if the epimerisation is faster 
than the rate at which the intermediate reacts with the electrophile then a dynamic 
kinetic resolution results whereby one diastereomeric intermediate reacts more readily 
with the electrophile (Scheme 84).  In this case the diastereoselectivity observed is 
determined by the difference in the transition state energies.137  
 
 
Scheme 83: Asymmetric substitution – dynamic thermodynamic resolution 
 
Scheme 84: Asymmetric substitution by dynamic kinetic resolution 
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Beak studied the configurational stability of the benzylic lithiated intermediate 
237 and effectively used a dynamic thermodynamic resolution to obtain enantioenriched 
products.  He did this by modifying the temperature of the reactions. Treatment of 
anilide 236 with secBuLi followed by a quench with TMSCl generates silane 238.  The 
product is formed in 82% ee if the racemic intermediate organolithium 237 is first 
treated with (−)-sparteine at −25 °C and then TMSCl at − 78 °C: the reaction is an 
asymmetric substitution, with sparteine governing the enantioselectivity of the 
electrophile quench step.  Adding sparteine at -78 °C reduces the ee of 238 to only 21%. 
(–)-sparteine is able to exert its effect more efficiently at higher temperatures, exactly as 
would be expected if it were controlling the equilibration of a pair of organolitiums 
(which might be fast at −25 °C but slow at −78 °C), but in contrast to what would be 
expected if it were controlling the rates of reaction of two organolithiums (Scheme 
85).138 
 
Scheme 85: Asymmetric substitution by dynamic thermodynamic resolution 
(a) -25 °C, (–)-sparteine, then -78 °C and TMSCl 
(b) -78 °C, (–)-sparteine, then TMSCl 
  At -78 °C the diastereomeric organolithium (–)-sparteine complexes 237-L* are 
configurationally stable in relation to the timescale on which they react with the 
electrophile and so the ratio of enantiomers 238 reflects the initial organolithium 
proportions.  However, at -25 °C the organolithiums are configurationally unstable and 
therefore the diastereomers 237-L* can interconvert.  This leads to an excess of the 
thermodynamically more stable organolithium 237a-L* which on reaction with TMSCl 
yields preferentially enantiomer 238a.   
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 Organolithium 237 is configurationally stable, thus transmetallation of the 
stannane 239 which has an ee of 66%, probably generates organolithium 237 with 66% 
ee.  If the transmetallation is carried out at −78 °C, the product 238 of electrophilic 
quench has an ee close to 66% (Scheme 86).  
 
Scheme 86: Transmetallation and electrophilic quench of pivaloyl at either -25 °C or -78 °C 
(a) -25 °C, (–)-sparteine, then -78 °C and TMSCl 
(b) -78 °C, (–)-sparteine, then TMSCl 
 This suggests that at this temperature (−)-sparteine is unable to perturb the ratio 
of the two enantiomeric organolithiums.  However, if the mixture of organolthium 237 
and (−)-sparteine is warmed to −25 °C for 2 h before being cooled again to −78 °C and 
quenched, the other enantiomer of the product 238b is formed in 85% ee. 
 The enantioselectivities arise on treatment of the non-racemising intermediate 
organolithium 237 with an excess of electrophile, such that both enantiomers react to 
completion.  But since the (–)-sparteine complexes 237-L* are diastereomeric, it should 
in principle be possible to separate them kinetically by using a defecit of electrophile, 
such that only the more reactive of the two diastereoisomeric complexes is quenched.  In 
such a case, ee should increase, and it does.  The 21% ee obtained on treatment of the 
unequilibrated 237-L* with a full equivalent of TMSCl at -78 °C can be improved to 
82% ee when only 0.1 equiv. TMSCl is used: in other words, the intermediate 
organolithium (–)-sparteine complexes are present in about a 60:40 ratio but the major 
diastereoisomeric complex reacts much faster than the minor, allowing the formation of 
one product in high enantiomeric excess.  An even better result is obtained if the 
organolithiums 237 are first allowed to equilibrate and then the faster reacting one (the 
major one in this case) is allowed to react selectively with a defecit of electrophile: the 
ee improves to 98%.128,139 
 Beak also showed that a dynamic kinetic resolution was in operation in the 
substitution reaction of lithiated benzamide 178 (Scheme 87).123 
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Scheme 87: Asymmetric substitution by dynamic kinetic resolution 
 The organolithium is not configurationally stable on the timescale of the 
reaction, however treating 178 with electrophiles in the presence of (–)-sparteine still 
gives products with good enantiomeric excesses.  The stereoselectivity is therefore a 
result of the (–)-sparteine complex reacting with the electrophile and not an initial 
deprotonation.  The enantiomeric excess of the product does not change during the 
course of the reaction. 
 It is possible for more than one pathway to be operative with a single substrate.  
Schlosser has shown that N-Boc-N-methyl-N-benzylamine undergoes an initial 
asymmetric deprotonation followed by equilibration of the resultant intermediate.140  In 
this case, the enantioselectivity of the product is determined in a postdeprotonation step, 
even though an asymmetric deprotonation occurs. 
 In some cases, crystallisation of the intermediate organolithium-(–)-sparteine 
complex complexes is necessary to force their equilibration to the major diastereomer.141  
In this type of dynamic thermodynamic resolution, the intermediate organolithium-(–)-
sparteine complexes might interconvert in solution, but one diastereomer crystalises 
preferentially, leading to a dynamic resolution of the organolithium. 
2.3.6.2.1 Investigating the reaction pathway in lithium substitution 
 Transmetallation studies (see section 2.3.6.1) indicated that our intermediate 
organolithium was probably configurationally stable under the conditions of the 
reaction.  An enantioenriched product is formed on electrophilic quench in the presence 
of (–)-sparteine (section 2.3.5, Table 29), but as the axis is likely to be stable at −78 °C, 
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the er must be a consequence of the kinetically determined selectivity in the 
deprotonation.  The relative stereochemistry of the product is then affected by the 
retentive or invertive nature of the electrophilic quench.   
We first set out to confirm that the deprotonation determines the overall 
enantioselectivity of the reaction by treating racemic stannane 203 to a tin-lithium 
exchange followed by an electrophilic quench in the presence of (–)-sparteine (Scheme 
88).  As there is no proton involved in the formation of the organolithium, the product of 
the electrophilic quench can only be determined by reaction of the organolithium with 
the electrophile.  
 
Scheme 88: Tin-lithium exchange in the presence of (–)-sparteine 
(a) nBuLi, 2 h, -78 °C, ether, (–)-sparteine, then E+ qunch with acetone 
 
 Although cude 1H NMR showed minimal conversion to product, alcohol 201 was 
proven to be racemic by chiral phase HPLC, confirming that deprotonation determines 
the ee of the product. 
Our method of deprotonation up until this point had been to add secBuLi in the 
presence of a stirring suspension of (–)-sparteine.  We therefore decided to carry out the 
deprotonation step without the presence of (–)-sparteine, only adding the chiral ligand 
after deprotonation was assumed to be complete.  As the chiral influence of (–)-sparteine 
can only affect the reaction of the organolithium in this case, an ee should not be 
observed if an asymmetric deprotonation solely governs the stereoselectivity (Scheme 
89). 
 
Scheme 89: Reaction of racemic organolithium 204 with electrophiles in the presence of (–)-sparteine 
(a) secBuLi, 0.5 h, -78 °C, ether 
OCbCbO
O
Ar
SnBu3
OCbCbO
O
Ar
203 201 er 50:50
a
(!)-sparteine
OH
-+
OCbCbO
O
Ar
Li
204
(CH3)2CO
OCbCbO
O
OCbCbO
O
Ar
195 199 E = (CH3)2COH
a E
OCbCbO
O
Ar
Li
204
Ar
(!)-sparteine
201 E = TMS
E+
 121 
 Unfortunately, the reaction failed in the presence of both acetone and TMSCl, 
and thus the stereochemical outcome of the reaction was unable to be interpreted.  We 
therefore decided to “premix” our sparteine and secBuLi with the intention of increasing 
the enentioselectivity of the product (Scheme 90). 
 
Scheme 90: Reaction of 195 with premixed (–)-sparteine 
(a) -78 °C, ether, 0.5 h 
 Again, the reaction returned a mixture of unidentifiable products and 
reprotonated starting material, however the elution times on chiral-phase HPLC in the 
case of 199 seemed to indicate an approximate 80:20 ratio of enantiomers where the 
product of 199  was usually found.  This indicates that the enantioselectivity is not 
improved.  A warm-cool sequence in the presence of (–)-sparteine, analogous to that 
described by Beak (section 2.3.6.2, Scheme 85), was also attempted both with a full 
equivalent of electrophile and with a defecit of electrophile.  We aimed to determine 
whether more than one pathway was operative in the enantioselectivities observed for 
our substrate. However the reaction returned starting material and an unidentified 
product in minimal yield by 1H NMR regardless of whether the electrophile was acetone 
or TMSCl, albeit in racemic form by chiral phase HPLC.  
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2.4 Other Stereoselective and Conformational Studies of Non-Biaryl 
Atropisomers 
The ability for stereocentres to induce conformational control over both the 
diaryl ether and the diaryl sulfide axis has recently been demonstrated via their sulfoxide 
controlled asymmetric syntheses.14,43 However, the ability for these axes to control the 
formation of new stereocentres themselves has not been investigated.  Therefore, we 
synthesised a diaryl-ether (section 2.4.1) and a diaryl sulfide (section 2.4.2) in order to 
study their stereoselective reactions.  A conformational analysis of what can be 
described as a “diaryl-amide” was also undertaken during a concurrent study into the 
solution behaviour of the oligo-benzanilides (section 2.4.3). 
 
2.4.1 Stereoselective reductions of a diaryl ether 
The ability of the diaryl ether axis to exert control over a new chiral centre was 
investigated via the reduction of a prochiral ketone 241 (capable of diastereoselective 
functionalisation) 1,3 remote from the axis (Scheme 91).   Stereoselective reductions 
carried out in the group so far have provided excellent results using bulky reducing 
agents such as LiBHEt3 “Superhydride®” (SH) and LiBHs-Bu3 “L-Selectride” (LS), 
thus these reagents were chosen for use throughout the study.  
 
Scheme 91: Stereoselective reductions controlled by the diaryl ether axis 
Compounds 246 and 247 were chosen as precursors for the stereoselective 
reductions due to the substitution pattern on the top aryl ring bestowing a large enough 
barrier to rotation to allow its resultant diastereomers to be separable and hence 
measurable by either HPLC or crude 1H NMR.  The prochiral ketone functionality allows 
us to determine whether the stereoselectivity observed is due to a relay of stereochemical 
information from the ether axis to the ketone. 
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Scheme 92: Synthesis and stereoselecte reduction of a prochiral ketone 
(a) NaBH4 0ºC, 1 hr,  
(b) i.NaH (1.2 eq); ii MeI (1.2 eq)  
(c) RMgBr (1.2 eq)  
(d) Dess-Martin periodinane 
(e) Superhydride, THF 0 °C; (f) L-Selectride THF 0 °C 
Monoaldehyde 140 was treated with a slight excess of NaH and MeI, as large 
excesses were found to result in nucleophilic attack at the aldehyde to yield a doubly O-
methylated product.  The protected alcohol 243 (76%) was then the target of Grignard 
addition to yield alcohols 244 (80%) and 245 (63%) as a mixture of diastereomers 
(R=Me, 244 = 30:70, R=Ph, 245 = 50:50).  Oxidation with Dess-Martin periodinane 
afforded the desired prochiral ketones 246 and 247 in yields of up to 97%.   Each ketone 
was then treated with the reducing agent at 0oC for 1 hour to yield back the desired 
alcohols, and their diastereomeric ratios were measured by crude 1H NMR analysis 
(Scheme 92, Table 33). 
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Entry  R Hydride Source Yield / % D.r.[a] 
1 244 Me Superhydride ® 98 43:57 
2 244 Me L-Selectride 98 88:12 
3 245 Ph Superhydride ® 92 >98:2 
4 245 Ph L-Selectride 98 >98:2 
Table 33: Results of stereoselective reductions of diaryl ether 246 and 247 
[a] Ratios determined by crude  1H crude analysis of the signals corresponding to the CH2OMe 
AB system of 244 and 245 
 
The results of 244 and 245 upon reduction with Superhydride® and L-Selectride 
seem to show that the ether axis is excellent at controlling diastereoselectivity at the new 
chiral centre, either when a large phenyl ketone is present (entries 3 and 4) or a reducing 
agent at least as bulky as L-selectride is used (entry 2).  The conformation of the ether 
axis in these cases has selectively directed attack of the hydride nucleophile to one face 
of the ketone.  The X-ray crystal structure of the single diastereomer 245 allowed its 
relative configuration to be determined, and showed the hydroxyl group to be anti in 
relation to the axis (Figure 26). 
 
Figure 26: X-ray of relative stereochemistry of 245 showing anti-configuration 
Heating the sample for two weeks at 50 ºC and submitting the compound to 
further NMR analysis suggested that 245 is the thermodynamically preferred 
conformation, as there was no evidence of any other diastereomer.  Given our 
experience with the large barriers to rotation seen in these compounds (see section 
2.2.2.5) it is also possible that there was no equilibration over this period. 
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The difference in selectivity between when R=Me compared to when R=Ph 
(entry1  entry 3) suggests that the conformation of the starting ketone differs in each 
case (Scheme 93).  When R is a large, bulky phenyl group, the atropisomers could exist 
as conformers 247a and 247b, with the ketone in each case sat in the plane of the biaryl 
and the less sterically demanding conformation 247b preferred.  In this case hydride 
attack occurs away from the bulky tert-butyl to produces a single diastereomer (entries 3 
and 4).  When R is a smaller methyl group the conformations 246a and 246b are likely, 
with each conformation having the methyl ketone sit out of the plane of the benzene ring 
it is attached to in order to minimise steric interactions, and with little difference in the 
population of the two conformations.  In this case, the trajectory of nucleophilic attack is 
governed by the hydride source, with increased selectivity observed only with the larger 
L-selectride reducing agent (compare entries 1 2).  
 
Scheme 93: Possible conformations of starting ketone, when R=Me and when R=Ph 
Thus the difference in conformation of the methyl and phenyl ketones leads to a 
difference in the factors controlling the selective of attack of the hydride. Lunazzi’s 
publication142 on the unexpected rotation barriers in biaryls bearing ortho-substituted 
ketones also pointed to a conformational difference between methyl and phenyl ketones.  
Through Variable Temperature NMR experiments, he discovered that “smaller” 
substituents had a higher barrier to rotation than “larger” substituents (Table 34). 
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Entry R ΔG≠ / kJ mol-1 
1 H 45.6 
2 Me 34.8 
3 iPr 37.3 
4 tBu 30.1 
Table 34:  Barriers to rotation published by Lunazzi142  
Their proposal was that a difference in the conformation of these ketones was the 
origin of these unexpected observations.  When R is small (H or Me, entry 1 or 2 ) the 
ketone sits essentially co-planar with the aryl ring.  In this conformation the C=O moiety 
exerts a relatively large steric effect upon the aryl-aryl bond rotation as the aryl rings 
become co-planar.  By contrast when R is large (entry 4) the steric effect of the R group 
forces the ketone out of the plane of the ring.  In this orthogonal conformation the steric 
hindrance exerted upon the axis is lower than when the ketone is co-planar leading to a 
lower barrier to rotation.  
It is also possible that one of the conformations reacts faster than the other with 
the hydride reagent, and that it is interconversion between the two during the reaction 
that accounts for the stereoselectivity.  However, the high barriers to rotation make this 
unlikely. 
It is also worth noting that methyl Grignard addition to our formyl derivative 243 
resulted in a 30:70 ratio of diastereomers, while phenyl Grigard addition gave no 
stereoselectivity (Scheme 92).  This suggests that the conformational freedom about the 
C-CHO bond allows the aldehyde to present either face to the incoming nucleophile in 
the case of phenyl Griganrd.  In the case of methyl Grignard, it is possible that the 
Lewis-acidic magnesium is able to coordinate to the oxygen of the carbonyl in order to 
present a preferred face for the organometallic reagent to attack (Figure 27). 
 
Figure 27: Stereoselectivity of Griganard addition to formyl 243 
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2.4.2 Stereoselective additions to diaryl sulfides 
The ability for diaryl-sulfides to exist as stable atropisomers was investigated by 
James Senior of the Clayden group on a project running concurrently with those of the 
diaryl ethers.  It was found that the diaryl sulfides could exist as seperable atropisomers 
if the axis was tetra ortho-substituted.14 
We decided to investigate the ability of the diaryl sulfide axis to direct 
diastereocontrol using ortho-brominated compounds 250 (Scheme 94). 
	  
Scheme 94:  Stereoselectivity of additions to a diaryl sulfide 
Buchwald143 and Wang144 have reported the coupling methodology employed in 
the synthesis of brominated diaryl sulfides of type 250.  They investigated the 
preferential coupling of iodines in the presence of bromides under copper(I) mediated 
cross coupling conditions, and in all cases, the considerably more reactive aryl iodide 
reacted preferentially with the thiophenol derivative.  
A copper(I) catalysed cross coupling of aromatic iodide 258 with thiophenol 256 
in the method reported by Buchwald was therefore used to afford 250 in 64% yield 
(Scheme 95).  Thiophenol 256 was reached via bromination of commercially available 
3,5-di-tert-butyl toluene (55%), where bromine addition occurs in the least sterically 
hindered position.  Dimethyl disulfide then reacts cleanly with the aryl lithium derived 
from 254 to yield sulfide 255 which was demethylated145 without purification to afford 
256 in excellent yields (87%).  Iodide 258 was reached via the conditions reported by 
Stavber:146 substituted benzene 257 was heated with elemental iodine and 1-
(chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octanebis(tetrafluoroborate), known 
under the commercial name Selectfluor™, in acetonitrile to afford 258 in 42% yield. 
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 128
 
Scheme 95: Synthesis of ortho-brominated diaryl sulfide 250 
(a) Br2, Fe powder, CHCl3, 0°C, 4h 
(b) i. t-BuLi,; ii.Me2S2 
(c) Sodium 2-methyl-2-propanethiolate (5 eq), 16h reflux 
(d) CuI (1 equiv), K2CO3 (2 equiv), ethylene glycol (2 equiv), tert-amyl alcohol, 120 °C, 24 h 
The diastereoselectivity in the addition reactions of a variety of aldehydes to 
diaryl sulfide 250 was undertaken by subjecting the brominated compound 250 to a Br-
Li exchange in THF with 1 equivalent of nBuLi at -78 °C for 1 minute before addition of 
a range of aldehyde quenches (Scheme 96, Table 35) 
 
Scheme 96: Stereoselective synthesis of diaryl sulfides 
(a) i. nBuLi, -78 °C, 1 min; ii. RCHO 
 
Entry  R Yield / % dr[a] 
1 259 Me 18 2:1 
2 260 Et 23 2:1 
3 261 i-Pr 38 6:1 
4 262 Ph 68 > 95:5 
Table 35: Stereoselective addition of aldehydes to diaryl sulfide 250 
[a] dr’s measured as a ratio of of diastereotopic signals in 1H NMR 
The reaction of diaryl sulfide 250 with acetaldehyde (entry 1), propionaldehyde 
(entry 2) and i-butryaldehyde (entry 3) occurred in low yields and gave complex reaction 
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mixtures, even after purification of the starting aldehydes.  This is thought to be due to 
polymerisation of the aldehydes under the basic conditions of the reaction, as reaction 
with sterically encumbered lithiated 251 is slow.  The diastereoselectivity increased 
from 2:1  6:1 when the size of R increased from a methyl/ethyl (entries 1 and 2) to an 
iso-propyl (entry 3). Heating the mixture of diastereomers of 260 for 16 h at 45 °C 
increased the presence of the less favoured diastereomer by around 14%, suggesting that 
that the observed selectivities must arise by kinetic control. 
In an attempt to suppress aldehyde polymerisation, and increase the 
stereoselectivity of these reactions, benzaldehyde was employed as a quench.  In this 
case, the reaction occurred in high yield (68%) and with complete control of 
stereoselectivity (entry 4).  Crude 1H NMR showed only one doublet peak corresponding 
to the C(OH)HPh proton. 
It is likely that the system seen here is analogous to that seen in the diaryl 
ureas13, where the reaction proceeds through the transition state 263 (Figure 28).   
 
Figure 28: Proposed transition state in the syn selective addition of ortho lithiated ureas to aldehydes13 
Aggregation of the lithiated moiety in solution results in the aldehyde 
approaching syn to the urea methyl group.  Steric hindrance between the R group and the 
methyl group then dictates the diastereofacial selectivity.  This leads to excellent 
selectivity for the syn isomer (Scheme 97, Table 36).    
 
Scheme 97: Stereoselective addition of aldehydes to urea 264 
(a) i) s-BuLi (2 equiv) -78 °C, THF; ii) RCHO 
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R 
−78 ˚C 
Ratio syn-265 : anti-265 
−90 ˚C 
Ratio syn-265 : anti-265 
Me 84:16 99:1 
Et 83:17 97:3 
i-Pr 97:3 98:2 
Ph 63:37 70:30 
Table 36: Stereoselective addition of aldehydes to urea 264 
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2.4.3 Conformational study of a diaryl amide in solution 
 
The amide bond structure has been studied extensively due to the amide moiety 
being one of the most important functions in biological systems.147 Its usefulness in 
synthesis has also been previously discussed within this thesis, namely in section 1.3, 
where the remote stereocontrol work carried out within the Clayden group was achieved 
by utilising their well-defined conformation.  However, the work proved difficult to 
extend beyond the 1,23-stereocontrol due to low yielding Suzuki couplings of more 
extended oligoxanthenes.  This prompted the investigation of helices as potential 
converyors of stereochemical information, replacing the xanthene monomer with 
another that would be more liable to oligomerisation, such as a benzanilide. 
Secondary benzanilides 266 generally adopt a ring-trans (formally Z) 
conformation (Figure 29) and their oligomers have proven to adopt a well-defined 
helical structure, a consequence of both the preferred geometry of the amide bonds and 
their hydrogen bonding ability.148 
 
Figure 29: Conformational control in the diaryl-amides 
The conformation of N-alkylated anilides have also been investigated in detail, 
and it has been shown that N-alkylated benzanilides favour the conformation 267, which 
places the aryl rings cis (formally E) in the crystal and in the solution. 149  The 
conformational ratio of these tertiary benzamides can be altered by the size of the 
substituents at the aromatic ortho position and on the nitrogen atom.150,151 and Clayden 
has shown that benzanilide 268 bearing two iodo substituents at the ortho position of 
each ring and a benzyl group on the nitrogen, exhibits high conformational control.151 
 A study investigating the conformational behaviour of this class of compound 
was therefore undertaken152 in the hope that limited conformational freedom and may be 
the formation of helical structures would be observed.   Dimeric compounds related to 
meta-linked benzanilides 269 were synthesised as part of this study and their 
conformational ratios in solution measured by NMR (Table 37).153  
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Substitution Entry 269 
R1 R2 
Ratio of conformers[a] 
1 a Me Me 80:20 
2 b Bn Me 80:20 
   81:12 (-60 °C) 
   82:18 (C6D6) 
   87:13 (THF) 
 
   87:13 (DMSO) 
3 c Bn Bn 85:15 
Table 37: Conformational isomerism in benzanilides 269 
[a] Ratio of conformers evident in NMR in CDCl3 at 23 °C unless otherwise stated 
 
It was seen that the tertiary diamides in entries 269a-c existed in solution as a 
mixture of two major conformers in a ratio of 4:1 to 7.5:1 depending on the solvent and 
temperature.  Although not conformationally uniform, this high level of control was still 
remarkable given the compounds’ potential to exhibit (on the NMR timescale) four 
geometrical (cis/trans) amide conformers multiplied by four axial (syn/syn, syn/anti etc.) 
conformers. 
It was somewhat unexpected that the size of the R1 group (=Me or Bn) had 
virtually no influence on the conformational selectivity (compare 269a to 269b, entries 1 
and 2).  Although the selectivity slightly increased when R2 was increased in size from 
Me to Bn (compare entries 2 and 3).  At low temperature (-60 °C, CDCl3), the 1H NMR 
showed an improvement of conformational ratio to 88:12, but with signals remaining 
broadened. Solvent effects on the conformational ratio of entry 2 were also studied at 25 
°C, with marginally better conformational selectivities obtained in C6D6 (82:18), THF-d8 
(87:13) and DMSO-d6 (87:13). 
X-ray crystallography154 allowed the solid-state structure of 269b to be 
determined (Figure 30). 
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Figure 30: X-ray crystal structure of 269b 
Both amide bonds were seen to adopt a cis C-N conformation, in line with 
precedent.  As has been previously observed within the group, the methyl groups on 
each aromatic ring flanking the benzanilide amide function align anti to avoid steric 
interaction.151 The cis orientation of benzamides across the central aromatic ring can be 
explained by a dipole-dipole interaction (shown in Fig. 30) between both amide 
functions.38  Unfortunately, attempts to determine whether the conformation in the solid 
state is the same as the major conformation in solution were unsuccessful - dissolving a 
crystal of 269b at low temperature (-50°C) and acquiring a 1H NMR spectrum 
immediately returned the same mixture of conformers as that obtained on cooling a 
room temperature solution. In an attempt to establish which of the conformational 
features of 269 are well controlled, and hence identify the second, minor, conformer, 
compound 272 was synthesized as part of a strategy towards studying analogues of 269b 
lacking one or more of the conformationally restricted amide N-CO, Ar-CO or Ar-N 
bonds (Scheme 98).  
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Scheme 98: Synthesis of conformational analogue 272  
(a) Et3N, DCM, 0 °C to RT 
Diaryl-amide monomer 272, analogous to the conformational features shown in 
bold in scheme 99, was synthesised via an amide coupling of acid chloride 270 with 
amine 271. 
The 1H NMR spectrum of 272 revealed the presence of two conformers in a ratio 
of 90:10, which must be due to rotamers about the N-CO bond (ring cis or ring trans).  
The observable peaks in the spectra (those of the CH2Ph groups of each conformer) are 
as the result of each conformer having a barrier to rotation about the Ar-CO bond.  We 
therefore undertook a Variable Temperature study to find the respective barriers to 
rotation for each conformer. 
2.4.3.1  Variable temperature NMR analysis of diaryl amide 272 
The CH2Ph group of the minor rotamer appeared as a sharp AB system (due to 
slow Ar-CO rotation) at ambient temperature (Figure 31). However, the CH2Ph group of 
the major conformer was a broadened singlet at rt, which decoalesced to an AB system 
on cooling to -50 °C in CDCl3.   
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Figure 31: VT NMR and lineshape simulation using gNMR for 272 
By modeling the resultanting line-shapes, and fitting the rates obtained to the 
Eyring equation (see Appendix I), we obtained a barrier to rotation about the Ar-CO 
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bond in the major (ring-cis) conformer 272a of 50.1 kJ mol-1 at 25 °C.  The 
corresponding barrier to rotation in the minor (ring-trans) conformer 272b was 62.6 kJ 
mol-1 at 25 °C.  This higher barrier also shows that N-CO rotation must be slow, or 
otherwise a stepwise mechanism for Ar-CO bond rotation of the minor conformer would 
exist by interconversion with the major conformer. 
  The major conformer 272a, which presumably has the two aryl rings cis about 
the N-CO bond as illustrated in Figure 31, has an Ar-CO barrier too low to exhibit 
rotamers (enantiomeric in this case) at rt, even with a large 2-iodo substituent. This 
presumably reflects the small size of the N-Ph group, an effect which Clayden 
decribed110 during his studies of the barriers to rotation in the benzamides.  Here he 
proposed two different transition states for the rotation about a benzamide axis, 
depending on the size of the substituents attached to nitrogen (Figure 32 and Figure 33).   
 
Figure 32: Transition states for rotation about a benzamide axis when R is small 
 
Rotation about the Ar-CO bond involves the nitrogen and oxygen atoms passing 
through the plane of the ring.  When R1 and R2 are small, the transition state outlined in 
Figure 32 is the preferred route to rotation:  the lower energy pathway will be that in 
which NR1R2 passes the smaller of R3 or R4 thus the key interactions are between R2 and 
R3 and between the carbonyl oxygen and R4. 
When R2 is especially large, however, and there is only one substituent at either 
R3 or R4, the group found that the sizes of R1 and R2 had little influence on the barrier to 
rotation.  Thus they proposed an alternative mechanism outlined in Figure 33. R3 is no 
longer small enough to allow R2 to slip past, and instead the only way in which the 
NR1R2 group can pass R3 is by rotating so it is no longer in the plane of the carbonyl 
group. The main interaction at the transition state is now between N and R3, and they 
observed that changing R2 affected the barrier to rotation less than when R2 was small. 
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Figure 33: Transition states for rotation about a benzamide axis when R is large 
It is therefore possible that the apparent conformational uniformity of dimeric  
269b could be due to a similarly fast Ar-CO bond rotation, with its Ar-CO rotomers 
becoming spectroscopicaly distinguishable only at low temperatures.  However, the fact 
that little change in the ratio of conformers is seen on lowering the temperature to -60 °C 
suggests this is unlikely. 
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3. Conclusions and Future Work 
 
We have established a synthesis to provide sterically encumbered atropisomeric 
diaryl ethers with four ortho-substituents.  A route towards their asymmetric syntheis 
through desymmetrisation has also been successful.  P-140 was achieved through the 
desymmetrisation of 119d and kinetic resolution of 140 with GAOase M3-5 and with 
treatment of 118d with KRED118 (Scheme 99).  The barrier to enantiomerisation in the 
product is greater than 130 kJ mol–1 at 90 °C. 
 
Scheme 99: Biocatalytic Desymmetrisation of an atropisomer by enantioselective oxidase and  
ketoreductases 
A route towards synthesising a phophine containing ligand is underway, and 
future work will look into an applicable area of asymmetric catalysis in which to utilise 
it.  Diaryl ether based ligands have seen success in the hydroformylation of alkenes, and 
an asymmetric version of this reaction would be a good starting point (Scheme 100): the	  
asymmetric hydroformylation of olefins serves as a direct route to optically active 
aldehydes which are valuable precursors for various pharmaceuticals and agrochemicals.  
 
Scheme 100: Hydroformylation of alkenes possible with bidentate ligand 
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The current world-record holder concerning ee for styrene is a hybrid phosphine-
phosphoramidite ligand adapted from BINAPHOS 276 and was developed in 2006.155  We 
could also apply our successful method of desymmetrisation to simple biaryls.  
 
Figure 34: Takaya’s (R,S)-BINAPHOS 
Excellent d.r.’s and moderate e.r.’s are achieveable in the lateral litiation of 
diaryl ethers flanked by carbamate directing groups.  However, our results from these 
investigations are limited due to the difficulties of the synthesis.  We were largely unable 
to eliminate products of reprotonation, oxidation and other unknown side products from 
the reaction.    
 We were nevertheless able to determine that the intermediate organolithium has 
some degree of configurational stability and presumably that the lateral lithiation of 195 
is stereoselective and yields a single diastereoisomeric atropisomer of organoithium 204.  
This organolithium reacts with most electrophiles to give 277 with what we assume is 
retention of stereochemistry (Scheme 101).   
 
Scheme 101: Assumed stereoselectivity in the lateral lithiation of 195 
(a): i. secBuLi, (–)-sparteine; ii. Electrophile 
 
 We were also able to prove that an asymmetric deprotonation determines the 
overall enantioselectivity of the reaction to generate 277. Consequently, as diethyl ether 
is a slightly coordinating solvent and may be competitively coordinating with the 
organolithium, (–)-sparteine might more strongly form a complex with lithium (and 
hence improve enantioselectivity) if a completely non-coordinating solvent such as 
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toluene is used.  Other chiral bases such as the bisoxazoline ligands (BOX) 278 used by 
Hoppe and the β-amino-alcohol 279 reported by Coldham156 might also establish higher 
enantioselectivities. 
 
Figure 35: Other chiral bases for the asymmetric deprotonation of 195 
X-ray crystallographic studies of the products of lateral lithiation were not 
possible due to the products being oils and gums.  High-level quantum chemical 
methods could therefore allow insight into the energetic situation of the intermediate 
lithiated complexes.  Molecular modelling of the analogues of 277 as achieved in the 
assignment of configuration of (P)-140 in section 2.2.2.3 could also provide useful 
information to help clarify the observed stereochemical results. 
 With regards to some of the problems experienced with the synthesis, lithiation α 
to the oxygen of carbamates are known in some cases to lead to products of 
rearrangement,157 particularly 1,2 acyl transfer.  It would be interesting to investigate the 
possibility of such a mechanism occurring in our own substrates.  Although the isolation 
of side products from complicated reaction mixtures was largely unsuccesfull, 
conditions known to favour rearrangement (such as more concentrated reaction 
solutions) might force the formation of a potential rearrangement product and allow for 
its analysis. 
Diastereisomeric atropisomers of diaryl ethers were additionally synthesised 
through a stereoselective reduction to give predominantly the anti isomer (Scheme 102). 
 
Scheme 102: Stereoselective synthesis of a diaryl ether 
(a) Superhydride, THF 0 °C or L-Selectride THF 0 °C 
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By utilising a chiral reducing agent such as the proline derived Corey-Bakshi-
Shibata catalyst158 280 a desymmetrising enantioselective reduction of prochiral 152a 
might be possible (Scheme 103). 
 
Scheme 103: Enantioselective synthesis of a diaryl ether 
The diastereoselective synthesis of a diaryl sulfide was achieved by addition of 
benzaldehyde to the lithioderivative of 250 (Scheme 104).  Smaller aldehydes led to the 
formation of a mixture of isomers.   
 
Scheme 104: Diastereoselective synthesis of a diaryl-sulfide by addition to an aldehyde 
 (a) i. nBuLi, 1 min, THF; ii. benzaldehyde 
Future work in this series could look at the ability of the sulfide axis to undergo 
stereoselective reductions in an analogous way to that of the diaryl ethers.  A precursor 
for the study might easily be accessible from a Br-Li exchange of 250 in the presence of 
DMF (Scheme 105).  
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Scheme 105: Stereoselective reductions of diaryl sulfides 
(a) i. nBuLi, 1 min, THF -78 °C; ii. DMF 
(b) i.RMgBr; ii dess-martin periodinane 
(c) Superhydride, THF 0 °C; or L-Selectride THF 0 °C 
A synthetic route towards substituted diaryl-sulfides was easily accessible 
through the coupling of aromatic iodides and thiophenols.  Mono-oxidation will afford 
diaryl sulfoxides 285, a structure also capable of displaying atropisomerism (see 
Appendix II).  With conditions for axial chirality established for diaryl ethers, sulfides 
and sulfoxides, future work could establish a set of structural conditions required for 285 
to display atropisomerism (Scheme 106). 
 
Scheme 106: Atropisomerism in diaryl-sulfoxides 
 We studied the conformation adopted in solution of diaryl-amide 272 and found 
that cis or trans conformers about the N-CO bond were evident in a 90:10 ratio at room 
temperature (Figure 36). 
 
Figure 36: Conformation preferences in solution of diaryl amide 272 
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 The benzylic protons of the major conformer 272a were not diastereotopic at 
room temperature because rotation about the Ar-N bond is fast on the NMR timescale, 
despite the presence of a bulky Ph.  This was presumably thought to reflect the “small 
size” of the N-Ph group.  
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4. Appendices 
I.  Calculation of barriers to rotation using VT NMR  
Variable temperature NMR studies were undertaken in order to calculate 
barriers, ΔG‡, to rotation about the Ar–C(O) axis for each rotamer of benzanilide 272.  
The general method for calculation of barriers to rotation in this way is described below.   
As the temperature of the NMR sample increases or decreases there is an 
increase or decrease in the rate of interconversion; this is observed as a coalescence / 
decoalescence of the CH2Ph AB system.  It is possible to use the temperature of 
coalescence of these signals to measure the rate of, and barrier to, rotation about the 
axis. 
 The 1H NMR spectrum is obtained at a temperature low enough for the 
interconverting groups to be at their slow-exchange limit. This is done to obtain the 
chemical shift difference Δν between the interconverting signals or the coupling 
constant of the diastereotopic protons, JAB. 
 The sample is gradually heated and spectra are recorded at regular temperature 
intervals to find the coalescence temperature Tc of the signals. 
The rate of exchange, k, at the coalescence temperature Tc can be estimated using the 
Gutowski-Holm approximation: 159 
€ 
k = πΔν2  (for uncoupled signals), or 
 
€ 
k = π (Δν )
2 + 6(JAB )2
2  (for coupled signals). 
 
 This calculation can be simplified by simulating the experimental lines shapes near 
the slow and fast exchange limits using commercially available gNMR software.  
From the approximated value of k, ΔG‡ can be found using the Eyring equation: 
€ 
ΔG‡ = 4.575 x 10-3 × Tc × 10.319 + log10
Tc
k
⎛ 
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⎥  
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The VT spectra were run on a Varian 400 MHz spectrometer equipped with 
variable temperature probe, with a range of –90 to +120 °C.  
Figure 31 (section 2 4.3.1) showed the modelled and observed line shapes at a 
series of temperatures and the rate constant, k, for the coalescence / decoalescence of an 
AB system for the CH2Ph group for each of the major (272a) and minor (272b) 
conformers of benzanilide 272.  The broadening of the two benzylic AB systems were 
simulated and compared with the acquired spectra using difference spectra.  From these 
simulations, the rate constant k for inversion could be determined as a function of 
temperature for each rotamer.  The values produced for 272a are shown in Table 38. 
 
Temp / ˚C k / s–1 error T / K ln (k / T) (1 / T) / K–1 
–40 55 3 233.15 -1.44435 0.004289 
–30 160 20 243.15 -0.41850 0.004113 
–20 360 20 253.15 0.35212 0.00395 
Table 38: Values produced from the Eyring equation for 272a 
Hence, from the Eyring equation, the activation parameters could be determined 
by plotting ln(k / T) versus (1 / T) (Figure 37) where:  
 ∆H‡ = – (slope) × R 
 ∆S‡ = [intercept + ln(h / Kb)] × R 
Where R = gas constant, h = Planck’s constant and Kb = Boltzmann’s constant.  
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Figure 37: Plot of ln kA vs 1/T to determine ΔH‡ and ΔS‡ for rotation in 272a 
 
The Eyring plot of ln(k/T) vs 1/T (Figure 37) gives a straight line from which, 
using the equation    y = mx + c, the gradient (m) gives the enthalpy of rotation (∆H‡) 
and the y intercept (c) gives the entropy of rotation (∆S‡) as described above.  Inserting 
these values into Gibbs´ equation for free energy (∆G‡ = ∆H‡ – T∆S‡) gives an 
estimation of the barrier to rotation (∆G‡) at room temperature (taken to be 25 ˚C).   
Errors were calculated from the R2 value of the line of best fit of the Eyring plot.  
For an analogous description of calculating activation parameters using variable 
temperature NMR see work by Shipman et al. on barriers to inversion in aziridines. 160 
m ΔH‡ c ΔS‡ ∆G‡298  
–5308 +44.1 kJ mol–1 21.35 –20.03 J mol–1 50.1 kJ mol–1 
Table 39: ΔH‡ and ΔS‡ and ΔG‡ for diaryl amide 272a 
 
Using this method of analysis the activation parameters for rotation about the 
axis for diaryl amide 272b was also calculated (Table 40 and 41, Figure 38). 
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Temp / ˚C k / s–1 error T / K ln (k / T) (1 / T) / K–1 
0 3 1 273.15 -4.51141 0.003661 
25 80 10 298.15 -1.31557 0.003354 
30 100 20 303.15 -1.10906 0.003299 
Table 40: Values produced from the Eyring equation for 272b 
 
Figure 38: Plot of ln kA vs 1/T to determine ΔH‡ and ΔS‡ for rotation in 272b 
m ΔH‡ c ΔS‡ ∆G‡298  
–9736 +80.9 kJ mol–1 31.15 –61.44 J mol–1 62.6 kJ mol–1 
Table 41: ΔH‡ and ΔS‡ and ΔG‡ for diaryl amide 272b 
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II. Synthesis of diaryl sulfoxides 
Sulfoxides display a configurational stereogenic center (the sulfur atom) in 
addition to the conformational stereogenic axis.  Consequently, when Ar-SO rotation is 
fast a pair of configurational enantiomers will be observed, whereas when this rotation is 
slowed a pair of atropisomers for each individual enantiomer should be detected (Figure 
39).   
 
Figure 39: Atropisomerism in diaryl sulfoxides 
With a direct route towards the diaryl sulfides easily accessible via the Buchwald 
coupling chemistry described in section 2.4.2, we synthesised diaryl sulfoxides 290a-c 
via the route shown (Scheme 107, Table 42).   
 
 
Scheme 107: Synthesis of diaryl sulfoxides 290a-c  
(a) CuI (1 eq.), K2CO3 (2 equiv), ethylene glycol (2 equiv), tert-amyl alcohol, 120 °C, 24 h 
(b) mCPBA (1 eq), DCM, 2 h 
 R Coupling Yield 289 / % Oxidation yield 290 / % 
a iso-Pr 85 95 
b tert-Bu 88 93 
c Naphthyl 90 90 
Table 42: Yields for formation of diaryl sulfides 289a-c and diaryl sulfoxides 290a-c 
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O
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Work undertaken in the Clayden group has already established the requirements 
for atropisomerism in the biaryl sulfides and sulfones and we aimed to determine a set of 
structural requirements to achieve atropisomerism in the diaryl sulfoxides.  
It was clear from results in previous studies that in order to observe 
atropisomerism, we would probably require a tetra ortho-substituted sulfoxide.   We 
aimed to synthesise tetra-ortho substituted biaryl sulfoxides via a double ortho-lithiation 
strategy (Scheme 108) and hoped to detect line broadening or even the presence of 2 sets 
of NMR signals appropriate for a pair of atropisomers.  VT NMR and computer line-
shape simulations (as used in section 2.4.3.1) could then yield the rate constants (k, in s-
1) for the interconversion and hence corresponding free energy of activation (ΔG). 
 
 
Scheme 108: Planned double Ortho-Ilithiation of diaryl sulfoxides  
Unfortunately, initial attempts to ortho-lithiate with either LDA or LiTMP and 
TMSCl failed when R = iso-Propyl, and when R = Napthyl, and owing to time 
constraints the study was abandoned. 
However, Snieckus has reported the sulfoxide functionality to direct ortho-
lithiation in good yields.161 When t-butyl aryl sulfone 293 is treated with nBuLi at –78 
ºC in THF for one hour an ortho anion is generated, which can be quenched with a range 
of electrophiles (Scheme 109, Table 43). 
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Scheme 109: Ortho-lithiation of tert-butyl aryl sulfoxide 293 
(a) i. nBuLi, -78 °C, 30 min; ii. E+ 
Entry Electrophile (E+) E Yield / % 
1 MeOD D 88 
2 MeI Me 96 
3 PhCHO Ph 82 
4 Br(CH2)2Br Br 85 
5 DMF CHO 0 
6 Me3SiCl Me3Si 89 
7 SnMe3Cl SnMe3 85 
Table 43: ortho-lithiation of tert-butyl aryl sulfoxide 293 
It might therefore be possible, utilising or modifying the ortho-lithiation strategy 
above, to synthesise suitable precursors for a study into the structural requirements 
needed to achieve atropisomerism in diaryl sulfoxides. 
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III.  Examples of HPLC traces used to calculate ee’s in section 2.2 
 
 
Figure 40: Normal phase HPLC for mixture of diol 119d, monoaldehyde 140 and dialdehyde 118d:  
  A = dialdehyde 118d; B = monoaldehyde M-140; C = monoaldehyde P-140; D = diol 119d. 
Chiralcel® ASH, isohexane : IPA = 93:7, λ = 254 nm, flow rate = 0.5-1.0 ml/min 
 
 
 
 
 
Figure 41: Reverse phase HPLC for mixture of monoaldehyde 140 and dialdehyde 118d: 
  A = monoaldehyde 140; B = dialdehyde 118d 
Eclipse XDB C18, acetonitrile : water = 50:50, λ = 254 nm, flow rate = 1.0 ml/min 
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Figure 42: Desymmetrisation of 119d using GOase (ee of 140 = 91%) 
  A = dialdehyde 118d; B = monoaldehyde M-140; C = monoaldehyde P-140; D = diol 119d 
Chiralcel® ASH, isohexane : IPA = 93:7, λ = 254 nm, flow rate = 0.5-1.0 ml/min 
 
 
 
 
 
Figure 43: Kinetic Resolution of racemic 140 using GOase (ee of 140 = 94%) 
  A = dialdehyde 118d; B = monoaldehyde M-140; C = monoaldehyde P-140 
Chiralcel® ASH, isohexane : IPA = 93:7, λ = 254 nm, flow rate = 0.5-1.0 ml/min 
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Figure 44: Reduction of dialdehyde 118d using ketoreductase KRED 118 (P-140) (ee of 140 = 77%) 
  A = dialdehyde 118d; B = monoaldehyde M-140; C = monoaldehyde P-140 
  Chiralcel® ASH, isohexane : IPA = 93:7, λ = 254 nm, flow rate = 0.5-1.0 ml/min 
 
 
 
 
 
 
 
Figure 45: Reduction of dialdehyde 118d using ketoreductase KRED108 (M-140) (ee of 2 = 78%) 
A = dialdehyde 118d; B = monoaldehyde M-140; C = monoaldehyde P-140 
Chiralcel® ASH, isohexane : IPA = 93:7, λ = 254 nm, flow rate = 0.5-1.0 ml/min 
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5. Experimental Section 
5.1 General Procedures 
All non-aqueous experiments were performed under an inert atmosphere of dry nitrogen 
or argon using oven dried apparatus, unless otherwise stated.  The temperatures quoted 
are those of an external bath.    
Reagents and solvents were used as received except where stated below, or in the 
experimental text.  All solvents and reagents requiring purification were done so using 
standard laboratory techniques.162  The solvents were either distilled or of Analar quality. 
Tetrahydrofuran and diethyl ether were freshly distilled over sodium under an 
atmosphere of nitrogen and using benzophenone as a radical indicator.  
Dichloromethane and toluene were distilled over calcium hydride under an atmosphere 
of nitrogen. Diisopropylamine was freshly distilled over potassium hydroxide under an 
atmosphere of nitrogen.  Petrol refers to the fraction of light petroleum ether boiling 
between 40-60 °C.  All other solvents and commercially obtained reagents were used as 
received or purified using standard procedures. n-Butyllithium was obtained as a 
solution (c. 2.5 M ) in cyclohexane, sec- Butyllithium was obtained as a solution (c. 1.3 
M) in cyclohexane and tert-Butyllithium was obtained as a solution (c. 1.5 M) in 
pentane.  All organolithium solutions were titrated to use against a stirred solution of 
diphenylacetic acid in THF at -78 °C. 
Analytical thin layer chromatography was carried out on Macher-Nagel pre-coated 0.2 
mm silica plates, visualisation by UV light at 254 nm.  Flash column chromatography 
was carried out on Fluorochem Davisil 40 – 63 µm 60 Å silica, under positive air 
pressure. 
Proton nuclear magnetic resonance (1H NMR) spectra were recorded on Varian XL 300 
(300 MHz), Bruker Ultrashield 400 (400 MHz) or Bruker Ultrashield 500 (500 MHz) 
spectrometer with residual non-deuterated solvent as the internal standard (δH: CDCl3 
7.27 ppm; δC: 77.0 ppm; δH: DMSO-d6 2.50 ppm; δC: DMSO-d6 39.4 ppm). Carbon 
nuclear magnetic resonance (13C NMR) spectra were recorded on Varian XL 300 (75 
MHz), Bruker Ultrashield 400 (100 MHz) or Bruker Ultrashield 500 (125 MHz) 
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spectrometer.  Chemical shifts (δH and δC) are quoted in parts per million (ppm), 
downfield of tetramethylsilane.  Multiplicity is abbreviated as follows: singlet (s), 
doublet (d), triplet (t), quartet (q), septet (sept.), multiplet (m), broad (br.) or a 
combination of these.  Coupling constants J are quoted in Hertz (Hz) and values rounded 
to nearest 0.5 Hz.  
Low resolution mass spectra were recorded on Kratos MS25, Kratos Concept IS and 
Fisons VG Trio 2000 spectrometers using electron impact (EI), chemical ionisation (CI) 
and electrospray (ES). High resolution mass spectra were recorded on a Kratos Concept-
IS mass spectrometer. 
Infrared spectra were recorded on a Perkin-Elmer Spectrum RX I FT-IR or an ATI 
Matterson Genesis FT-IR spectrometer. All samples were run as an evaporated film on a 
sodium chloride plate. Absorption maxima (νmax) are quoted in wavenumbers (cm-1). 
Melting points are uncorrected and were carried out on a ‘GallenKamp Melting Point’ 
apparatus or a Kofler microscope melting point machine. 
Chiral HPLC measurements were carried out on a Hewlett Packard Series 1050 
instrument with a Diode Array Detector, using Daicel Chiralcel OD-H, Daicel ChiralPak 
OT(+), Daicel Chiralcel AD-H, (R,R)-Whelk 01 or (R,R)-β-Gem 1 chiral stationary 
phases using a mixture of hexane and isopropanol (IPA) as eluent. 
Chiral HPLC was also performed on an Agilent system equipped with a G1379A 
degasser, G1312A binary pump, a G1329A autosampler unit, a G1367A diode array 
detector and a G1316A temperature controlled column compartment; column Chiralcel® 
ASH, using a mixture of hexane and IPA as eluent, λ = 254 nm 
 
Reverse phase chiral HPLC was performed on an Agilent system equipped with a 
G1379A degasser, G1312A binary pump, a G1329A autosampler unit, a G1367A diode 
array detector and a G1316A temperature controlled column compartment; column 
Eclipse XDB C18, using a mixture of acetonitrile and water as eluent, λ = 254 nm,  
 
Optical rotations were measured on an Optical Activity AA-100 polarimeter with a 0.5 
ml, 0.25 dm cell. 
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General Procedure A:  Nucleophilic aromatic substitution – two step method 
Phenoxide 
Phenol (1 equiv.), potassium hydroxide (1 equiv.), and toluene (100 cm3) were charged 
to a flask and heated under reflux using Dean-Stark conditions for 2 hours, cooled to RT 
and solvent removed under reduced pressure, to yield the product that was used without 
further purification. 
 
2-Phenoxy-isophthalonitrile 
2-chloro-isophthalonitrile (1 equiv.), phenoxide (1 equiv.), and anhydrous DMF (100 
cm3) were charged to a flask and heated up to 156oC under N2.  The reaction mixture 
was allowed to stir at this temperature for 16 hours, and the excess DMF removed by 
vacuum distillation.  The resultant brown oil was dissolved in portions of EtOAc (x 3) 
and the combined organic phase washed with water (x 3), brine, dried (Na2SO4), and 
solvent removed under reduced pressure. 
General Procedure B:  Nucleophilic aromatic substitution – one step method 
Phenol (1 equiv.), base (1 equiv.), 3 Å molecular sieves (ca. 10 g) and anhydrous DMF 
(400 cm3) were charged to a flask and stirred at RT for 30 minutes. 2-chloro-
isophthalonitrile (1 equiv.) was added and the reaction mixture heated up to 156 °C 
under N2.  The reaction mixture was allowed to stir at this temperature for 16 hours, and 
the excess DMF removed by vacuum distillation.  The resultant brown oil was dissolved 
in portions of EtOAc (x 3) and the combined organic phases washed with water (x 3), 
brine, dried (Na2SO4), and solvent removed under reduced pressure. 
General Procedure C:  DiBAl-H reduction of nitriles 
DiBAl-H (1M solution in DCM or Toluene) (2.5 equiv.) was added slowly to a stirring 
solution of nitrile (1 equiv.) in dry solvent (DCM or Toluene) under nitrogen at –78 °C, 
unless otherwise stated.  The mixture was allowed warm to RT over a period of 16 
hours, HCl (cooled to 5 °C) was added to the reaction mixture and allowed to stir for a 
further hour.  A saturated solution of potassium sodium tartrate (“Rochelles salt”) was 
added and the reaction micture stirred at rt for a minimum of 2 h.  The solution was 
dilute diluted using EtOAc or DCM and the organic phase washed with water (x 3), 
brine, dried (Na2SO4), and the solvent removed under reduced pressure.  If an insoluble 
precipitate remained after dilution with EtOAc or DCM, conc. HCl was added dropwise 
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to the insoluble precipitate only, until the precipitate dissolved.  This was then diluted in 
DCM and the organic phase washed with water (x 3), brine, dried (Na2SO4), and the 
solvent removed under reduced pressure. 
General Procedure D:  Reduction of aldehydes 
The aldehyde dissolved in THF (50 cm3) was added to a stirring suspension of sodium 
borohydride in THF (100 cm3) under N2 and stirred for 16 hours.  NaOH solution (1.0 
M) was added and the mixture stirred for 1 min, diluted using EtOAc and layers 
separated, the organic fraction was washed with water, brine, dried (Na2SO4), and 
solvent removed under reduced pressure. 
General Procedure E:  Mono-reduction of di-aldehydes 
NaBH4/LiBH4 (0.25 equiv.) was added to a stirring solution of dialdehyde (1 equiv.) in 
ethanol (50 cm3) at 0 °C.  The mixture was stirred for 1 hour at RT and quenched by 
addition of water.  The solution was diluted using EtOAc, the organic phase washed 
with water, brine, dried (Na2SO4), and solvent removed under reduced pressure. 
General Procedure F:  Methyl protection of alcohols 
Alcohol (1 equiv.), dissolved in anhydrous THF (50 cm3), was added to a stirring 
suspension of NaH (6 equiv.) in THF (50 cm3) under N2 and stirred for 30 mins at rt.  
MeI was added and the mixture stirred for 16 hours, and quenched by addition of water. 
The solution was diluted using EtOAc, the organic phase washed with water, brine, 
dried (Na2SO4), and solvent removed under reduced pressure. 
General Procedure G:  Lateral lithiation of diaryl ethers 
Desired ether (1 equiv.) dissolved in ether (10 cm3) was freeze-thaw degassed under an 
atmosphere of argon.   secBuLi solution (1.6 equiv.) was added dropwise at -78 °C and 
the reaction mixture was stirred for 30 minutes (or the specified time if stated). The 
reaction was quenched with the desired electrophile and stirred at –78 °C with warming 
to rt over 16 h (or another specified time if stated). The reaction was quenched by 
addition of saturated NH4Cl solution and diluted using EtOAc.  The layers were 
separated and the organic phase was washed with water, brine, dried (Na2SO4), and 
solvent removed under reduced pressure. 
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General Procedure H: Lateral lithiation of diaryl ethers in the presence of (−)- 
sparteine 
Desired ether (1 equiv.) and freshly distilled (−)-sparteine (1.6 equiv) were dissolved in 
ether and freeze-thaw degassed under an atmosphere of argon. secBuLi solution (1.6 
equiv.) was added dropwise at -78 °C and the reaction mixture was stirred for 30 
minutes (or the specified time if stated). The reaction was quenched with the desired 
electrophile and stirred at –78 °C with warming to rt over 16 h (or another specified time 
if stated). The reaction was quenched by addition of saturated NH4Cl solution and 
diluted using EtOAc. The layers were separated and the organic phase was washed with 
water, brine, dried (Na2SO4), and solvent removed under reduced pressure. 
General Procedure I:  Sn   Li exchange 
A solution of stannane (1 equiv.) in ether (10 cm3) was freeze-thaw degassed under an 
atmosphere of Argon.  nBuLi solution (1.5 equiv.) was added dropwise to the solution at 
-78 °C and the reaction mixture was stirred for 2 hours (or the specified time if stated). 
The reaction was quenched with the desired electrophile and stirred at –78 °C with 
warming to rt over 16 h. The reaction was quenched by addition of saturated NH4Cl 
solution and diluted using EtOAc.  The layers were separated and the organic phase was 
washed with water, brine, dried (Na2SO4), and solvent removed under reduced pressure. 
General Procedure J:  Alkylation of mono-aldehydes 
MeMgBr (1.0 M in ether) / PhMgBr (1.0 M in THF) (1.2 equiv) was added dropwise to 
a stirring solution of aldehyde (1 equiv.) in THF (10 cm3) at 0 °C under N2, srirred for 2 
hours, warmed to rt and stirred for a further 16 hours.  HCl (1.0 M) was added and the 
mixture was stirred for 1 min.   The solution was diluted using EtOAc, the organic phase 
was washed with water, brine, dried (Na2SO4), and solvent removed under reduced 
pressure. 
General Procedure K:  Stereoselective reduction of ketones 
L-Selectride (LS) / SuperHydride (SH) (1.0 M in THF) (1 equiv.) was added dropwise to 
a stirring solution of ketone (1 equiv) in THF (10 cm3) at 0 °C under N2 and stirred for 1 
h.  The mixture was quenched by addition of 2M NaOH solution in H2O2 60 % solution 
in H2O, and then diluted using EtOAc. The organic phase was washed with water, brine, 
dried (Na2SO4), and solvent removed under reduced pressure. 
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General Procedure L:  Dess-Martin oxidation 
Alcohol (1 equiv) was added to a stirring suspension of Dess-Martin periodinane in 
anhydrous DCM (20 cm3)  at rt under N2, for 1 hour.  2M NaOH was added and the 
mixture was stirred for 0.5 h. The solution was diluted using DCM, the organic phase 
was washed with water, brine, dried (Na2SO4), and solvent removed under reduced 
pressure. 
General procedure M:  Br   Li exchange 
nBuLi solution (1 equiv.) was added dropwise to a solution of bromide (1 equiv.) in 
anhydrous THF (5 cm3)   at –78 °C under an atmosphere of nitrogen and stirred for 1 
minute.  The reaction was quenched with the desired electrophile and stirred at –78 °C 
with warming to rt over 16 h.  The reaction was quenched by addition of saturated 
NH4Cl solution and diluted using EtOAc.  The layers were separated and the organics 
were washed with water, brine, dried (Na2SO4), and solvent removed under reduced 
pressure. 
General procedure N:  Oxidation of sulfide to sulfone 
Solid mCPBA (1 equiv.) was added in one portion to a solution of sulfide (1 equiv.) in 
DCM (0.1 M solution) at rt.  The reaction was stirred at rt for a specified time and 
quenched by dropwise addition of saturated Na2S2O3 solution.  Organics were washed 
with water, NaOH solution (3.0 M) and brine, dried over MgSO4 and solvent removed 
under reduced pressure. 
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5.2 Experimental Data 
2-Chloro-isophthalonitrile (116) 
 
Using a modification of the method described by Krizan87 a solution of isophthalonitrile 
(5 g, 39.02 mmol, 1 equiv.) in anhydrous THF (100 cm3) was added dropwise to a 
stirring solution of LDA (46.82 mmol, 1.2 equiv.) in anhydrous THF (150 cm3) at –95oC 
and allowed to stir for approximately 1 hr.  Hexachloroethane (14.8 g, 62.44 mmol, 1.6 
equiv.) dissolved in anhydrous THF (150 cm3) was added to the reaction mixture at this 
temperature and the mixture allowed to stir for 1 hr and warmed to RT over a period of 
16 hrs.  The mixture was quenched by addition of saturated ammonium chloride solution 
and organics diluted using EtOAc.  The organic phase was washed with water, brine, 
dried (Na2SO4) and solvent removed under reduced pressure.  The product was purified 
by flash column chromatography (9:1 petrol : EtOAc) to yield the product as a light 
yellow solid (5.69 g, 89 %).   
δΗ (300 MHz, CDCl3) 7.94 (2H, d, J 8, H-1), and 7.57 (1H, t, J 8, H-2).; δC (100 MHz; 
CDCl3) 139.8, 137.6, 127.9, 115.5, and 114.3,  Analyses matched the reported data.87 
LDA: nBuLi (2.5M in Hexanes) (23 cm3, 28.09 mmol, 1 equiv.) was added dropwise to a 
stirred solution of anhydrous diisopropylamine (6.6 cm3, 28.09 mmol, 1 equiv.) 
dissolved in anhydrous THF (100 cm3) at 0oC under N2 and allowed to stir for 30 mins at 
this temperature. 
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2-(2-Isopropylphenoxy)isophthalonitrile (117a) 
 
2-Isopropylphenoxide 
2-Isopropylphenol (3.31 cm3, 24.6 mmol, 1 equiv.), potassium hydroxide (1.38 g, 24.6 
mmol, 1 equiv.), and toluene (100 cm3) were treated as described in general procedure 
A. 
2-(2-Isopropylphenoxy)isophthalonitrile 
2-Chloro-isophthalonitrile (4 g, 24.6 mmol, 1 equiv.), 2-isopropyl-phenoxide (4.31 g, 
24.6 mmol, 1 equiv.), and anhydrous DMF (100 cm3) were treated as described in 
General Procedure A.  The crude product was purified by flash column chromatography 
(4:1 petrol : EtOAc) to yield the desired product as a light yellow powder (5.55 g, 86 %). 
m.p. 92 – 94 °C;  Rf = 0.35 (5:1 petrol:EtOAc);  vmax(film/cm-1) 2238 (CN); δH (300 
MHz; CDCl3) 7.93 (2H, d, J 8, H-1), 7.44 (1H, dd, J 8 and 2, H-3), 7.40 (1H, t, J 8, H-
2), 7.24 (1H, td, J 8 and 2, H-4), 7.17 (1H, td, J 8 and 2, H-5), 6.60 (1H, dd, J 8 and 1.5, 
H-6), 3.48 (1H, sept, J 7, H-7) and 1.39 (6H, d, J 7, H-8).; δC (75 MHz; CDCl3) 160.0, 
154.3, 139.1, 138.9, 127.9, 127.2, 125.7, 124.9, 115.9, 113.9, 108.0, 27.7 and 22.9.; EI 
m/z 262 (M); CI m/z 280 (M + NH4+); HRMS found M 262.1100, C17H14N2O requires 
262.1101. 
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2-(2-tert-Butyl-phenoxy)-isophthalonitrile (117b) 
 
2-t-Butylphenoxide 
2-t-Butylphenol (3.76 cm3, 24.6 mmol, 1 equiv.), potassium hydroxide (1.38 g, 24.6 
mmol, 1 equiv.) and toluene (100 cm3) were treated as described in general procedure A. 
2-(2-tert-Butyl-phenoxy)-isophthalonitrile 
2-Chloro-isophthalonitrile (4.0 g, 24.6 mmol, 1 equiv.), 2-t-butyl-phenoxide (4.64 g, 
24.6 mmol, 1 equiv.), and anhydrous DMF (150 cm3) were treated as described in 
general procedure A.  The crude product was purified by flash column chromatography 
(4:1 petrol : EtOAc) to yield the desired product as a light brown powder (5.69 g, 83 %). 
Also synthesised by treatment of 2-t-Butylphenol (15 cm3,  98.4 mmol, 1.0 equiv.), NaH 
(60% dispersion in mineral oil) (1.97 g, 98.4 mmol, 1 equiv.), 2-Chloro-isophthalonitrile 
(16.0 g, 98.4 mmol, 1 equiv.), 3 Å molecular sieves (ca. 10 g) and anhydrous DMF (400 
cm3) as described in general procedure B. The crude product was purified by flash 
column chromatography (4:1 petrol : EtOAc) to yield the desired product as a light 
brown powder ( 22.27 g, 82 %). 
m.p. 117 – 119 °C; Rf = 0.31 (5:1 petrol:EtOAc); vmax(film/cm-1) 2238 (CN); δH (300 
MHz; CDCl3) 7.94 (2H, d, J 8, H-1), 7.52-7.50 (1H, m, H-3), 7.40 (1H, t, J 8, H-2), 
7.21-7.18 (2H, CH m, H-4 and H-5), 6.60-6.58 (1H, m, H-6) and 1.54 (9H, s, H-7).; δC 
(75 MHz; CDCl3) 159.6, 155.7, 140.1, 139.0, 128.3, 127.6, 125.3, 124.8, 116.7, 114.1, 
107.8, 35.2 and 30.4.; EI m/z 276 (M); CI m/z 294 (M + NH4+); HRMS found M 
276.1247, C18H16N2O requires 276.1257. 
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2-(2-isopropyl-6-methylphenoxy)benzene-1,3-dicarbonitrile (117c) 
 
2-Isopropyl-6-methylphenoxide 
2-Isopropyl-6-methylphenol 123 (0.88 g, 5.83 mmol, 1 equiv.), potassium hydroxide 
(0.33 g, 5.83 mmol, 1 equiv.) and toluene (50 cm3) were treated as described in general 
procedure A. 
2-(2-Isopropyl-6-methylphenoxy)benzene-1,3-dinitrile 
2-Chloro-isophthalonitrile (0.95 g, 5.83 mmol, 1 equiv.), 2-isopropyl-6-
methylphenoxide (1.1 g, 5.83 mmol, 1 equiv.), and anhydrous DMF (100 cm3) were 
treated as described in general procedure A.  The crude product was purified by flash 
column chromatography (10:1 petrol : EtOAc) to yield the product as a light yellow 
solid (0.81 g, 50 %).  
m.p. 79 – 81 °C; Rf = 0.44 (9:1 petrol:EtOAc); vmax(film/cm-1) 2236 (CN); δH (300 MHz; 
CDCl3) 7.84 (2H, d, J 8, H-1), 7.30-7.28 (2H, m, H-3 and H-4), 7.22 (1H, t, J 8, H-2), 
7.15 (1H, ddd, J 7.5, 2 and 0.5 H-5), 3.06 (1H, sept, J 7, H-7), 2.18 (3H, s, H-6) and 1.28 
(6H, d, J 7, H-8).; δC (75 MHz; CDCl3) 160.6, 149.6, 141.8, 139.7, 130.9, 129.1, 128.1, 
125.0, 122.5, 113.9, 102.9, 28.0, 23.2 and 16.8.; EI m/z 276 (M); CI m/z 294 (M + 
NH4+); HRMS found M + NH4+ 294.1599, C18H20N3O requires 294.1601. 
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2-(2-tert-Butyl-6-methylphenoxy)benzene-1,3-dinitrile (117d) 
 
2-tert-Butyl-6-methylphenoxide 
2-tert-Butyl-6-methylphenol (5.25 g, 32.03 mmol, 1 equiv.), potassium hydroxide (1.79 
g, 32.03 mmol, 1 equiv.) and toluene (50 cm3) were treated as described in general 
procedure A. 
2-(2-tert-Butyl-6-methylphenoxy)benzene-1,3-dinitrile 
2-Chloro-isophthalonitrile (5.2 g, 32.03 mmol, 1 equiv.), 2-tert-butyl-6-
methylphenoxide (6.48 g, 32.03 mmol, 1.1 equiv.), and anhydrous DMF (150 cm3) were 
treated as described in general procedure A.  The crude product was purified by flash 
column chromatography (9:1 petrol : EtOAc) to yield the product as a yellow solid (4.58 
g, 49 %).  
Also synthesised by treatment of 2-tert-Butyl-6-methylphenol (10.5 cm3, 64.06 mmol, 
1.0 equiv.), K2CO3 (8.86 g, 64.06 mmol, 1 equiv.), 2-Chloro-isophthalonitrile (10.4 g, 
64.06 mmol, 1 equiv.), 3 Å molecular sieves (ca. 10 g) and anhydrous DMF (300 cm3) 
as described in general procedure B. The crude product was purified by flash column 
chromatography (9:1 petrol : EtOAc) to yield the desired product as a yellow solid 
(10.03 g, 54 %). 
m.p. 65 – 68 °C; Rf = 0.36 (9:1 petrol:EtOAc); vmax(film/cm-1) 2253 (CN); δH (300 MHz; 
CDCl3) 7.85 (2H, d, J 8, H-1), 7.38 (1H, dd, J 8 and 1.5, H-3), 7.30 (1H, t, J 8, H-4), 
7.22 (1H, t, J 8, H-2), 7.15 (1H, ddd, J 8, 2 and 1, H-5), 2.05 (3H, s, H-6) and 1.44 (9H, 
s, H-7).; δC (75 MHz; CDCl3) 160.7, 151.1, 143.3, 139.6, 130.8, 129.8, 127.6, 126.0, 
122.4, 114.0, 103.2, 35.3, 30.8 and 17.2.; EI m/z 290 (M); CI m/z 308 (M + NH4+); 
HRMS found M + NH4+ 308.1765, C19H22N3O requires 308.1757.; EA found C, 77.71; 
H, 6.09; N; 10.15, C19H18N2O requires C 78.59; H, 6.25; N, 9.65%. 
 
O
NC CN
1 1
2
3 4
5
6
7
7
7
 170
2-(2-tert-Butyl-4,6-dimethylphenoxy)benzene-1,3-dinitrile (117e) 
 
2-tert-Butyl-4,6--dimethylphenoxide 
2-tert-Butyl-4,6-xylenol (4.28 cm3, 23.07 mmol, 1 equiv.), potassium hydroxide (1.29 g, 
23.07 mmol, 1 equiv.) and toluene (100 cm3) were treated as described in general 
procedure A. 
2-(2-tert-Butyl-4,6-dimethylphenoxy)benzene-1,3-dinitrile 
2-Chloro-isophthalonitrile (3.75 g, 23.07 mmol, 1 equiv.), 2-tert-butyl-4,6-xylenoxide 
(4.99 g, 23.07 mmol, 1 equiv.) and anhydrous DMF (150 cm3) were treated as described 
in general procedure A.  The crude product was purified by flash column 
chromatography (9:1 petrol : EtOAc) to yield the product as a yellow solid (4.35 g, 62 
%).  
Also synthesised by treatment of 2-tert-Butyl-4,6-xylenol (2.85 cm3, 15.38 mmol, 1.0 
equiv.), K2CO3 (0.86 g, 15.38 mmol, 1 equiv.), 2-Chloro-isophthalonitrile (2.5 g, 15.38 
mmol, 1 equiv.), 3 Å molecular sieves (ca. 10 g) and anhydrous DMF (100 cm3) as 
described in general procedure B. The crude product was purified by flash column 
chromatography (9:1 petrol : EtOAc) to yield the desired product as a yellow solid (2.53 
g, 54 %). 
m.p. 63 – 66 °C; Rf = 0.37 (9:1 petrol:EtOAc); vmax(film/cm-1) 2235 (CN); δH (300 MHz; 
CDCl3) 7.85 (2H, dd, J 8 and 0.5, H-1), 7.21 (1H, td, J 8 and 0.5, H-2), 7.16 (1H, d, J 
0.5, H-3), 6.96 (1H, br s, H-4), 2.41 (3H, s, H-5) 2.01 (3H, s, H-6) and 1.43 (9H, s, H-
7).; δC (75 MHz; CDCl3) 161.0, 149.0, 142.7, 139.6, 137.1, 130.4, 130.1, 126.7, 122.2, 
114.1, 103.2, 35.2, 30.8, 21.6 and 17.2.; EI m/z 322 (M + NH4+), 304 (M); CI m/z 322 
(M + NH4+); HRMS found M 304.1568, C20H20N2O requires 304.1570. 
 
 
O
NC CN
1 1
2
3
4
5
6
7
7
7
 171 
2-(2-Isopropylphenoxy)benzene-1,2-dicarbaldehyde (118a) 
 
DiBAl-H (1.0 M solution in toluene) (22.9 cm3, 22.8 mmol, 3 equiv.), dicyano 117a (2 
g, 7.6 mmol, 1 equiv.) and toluene (200 cm3) were treated as described in general 
procedure C.  The crude product was purified by flash column chromatography (5:1 
Petrol : EtOAc) to yield the product as a yellow solid (1.28 g, 63 %).  
m.p. 63 – 65 °C;  Rf = 0.69 (5:1 petrol:EtOAc); vmax(film/cm-1) 1708 and 1684 (CHO); 
δH (300 MHz; CDCl3) 10.22 (2H, s, H-7), 8.30 (2H, d, J 7.5, H-1), 7.57 (1H, tt, J 7.5 and 
0.5, H-2), 7.42-7.40 (1H, m, H-3), 7.09-7.04 (2H, m, H-4 and H-5), 6.37-6.35 (1H, m, 
H-6), 3.64 (1H, sept, J 7, H-8) and 1.41 (6H, d, J 7, H-9).; δC (75MHZ; CDCl3) 187.9, 
159.8, 158.5, 136.4, 135.1, 130.4, 127.9, 127.5, 126.3, 123.7, 113.7, 27.6 and 23.0.; EI 
m/z 268 (M); CI m/z 286 (M + NH4+); HRMS found M + NH4+ 286.1445, C17H16O3 
requires 286.1438. 
 
 
 
2-(2-tert-Butylphenoxy)benzene-1,2-dicarbaldehyde (118b) 
 
DiBAl-H (1.0 M solution in toluene) (61.4 cm3, 61.37 mmol, 3 equiv.), dinitrile 117b 
(5.69 g, 20.46 mmol, 1 equiv.) and anhydrous toluene (200 cm3) were treated as 
described in general procedure C.  The crude was purified by flash column 
chromatography (15:1 Petrol : EtOAc) to the product as a light yellow solid (3.0 g, 54 
%). 
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m.p. 81 – 84 °C; Rf = 0.41 (9:1 petrol:EtOAc); vmax(film/cm-1) 1708 and 1684 (CHO); δH 
(300 MHz; CDCl3) 10.21 (2H, s, H-7), 8.31 (2H, d, J 8, H-1), 7.57 (1H, tt, J 8 and 0.5, 
H-2), 7.49-7.47 (1H, m, H-3), 7.09 (2H, CH m, H-4 and H-5), 6.38-6.35 (1H, m, H-6) 
and 2.62 (9H, s, H-8).; δC (75 MHz; CDCl3) 188.0, 160.1, 159.3, 137.3, 135.2, 130.5, 
128.3, 128.1, 136.3, 123.5, 114.6, 35.3 and 30.0.; EI m/z 282 (M); CI m/z 300 (M + 
NH4+); HRMS found M 282.1245, C18H18O3 requires 282.1250. 
 
 
 
2-(2-isopropyl-6-methylphenoxy)benzene-1,3-dicarbaldehyde (118c) 
 
DiBAl-H (1M solution in toluene) (7 cm3, 7 mmol, 2.5 euiv.), dinitrile 117c (0.77 g, 2.8 
mmol, 1 equiv.) and anhydrous toluene (40 cm3) were treated as described in general 
procedure C.  The crude product was purified by flash column chromatography (15:1 
Petrol : EtOAc) to yield the product as a yellow oil (0.59 g, 75 %).  
Rf = 0.65 (9:1 petrol:EtOAc); vmax(film/cm-1) 1679 (CHO); δH (300 MHz; CDCl3) 10.08 
(2H, s, H-6), 8.10 (2H, d, J 7.5, H-1), 7.30–7.25 (2H, m, H-3 and H-4), 7.21 (1H, t, J 
7.5, H-2), 7.10 (1H, ddd, J 7.5, 2 and 0.5, H-5), 3.29 (1H, sept, J 7, H-8), 2.10 (3H, s, H-
7) and 1.26 (6H, d, J 7, H-9).; δC (75MHz; CDCl3) 188.1, 161.8, 154.6, 139.7, 135.3, 
130.6, 128.3, 127.5, 126.7, 126.0, 123.0, 28.0, 23.2 and 17.6.; EI m/z 282 (M); CI m/z 
300 (M + NH4+), 283 (M + H); HRMS found M 282.1252, C18H18O3 requires 282.1250. 
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2-(2-tert-butyl-6-methylphenoxy)benzene-1,3-dialdehyde (118d) 
 
DiBAl-H (1.0 M solution in toluene) (40.6 cm3, 40.6 mmol, 2.5 equiv.), dinitrile 117d 
(3.93 g, 13.5 mmol, 1 equiv.) and anhydrous toluene (200 cm3) were treated as described 
in general procedure C.  The crude product was dissolved in a further portion of EtOAC 
and 6.0 M HCL added (30 cm3) until the solid dissolved. The organic phase was then 
washed with water, brine, dried (Na2SO4) and the solvent removed under reduced 
pressure.  The crude product was purified by flash column chromatography (20:1 
Petrol:EtOAc) to yield the product as a yellow solid (2.99 g, 74 %).  
m.p. 75 – 79 °C; Rf = 0.78 (9:1 petrol:EtOAc); vmax(film/cm-1) 1679 (CHO); δH (400 
MHz; CDCl3) 9.98 (2H, s, H-6), 8.10 (2H, d, J 7.5, H-1), 7.36 (1H, d, J 7.5, H-3), 7.25-
7.22-7.20 (1H, m, H-4), 7.15 (1H, t, J 7.5, H-2), 7.08 (1H, d, J 7.5, H-5), 1.93 (3H, s, H-
7) and 1.46 (9H, s, H-8).; δC (100MHz; CDCl3) 187.9, 161.1, 155.7, 140.9, 135.4, 
131.5, 127.6, 127.0, 126.5, 126.1, 122.7, 35.3, 30.4 and 17.8.; EI m/z 296 (M); CI m/z 
314 (M + NH4+), 297 (M + H); HRMS found M + NH4+ 314.1752, C15H24NO3 requires 
314.1751. 
 
 
 
2-(2-tert-Butyl-4,6-dimethylphenoxy)benzene-1,3-dialdehyde (118e) 
 
DiBAl-H (1.0 M solution in toluene) (33.6 cm3, 33.6 mmol, 3 equiv.), dinitrile 117e 
(3.41 g, 11.2 mmol, 1 equiv.) and anhydrous toluene (200 cm3) were treated as described 
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in general procedure C, at -40 °C.  The crude product was purified by flash column 
chromatography (20:1 Petrol : EtOAc) to yield the product as a cream coloured solid 
(2.15 g, 62 %).  
m.p. 118 – 121 °C; Rf = 0.81 (9:1 petrol:EtOAc); vmax(film/cm-1) 1683 (CHO); δH (300 
MHz; CDCl3) 10.06 (2H, s, H-6), 8.16 (2H, d, J 7.5, H-1), 7.29 (1H, t, J 7.5, H-2), 7.21 
(1H, s, H-3), 6.95 (1H, s, H-4), 2.40 (3H, s, H-5), 1.976 (3H, s, H-7) and 1.51 (9H, s, H-
8).; δC (75MHz; CDCl3) 188.4, 162.0, 153.8, 140.7, 135.8, 135.6, 132.0, 127.5, 127.4, 
127.3, 122.7, 35.4, 30.6, 21.4 and 17.9.; EI m/z 328 (M + NH4+), 310 (M); CI m/z 328 
(M + NH4+), 310 (M); HRMS found M 310.1563, C20H22O3 requires 310.1563. 
 
 
 
[3-Hydroxymethyl-2-(2-isopropyl-phenoxy)-phenyl]-methanol (119a) 
 
Dialdehyde 118a (2.6 g, 9.69 mmol, 1 equiv.), sodium borohydride (3.67 g, 97 mmol, 10 
equiv.) and anhydrous THF (150 cm3) were treated as described in general procedure D, 
to yield the product, with no purification, as a white powder (2.13 g, 81 %).   
m.p. 106 – 108 °C; Rf = 0.12 (5:1 petrol:EtOAc); vmax (film/cm-1) 3258 (OH).; δH (300 
MHz; CDCl3) 7.55 (2H, d, J 7.5, H-1), 7.36-7.32 (2H, m, H-2 and H-3), 7.02-6.97 (2H, 
m, H-4 and H-5), 6.29-6.27 (1H, m, H-6), 4.68 – 4.52 (4H, CH AB m, H-7), 3.56 (1H, 
sept, J 7, H-8) and 1.39 (6H, d, J 7, H-9).; δC (75 MHz; d6-DMSO) 155.2, 147.7, 135.9, 
135.7, 127.5, 127.3, 127.0, 125.9, 122.3, 112.0, 58.2, 27.4 and 23.3.; CI m/z 290 (M + 
NH4+); HRMS found: M + NH4+ 290.1742, C17H24NO3 requires 290.1751.   
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[2-(2-tert-Butyl-phenoxy)-3-hydroxymethyl-phenyl]-methanol (119b) 
 
2-tert-Butyl-dialdehyde 118b (1.44 g, 5.25 mmol, 1 equiv.), sodium borohydride (1.99 
g, 52.5 mmol, 10 equiv.) and anhydrous THF (150 cm3) were treated as described in 
general procedure D. The crude product was purified by flash column chromatography 
(5:1 petrol : EtOAc) to yield the product as a white solid (1.34 g, 92 %).   
m.p. 102 – 105 °C; Rf = 0.08 (7:1 petrol:EtOAc); vmax (film/cm-1) 3305 (OH).; δH (300 
MHz; CDCl3) 7.58 (2H, d, J 8, H-1), 7.43 (1H, dd, J 7.5 and 2, H-3), 7.38 (1H, t, J 8, H-
2), 7.01-6.97 (2H, CH m, H-4 and H-5), 6.31 (1H, dd, J 7.5 and 2, H6), 4.68 – 4.56 (4H, 
CH AB m, H-7) and 1.57 (9H, s, H-8).; δC (75 MHz; d6-DMSO) 156.5, 147.1, 136.8, 
135.6, 128.0, 127.8, 127.1, 126.0, 122.1, 112.3, 58.4, 35.3 and 30.3.; EI m/z 286 (M); CI 
m/z 304 (M + NH4+); HRMS found M 286.1558, C18H22O3 requires 286.1563. 
 
 
 
(2-(2-isopropyl-6-methylphenoxy)-1,3-phenylene)dimethanol (119c) 
 
Dialdehyde 118c (1.24 g, 4 mmol, 1 equiv.), sodium borohydride (1.51 g, 40 mmol, 10 
equiv.) and anhydrous THF (150 cm3) were treated as described in general procedure D. 
The crude product was purified by flash column chromatography (4:1 petrol : EtOAc) to 
yield the product as a white solid (920 mg, 73 %).  
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m.p. 107 – 110 °C; Rf = 0.14 (4:1 petrol:EtOAc);  vmax (film/cm-1) 3311 (OH).; δH (500 
MHz; CDCl3) 7.4 (2H, d, J 7.5, H-1), 7.13-7.10 (2H, m, H-3 and H-4), 7.1 (1H, t, J 7.5, 
H-2), 6.78 (1H, ddd, J 7.5, 2 and 0.5, H-5), 4.53-4.43 (4H, CH AB m, H-6), 3.40 (1H, 
sept, J 7, H-8), 2.3 (3H, s, H-7), 1.40 (6H, d, J 7, H-9).; ES+ m/z 309.2 (M + Na); 
HRMS found M + Na 309.1466, C18H22O3Na requires 309.1467. 
 
 
 
[2-(2-tert-Butyl-6-methyl-phenoxy)-3-hydroxymethyl-phenyl]-methanol (119d) 
 
Dialdehyde 118d (2.59 g, 8.74 mmol, 1 equiv.), sodium borohydride (3.3 g, 87.4 mmol, 
10 equiv.) and anhydrous THF (150 cm3) were treated as described in general procedure 
D.  The crude product was purified by flash column chromatography (7:1 petrol : 
EtOAc) to yield the product as a white solid (2.5 g, 95 %).  
 m.p. 103 – 108 °C; Rf = 0.32 (4:1 petrol:EtOAc); vmax (film/cm-1) 3323 (OH).; δH (300 
MHz; CDCl3) 7.45 (2H, d, J 8, H-1), 7.32 (1H, dd, J 7.5 and 2, H-3), 7.16 (1H, t, J 7.5, 
H-4), 7.07 (1H, t, J 8, H-2), 7.00 (1H, ddd, J 7.5, 2 and 0.5, H-5), 4.57 – 4.44 (4H, CH 
AB m, H-8), 1.84 (3H, s, H-6) and 1.48 (9H, s, H-7).; δC (75 MHz; CDCl3) 155.0, 151.8, 
140.4, 130.6, 130.1, 129.0, 128.1, 125.9, 124.3, 123.3, 61.1, 35.6, 30.7 and 18.1.; EI m/z 
300 (M); CI m/z 318 (M + NH4+), 300 (M), 283 (M – OH); HRMS found M + Na, 
318.2066, C19H24O3Na requires 318.2064. 
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[2-(2-tert-butyl-4,6-dimethylphenoxy)-1,3-phenylene]-dimethanol (119e) 
 
Dialdehyde 118e (1.24 g, 4 mmol, 1 equiv.), sodium borohydride (1.51 g, 40 mmol, 10 
equiv.) and anhydrous THF (150 cm3) were treated as described in General Procedure D. 
The crude product was purified by flash column chromatography (4:1 petrol : EtOAc) to 
yield the product as a white solid (0.92 g, 73 %).  
m.p. 128 - 130 °C; Rf = 0.14 (4:1 petrol:EtOAc); δH (500 MHz; CDCl3) 7.4 (2H, d, J 7.5, 
H-1), 7.10 (1H, t, J 7.5, H-2), 7.06 (1H, s, H-3), 6.78 (1H, s, H-4), 4.53-4.43 (4H, CH 
AB m, H-8), 2.3 (3H, s, H-5), 1.8 (3H, s, H-6), 1.4 (9H, s, H-7).; δC (75 MHz; CDCl3) 
152.6, 151.8, 139.8, 133.3, 130.6, 129.8, 128.9, 127.5, 126.5, 122.9, 64.3, 43.8, 30.5, 21 
and 17.7.; ES+ m/z 337 (M + Na); HRMS found M + Na 337.1771, C20H26O3Na  
requires 337.1775.; EA found C, 75.81; H, 8.89, C20H26O3 requires C 76.40; H, 8.33%. 
   
 
 
3'-tert-butyl-4'-hydroxy-5'-methylbiphenyl-2,6-dicarbonitrile (120) 
 
2-Chloro-isophthalonitrile 116 (0.49 g, 3.04 mmol, 1 equiv.), 2-tert-butyl-6-
methylphenol (0.5 g, 3.04 mmol, 1 equiv.), NaH (60% dispersion in mineral oil) (0.22 g, 
9.13 mmol, 3 equiv.) and anhydrous DMF (50 cm3) were treated as described in general 
procedure B.  The crude product was purified by flash column chromatography (9:1 
petrol : EtOAc) to yield the product as an orange solid (0.11 g, 13 %). 
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m.p. 207 – 210 °C; Rf = 0.13 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.94 (2H, d, J 
7.9, H-1), 7.51 (1H, t, J 7.9, H-2), 7.33 (1H br s, H-3 or H-4), 7.21 (1H, br s, H-3 or H-
4), 2.32 (3H, s, H-5), 1.46 (9H, s, H-6).; δC (125 MHz; CDCl3) 154.6, 149.41, 137.25, 
136.1, 129.36, 127.51, 126.95, 125.47, 123.73, 117.2, 114.2, 34.9, 29.6 and 16.13.; ES- 
m/z 289.2 (M – H+); HRMS found M – H+ 289.1332, C19H18N2O requires 289.1341. 
 
 
 
2-(dimethylamino)benzene-1,3-dicarbonitrile (121)150 
 
2-Chloro-isophthalonitrile 116 (0.49 g, 3.04 mmol, 1 equiv.), 2-tert-butyl-6-
methylphenol (0.5 g, 3.04 mmol, 1 equiv.), NaH (60% dispersion in mineral oil) (0.22 g, 
9.13 mmol, 3 equiv.) and anhydrous DMF (50 cm3) were treated as described in general 
procedure B.  The crude product was purified by flash column chromatography to yield 
the product as a light brown solid (0.03 g, 3%).  
m.p. 138 – 141 °C; Rf = 0.25 (9:1 petrol EtOAc); δH (400 MHz; CDCl3) 7.65 (2H, d, J 
7.8, H-1), 6.93 (1H, t, J 7.8, H-2), 3.25 (6H, s, H-3). Analyses matched the reported 
data.163 
 
 
 
2-Isopropyl-6-methylphenol (123)164 
 
By the method of Jones;88 2-iso-propyl-6-methylaniline (2 cm3, 12.87 mmol, 1 equiv.) 
was dissolved in conc HCl (4 cm3, 2 vol’), water (4 cm3, 2 vol’) and dioxane (10 cm3) 
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and treated with sodium nitrite (0.977 g, 14.16 mmol, 1.1 equiv.) dissolved in water (20 
cm3) at rt for 4 h to yield the diazonium salt.  
By the method of Shine;89 the mixture containing the diazonium salt was added to a 
stirred solution of conc H2SO4 (6 cm3, 3 vol’) in water (12 cm3) and heated to 50 °C.  
The mixture was stirred at this temperature for 16 h, cooled to RT and extracted using 
EtOAc (3 x 30 cm3).  The combined organic phases were washed with water (x 3), brine, 
dried (Na2SO4) and solvent removed under reduced pressure.  The crude product was 
purified by flash column chromatography (10:1 petrol : EtOAc) to yield the product as a 
light yello oil (1.53 g, 79 %).   
b.p 225 – 226 °C (1 mmHg); Rf = 0.80 (4:1 petrol:EtOAc); vmax(film/cm-1) 3466 (OH); 
δH (300 MHz; CDCl3) 7.15 (1H, t, J 5.5, H-2),  7.05 (2H, d, J 5.5, H-1), 3.43 (1H, sept, J 
7, H-3), 2.35 (3H, s, H-5) and 1.26 (6H, d, J 7, H-4).; EI m/z 150 (M).  Analysis matched 
the published data.151 
Also synthesised by slow (40 min) addition at between 0-10°C under N2 of 136 (1g, 4.53 
mmol, 1 equiv.) to a solution of tetramethylethylenediamine (1.21 cm3 8.16 mmol) 
which had been added to a 2.4 N solution of n-butyllithium in n-hexane (3.4 cm3, 8.16 
mmol) and ether (20 cm3 at 25°C with stirring and under N2.  After 20 mins, MeI ( 
0.5cm3, 8.16 mmol, 1 equiv.) was added, and the solution stirred for 16 hours. The 
mixture was quenched by addition of saturated ammonium chloride solution and 
organics diluted using EtOAc.  The organic phase was washed with water, brine, dried 
(Na2SO4) and the solvent removed under reduced pressure.  The crude product was then 
added to a solution of THF (20 cm3, 1 vol’), AcOH (80 cm3, 4 vol’) and water (40 cm3, 2 
vol’) and heated at 45°C for 16 hours, cooled to rt and diluted using EtOAc (3 x 30 cm3).  
The combined organic phases were washed with water (x 3), brine, dried (Na2SO4) and 
the solvent removed under reduced pressure.  The crude product was purified by flash 
column chromatography (19:1 petrol : EtOAc) to yield the product as a light yellow oil 
(2.06 g, 56 %). 
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2-(2-isopropylphenoxy)-tetrahydro-2H-pyran (136) 
 
A solution of 2-isopropyl phenol (20 cm3, 149 mmol, 1 equiv.) in 3,4-dihydro-2H-pyran 
(27 cm3, 297 mmol) in DCM (150 cm3) was stirred at room temperature in the presence 
of acidic silica gel (0.02 g, catalytic) for 1 hour.  The catalyst was removed by filtration 
and 1-2 drops triethylamine added.  The solvent was removed under reduced pressure 
and the residue purified by column chromatography on silica gel (15:1 Petrol : EtOAc) 
to yield the product as a colourless oil (29.7 g, 90 %).  
Rf = 0.82 (9:1 petrol:EtOAc); δH (500 MHz; CDCl3) 7.14 (1H, d, J 8, H-3), 7.08-7.00 
(2H, m, H-1 and H-4), 6.88 (1H, t, J 7, H-2), 5.36 (1H, t, J 3, H-7), 3.83 (1H, td, J 8 and 
3, H-11), 3.55 (1H, dt, J 11 and 3 H-11), 3.28 (1H, sept, J 7, H-6) 2.02-1.90 (1H, m, H-
8), 1.84-1.79 (2H, m, H-9 and H-10), 1.69-1.48 (3H, m, H-9, H-10 and H-8) and 1.17 
(6H, dd, J 15 and 8, H-5).; δC (75 MHz; CDCl3) 151.2, 135.5, 126.8, 126.4, 121.7, 
114.4, 96.5, 63.8, 30.9, 27.6, 25.6, 23.1 and 19.1; not visible by MS. 
Adsorption of Sulfuric Acid on Silica Gel: 
A solution of concentrated sulphuric acid (2 cm3 ) in acetone (18 cm3) was added to a 
suspension of silica gel (100g, Fluorochem Davisil 40-63 µm 60 A) in acetone (200 
cm3) at room temperature with vigorous stirring.  After 1 h, the solvent was removed in 
a rotary evaporator under reduced pressure at 50°C for 4 hours. 
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2-(2-tert-butyl-6-methylphenoxy)-3-(hydroxymethyl)benzaldehyde (140) 
 
Dialdehyde 118d (2.25 g, 7.59 mmol, 1 equiv.), lithium borohydride (72 mg, 1.90 mmol, 
0.25 equiv.) and ethanol (20 cm3) were treated as described in general procedure E. The 
crude product was purified by flash column chromatography (9:1 petrol : EtOAc) to 
yield the product as a light yellow oil (1.46 g, 64 %).  
Also synthesised by kinetic resolution of 140 and desymmetrisation of 119d (see section 
4.3) to afford (P)-140 
HPLC: (R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 0.5 ml/min; retention times 
34.18 (minor) and 35.68 min (major). 
Rf = 0.10 (9:1 petrol:EtOAc); vmax (film/cm-1) 3406 (OH), 1675 (CHO).; δH (500 MHz; 
CDCl3) 9.45 (1H, s, H-8), 7.63 (2H, dd, J 7.5 H-1 and H-3), 7.18 (1H, d, J 8.0, H-4), 
7.03 (1H, t, J 8.0, H-5), 6.95 (1H, t, J 7.5, H-2), 6.89 (1H, d, J 8.0, H-6), 4.69 – 4.60 
(2H, CH AB m, H-7), 1.72 (3H, s, H-9) and 1.32 (9H, s, H-10).; δC (125 MHz; CDCl3) 
188.6, 156.7, 155.8, 140.5, 134.6, 131.1, 129.8, 128.6, 127.7, 126.1, 126.0, 125.2, 122.6, 
60.81, 35.3, 30.4, and 17.6; ES+ m/z 321.2; (M + Na); ES- m/z 296.9 (M) ; HRMS found 
M + Na, 321.1467, C15H21O3Na requires 321.1467.   
Material of 42% ee derived from kinetic resolution had [α]D26 = +2.4 (c = 0.166,  
heptane. 
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2-(2-tert-butyl-6-methylphenoxy)-3-formylbenzyl ethanoate (141) 
 
Monoaldehyde 140 (0.1 g, 0.35 mmol, 1 equiv.), sodium hydride (0.025 g, 0.62 mmol, 
1.8 equiv.) and ether (15 cm3) were charged to a flask at RT and stirred under an 
atmosphere of nitrogen for 30 minutes.  Acetic anhydride (0.13 cm3, 1.38 mmol, 4 
equiv.) was then added and the reaction mixture heated to 40 °C for 12 hours.  The 
reaction mixture was quenched with water, and the organic phase washed with water, 
brine, dried (Na2SO4) and the solvent removed under reduced pressure.  The crude 
product was purified by flash column chromatography (9:1 petrol:EtOAc) to yield the 
product as a cream coloured solid (0.08 g, 74 %).  
m.p. 107 – 109 °C; Rf = 0.60 (4:1 petrol:EtOAc); vmax (film/cm-1) 3434 (OH), 1728 
(MeCOOCH2Benz).; δH (400 MHz; CDCl3) 9.46 (1H, s, H-7), 7.80 (1H, dd, J 7.5 and 2, 
H-1), 7.65 (1H, dd, J 7.5 and 2, H-3), 7.32 (1H, dd, J 8, H-4), 7.14 (1H, t, J 8, H-5), 7.09 
(1H, t, J 7.5, H-2), 7.03 (1H, dd, J 8 and 2, H-6), 5.23 (2H, CH AB m, H-8), 2.11 (3H, s, 
H-9), 1.86 (3H, s, H-10) and 1.45 (9H, s, H-11).; δC (100 MHz; CDCl3) 188.27, 170.7, 
157.5, 155.9, 140.5, 136.26, 131.14, 129.8, 127.6, 126.6, 126.2, 126.1, 125.3, 122.4, 
61.9, 35.3, 30.28, 21.0 and 17.5.; ES+ m/z 363 (M + Na); HRMS found M + Na 
363.1555, C21H24O4Na requires 363.1567. 
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2-(2-tert-butyl-6-methylphenoxy)-3-(hydroxymethyl)benzyl ethanoate (142) 
 
Monoaldehyde 141 (0.08 g, 0.25 mmol, 1 equiv.), sodium borohydride (0.028 g, 1.0 
mmol, 4 equiv.) and THF (2 cm3) were charged to a flask at RT and stirred under an 
atmosphere of nitrogen at RT for 16 hours.  The reaction mixture was quenched with 
water, and the organics washed with water, brine, dried (Na2SO4) and the solvent 
removed under reduced pressure.  The crude product was purified by flash column 
chromatography (9:1 petrol : EtOAc) to yield the product as a colourless oil (0.08 g, 97 
%).   
Rf = 0.47 (4:1 petrol:EtOAc); vmax (film/cm-1) 3430 (OH), 1739 (MeCOOCH2Benz).; δH 
(300 MHz; CDCl3) 7.50 (1H, dd, J 7.5 and 2, H-3), 7.34 (1H, dd, J 7.5 and 2, H-1), 7.31 
(1H, dd, J 8 and 2, H-4), 7.14 (1H, t, J 7.5, H-2), 7.06 (1H, t, J 8, H-5), 6.96 (1H, ddd, J 
8, 2 and 0.5, H-6), 5.02 (2H, s, H-8), 4.43 (2H, CH AB m, H-7), 2.07 (3H, s, H-9), 1.86 
(3H, s, H-10) and 1.47 (9H, s, H-11).; δC (75 MHz; CDCl3) 170.9, 154.7, 152.5, 140.4, 
130.4, 130.4, 130.3, 130.1, 128.3, 125.9, 125.4, 124.3, 123.0, 62.4, 60.8, 35.6, 30.6, 21.2 
and 18.0.; EI m/z 360 (M + NH4+), 342 (M); CI m/z 360 (M + NH4+), 342 (M); HRMS 
found M + NH4+ 360.2176, C21H30NO4 requires 360.2169. 
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Acetic acid-3-acetoxymethyl-2-(2’-tert-butyl-6’-methyl-phenoxy)-benzyl ester (143) 
 
Monoaldehyde 140 (0.1 g, 0.35 mmol, 1 equiv.), sodium hydride (0.056 g, 1.38 mmol, 4 
equiv.) and ether (15 cm3) were charged to a flask at RT and stirred under an atmosphere 
of nitrogen for 30 minutes.  Acetic anhydride (0.26 cm3, 2.76 mmol, 8 equiv.) was then 
added and the reaction mixture heated to 40 °C for 12 hours.  The reaction mixture was 
quenched with water, and the organics washed with water, brine, dried (Na2SO4) and the 
solvent removed under reduced pressure.  The crude product was purified by flash 
column chromatography (9:1 petrol : EtOAc) to yield the product as a white solid (0.093 
g, 69 %).   
m.p. 102 – 105 oC; Rf = 0.55 (4:1 petrol:EtOAc); vmax (film/cm-1) 1730 
(MeCOOCH2Benz).; δH (300 MHz; CDCl3) 7.35 (2H, d, J 7.5, H-1), 7.27 (1H, dd, J 7.5 
and 2, H-3), 7.10 (1H, t, J 7.5, H-2), 7.03 (1H, t, J 8, H-4), 6.96 (1H, ddd, J 7.5, 2 and 
0.5, H-5), 4.92 (4H, s, H-6), 2.04 (6H, s, H-7), 1.86 (3H, s, H-8) and 1.45 (9H, s, H-9).; 
δC (75 MHz; CDCl3) 170.8, 154.3, 153.3, 140.4, 131.4, 130.3, 128.5, 125.8, 125.5, 
124.4, 122.8, 62.2, 35.6, 30.6, 21.1 and 18.0.; CI m/z 402 (M + NH4+); HRMS found M 
+ NH4+ 402.2276, C23H32NO5 requires 402.2275. 
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3-(hydroxymethyl)-2-(2-isopropyl-6-methylphenoxy)benzaldehyde (149) 
 
Dialdehyde 118c (0.24 g, 0.86 mmol, 1 equiv.), lithium borohydride (0.005 g, 0.22 
mmol, 0.25 equiv.) and anhydrous THF (20 cm3) were treated as described in general 
procedure E. The crude product was purified by flash column chromatography (9:1 
petrol : EtOAc) to yield the product as a light yellow oil (0.12 g, 50 %).    
Rf = 0.11 (9:1 petrol:EtOAc); 3386 (OH), 1672 (CHO).; δH (500 MHz; CDCl3) 9.79 (1H, 
s, H-8), 7.69 (1H, d, J 7.5  H-1), 7.62 (1H, d, J 7.5, H-3), 7.13 (1H, d, J 8, H-4), 7.09 
(1H, t, J 7.5, H-2), 7.04 (1H, t, J 8, H-5), 6.94 (1H, d, J 8, H-6), 4.61 – 4.51 (2H, CH 
AB, m, H-7), 3.18 (1H, sept, J 7, H-10), 1.93 (3H, s H-9), 1.16 (3H, d, J 7 H-11) and 
1.11 (3H, d, J, H-11).; δC (125 MHz; CDCl3) 188.8, 157.6, 154.0, 139.4, 135.0, 131.3, 
129.9, 128.5, 128.0, 126.5, 125.6, 125.3, 122.8, 60.9, 27.5, 23.3, 23.1, and 17.5.; ES+ 
m/z 307.3 (M + Na); HRMS found M + Na 307.1310, C18H20O3Na requires  307.1310. 
HPLC: (R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 0.5 ml/min; retention times 
41.28 min and 42.51 min. 
 
 
 
(2-(2-tert-butyl-6-methylphenoxy)-1,3-phenylene)bis(phenylmethanol) (150b) 
 
PhMgBr (1.4 M in THF) (3.26 cm3, 4.56 mmol, 4 equiv.) was added dropwise to a 
stirring solution of dialdehyde 118d (0.2 g, 0.76 mmol, 1 equiv.) in anhydrous ether at -
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78 °C under N2, The crude product was purified by flash column chromatography (9:1 
petrol : EtOAc) to yield the product as a light yellow gum (0.01 g, 62 %).   
Rf = 0.13 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.56 (1H, dd, J 7.5, H-1 or H-3), 
7.31-7.20 (9H, m, H-11 or H-12 or H-13 or H-1 or H-3 or H-4 or H-5), 7.14-7.10 (2H, 
m, H-11 or H-12 or H-13 or H-4 or H-5), 6.94 (1H, t, J 7.5, H-2), 6.79 (1H, dd, J 8 and 
2, H-6), 6.18 (1H, d, J 4, H-8), 5.87 (1H, d, J 5, H-8), 1.57 (3H, s, H-9), and 1.41 (9H, s, 
H-10).; δC (100 MHz; CDCl3) 155.4, 152.2, 143.4, 142.1, 140, 133.4, 133.3, 
130.2,130.1, 128.3, 128.0, 127.7, 127.7, 71.1, 69, 35.4, 30.5, and 17.8.; ES- m/z 451.4 
(M); ES+ m/z 475.6 (M + Na); HRMS found M + Na 475.2247, C31H32O3Na requires 
475.2249. 
 
 
 
2-(2-t-Butyl-6-methylphenoxy)-3-(1-hydroxyethyl)benzaldehyde (151a) 
 
MeMgBr (1.4 M in THF) (2.17 cm3, 3.04 mmol, 4 equiv.) was added dropwise to a 
stirring solution of dialdehyde 118d (0.20 g, 0.76 mmol, 1 equiv.) in anhydrous THF at 
0 °C under N2, The crude product was purified by flash column chromatography (15:1 
petrol : EtOAc) to yield the product as a light yellow oil (0.10 g, 52 %).   
Rf = 0.71 (5:1 petrol:EtOAc); vmax(film/cm-1) 3424 (OH), 1678 (CHO); δH (300 MHz; 
CDCl3) 9.52 (1H, s, H-7), 7.85 (1H, ddd, J 7.5, 2 and 0.5, H-3), 7.74 (1H, dd, J 8 and 2, 
H-1), 7.35 (1H, dd, J 8 and 2, H-4), 7.20 (1H, t, J 8, H-2), 7.12 (1H, t, J 7.5, H-5), 7.05 
(1H, ddd, J 7.5, 2 and 0.5, H-6), 5.38 (1H, q, J 6.5, H-8), 1.87 (3H, s, H-11), 1.56 (3H, d, 
J 6.5, H-9) and 1.50 (9H, s, H-10); δC (75 MHz; CDCl3) 188.8, 156.3, 156.2, 140.7, 
136.2, 133.1, 131.6, 128.8, 127.5, 126.4, 125.4, 123.1, 65.0, 35.5, 30.7, 23.6 and 18.1.; 
ES- m/z 311.2 (M - H); ES+ m/z 330 (M + NH4+), 312 (M), 295 (M – OH); HRMS 
found M + NH4+ 330.2069, C20H28NO3 requires 330.2064. 
OOH
1 3
2
4 510
10
610
11
O
7
89
 187 
Also obtained was a second diastereoisomer as a white solid (0.06 g, 28 %).  
m.p. 45 – 48 °C;  Rf = 0.58 (5:1 petrol:EtOAc);  vmax(film/cm-1) 3424 (OH), 1679 
(CHO); δH (300 MHz; CDCl3) 9.45 (1H, s, H-7), 7.90 (1H, ddt, J 8, 2 and 0.5, H-3), 7.75 
(1H, dd, J 8 and 2, H-1), 7.34 (1H, dd, J 7.5 and 2, H-4), 7.21 (1H, td, J 8 and 0.5, H-2), 
7.10 (1H, t, J 7.5, H-5), 7.03-7.00 (1H, m, H-6), 5.51 (1H, q, J 6.5, H-8), 1.85 (3H, s, H-
11), 1.63 (3H, d, J 6.5, H-9) and 1.49 (9H, s, H-10).; δC (75 MHz; CDCl3) 188.7, 156.8, 
156.0, 140.4, 137.2, 132.6, 131.7, 128.6, 127.4, 126.4, 126.3, 125.2, 123.2, 64.7, 35.5, 
30.4, 24.9 and 18.1.; ES- m/z 311.2 (M-H); ES+ m/z  335.1 (M + Na); CI m/z 330 (M + 
NH4+), 312 (M), 295 (M – OH); HRMS found M + NH4+ 330.2070, C20H28NO3 requires 
330.2064. 
 
 
 
2-(2-tert-butyl-6-methylphenoxy)-3-(hydroxy(phenyl)methyl)benzaldehyde (151b) 
 
PhMgBr (1.4 M in THF) (2.17 cm3, 3.04 mmol, 4 equiv.) was added dropwise to a 
stirring solution of dialdehyde 118d (0.20 g, 0.76 mmol, 1 equiv.) in anhydrous THF at 
0 °C under N2, The crude product was purified by flash column chromatography (15:1 
petrol : EtOAc) to yield the product as a light yellow gum (0.08 g, 31 %).   
Rf = 0.53 (4:1 petrol:EtOAc);  vmax(film/cm-1) 3425 (OH), 1675 (CHO); δH (300 MHz; 
CDCl3) 9.17 (1H, s, H-7), 8.03 (1H, dd, J 7.5 and 2, H-3), 7.70 (1H, dd, J 8 and 2, H-1), 
7.41 (2H, dd, J 8 and 2, H-11), 7.33-7.26 (4H, m, H-4, H-12 and H-13), 7.20 (1H, t, J 8, 
H-2), 7.03 (1H, t, J 8, H-5), 6.88 (1H, dd, J 7.5 and 1, H-6), 6.34 (1H, s, H-8), 1.49 (9H, 
s, H-10) and 1.13 (3H, s, H-9).; δC (75 MHz; CDCl3) 188.5, 156.3, 156.1, 142.5, 140.8, 
134.2, 132.9, 131.5, 129.0, 128.9, 128.3, 128.1, 127.6, 126.2, 126.0, 125.5, 122.6, 72.1, 
35.4, 30.8 and 16.7.; EI m/z 374 (M); CI m/z 392 (M + NH4+), 375 (M + H); HRMS 
found M + Na+ 397.1778, C25H26O3Na requires 397.1774. 
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1,1'-(2-(2-tert-butyl-6-methylphenoxy)-1,3-phenylene)diethanone (152a) 
 
MeLi (1.2 M solution in hexanes) (3.8 cm3, 4.5 mmol, 6 equiv.) was added dropwise to a 
stirring solution of dinitrile 117d (0.20 g, 0.76 mmol, 1 equiv.) in ether at -78 °C under 
N2, stirred for 90 minutes and warmed to RT.  1.0 M HCl was added (1 cm3) and the 
mixture stirred for a further 20 minutes.   The reaction mixture was diluted using EtOAc, 
the organic phase was washed with water, brine, dried (MgSO4), and the solvent 
removed under reduced pressure. The crude product was purified by flash column 
chromatography (9:1 petrol : EtOAc) to yield the product as a light yellow solid (0.16 g, 
72 %).  
m.p 148 – 150 °C; Rf = 0.71 (4:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.96 (1H, dd, J 
7.6 and 2, H-1 or H-3), 7.81 (1H, dd, J 7.6  H-1 or H-3), 7.35 (1H, d, J 8, H-4), 7.15 
(1H, d, J 8, H-6), 7.08 (1H, t, J 7.6, H-2), 6.93 (1H, t, J 8, H-5), 2.76 (3H, s, H-7), 2.20 
(3H, s, H-7), 2.03 (3H, s, H-8), and 1.32 (9H, s H-9).; δC (100 MHz; CDCl3) 199.9, 
172.5, 163.6, 144.1, 140.3, 134.5, 133.7, 128.7, 128.0, 124.8, 117.4, 35.2, 30.5, 18.8 and 
18.4.; ES+ m/z 347.3 (M + Na); HRMS found M + Na 347.1617, C21H24O3Na requires  
347.1623.  
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1-(2-(2-tert-butyl-6-methylphenoxy)-3-(1-hydroxyethyl)phenyl)ethanone (154) 
 
Diketone 152a (0.1 g, 0.29 mmol, 1 equiv.), lithium borohydride (0.0016 g, 0.07 mmol, 
0.25 equiv.) and anhydrous THF (10 cm3) were treated as described in general procedure 
E. The crude product was purified by flash column chromatography (9:1 petrol : EtOAc) 
to yield the product as a light yellow oil, and as a mixture of diastereomers (0.07 g, 68 
%).    
Rf = 0.28 (9:1 petrol:EtOAc);  vmax(film/cm-1) 3412 (OH); δH (400 MHz; CDCl3) 7.56 
(1H, dd, J 8 and 2, H-1), 7.44 (1H, dd, J 8 and 2, H-3), 7.33 (1H, dd, J 8 and 2, H-4), 
7.13-7.11 (1H, m, H-6), 7.06 (1H, t, J 8, H-2), 6.90 (1H, t, J 8, H-5), 5.19 (1H, q, J 6, H-
11), 2.98 (3H, s, H-7), 2.02 (3H, s, H-8), 1.61 (3H, d, J 7, H-10), and 1.30 (9H, s, H-9).; 
ES+ m/z 349.4 (M + Na); HRMS found M + Na 349.1780, C21H26O3Na requires 
349.1780. 
Also obtained was a 2nd diastereomer as a light yellow oil. Rf = 0.27 (9:1 petrol:EtOAc). 
 
 
 
2-(2-tert-butyl-6-methylphenoxy)-3-(chloromethyl)benzaldehyde (161) 
 
A mixture of Monoaldehde 140 (0.066 g, 0.21 mmol, 1 equiv.) and SOCl2 (1 cm3) was 
refluxed for 1 h. SOCl2 was then evaporatd off with nitrogen and the residue was treated 
with aq. 10% K2CO3 and diluted using CHCl3.  The organic phase was washed with 
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water, brine, dried (MgSO4), and solvent removed under reduced pressure. The crude 
product was purified by flash column chromatography (9:1 petrol : EtOAc) to yield the 
product as a light yellow oil (0.046 g, 73 %).  
Rf = 0.32 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 9.43 (1H, s, H-7), 7.78 (1H, dd, J 8 
and 2, H-1), 7.71 (1H, dd, J 8 and 2, H-3), 7.32 (1H, dd, J 7.6 and 2, H-4), 7.15 (1H, t, J 
7.6, H-2), 7.10 (1H, t, J 7.6, H-5), 7.04 (1H, dd, J 7.6 and 1.5, H-6), 4.76 (2H, CH AB 
m, H-8), 1.88 (3H, s, H-9), and 1.47 (9H, s, H-10).; ).; δC (100 MHz; CDCl3) 188.1, 
157.1, 155.9, 140.6, 137.0, 133.4, 130.7, 128.1, 127.7, 126.1, 125.79, 125.4, 122.6, 41.2 
(C-Cl), 35.3, 30.3, and 17.7.; ES+ m/z 339 (M + Na); HRMS found M + Na 339.1122, 
C19H24O2ClNa requires 339.1128. 
 
 
 
2-tert-butyl-4-methyl-6-nitrophenol (169)115 
 
A suspension of 2-tert-butyl-4-methyl phenol (1 g, 6.0 mmol, 1 equiv.), silica sulphuric 
acid (1.35 g, equiv. = 0.225 g mmol-1), wet SiO2 (1.2 g, equiv. = 50% w/w) and 
Al(NO3)3.9H2O (1.6 g, 4.3 mmol, 0.7 equiv.) in DCM (50 cm3) was stirred at rt for 7 h 
and then filtered. The organic phase was dried (MgSO4), and solvent removed under 
reduced pressure. The crude product was purified by flash column chromatography 
(100% DCM) to yield the product as a yellow solid (0.68 g, 53%).  
m.p. = 89 – 90 °C; Rf = 0.58 (4:1 petrol:EtOAc);  vmax(film/cm-1) 3089 (OH), 1537 and 
1487 (NO); δH (400 MHz; CDCl3) 11.43 (1H, s, H-5), 7.79 (1H, s, H-1), 7.39 (1H, s, H-
2), 2.33 (3H, s, H-3) and 1.44 (9H, s, H-4).; δC (100 MHz; CDCl3) 153.1, 140.2, 136.1, 
133.8, 128.6, 122.2, 35.4, 29.3, and 20.7.  Analyses matched the reported data.120 
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2-amino-6-tert-butyl-4-methylphenol (170) 
 
Nitrophenol 169 (1 g, 4.8 mmol, 1 equiv.), Fe (reduced) (2.67 g, 0.05 mol, 10 equiv.), 
ethanol (4 cm3), conc. HCl (0.05 cm3) and H2O (1 cm3) were charged to a flask fitted 
with a reflux condenser and heted at 100 °C  for 1 h.  The reaction mixture was filtered 
over celite and solvent removed under reduced pressure. The crude product was purified 
by flash column chromatography (4:1 petrol: EtOAc) to yield the product as a light 
purple powder (0.57 g, 67%). 
Rf = 0.25 (4:1 petrol:EtOAc);  vmax(film/cm-1) 3389 (OH), 3418, 3340 and 1628 (NH2); 
δH (500 MHz; CDCl3) 6.68 (1H, s, H-1), 6.61 (1H, s, H-2), 2.23 (3H, s, H-3), 1.41 (9H, 
s, H-4).; δC (100 MHz; CDCl3) 143.7, 136.6, 129.2, 123.5, 120.4, 118.8, 34.6, 29.8, 21.; 
ES- m/z 178 (M - H); HRMS found M - H 178.1231, C11H17NO requires 178.1237. 
 
 
 
2-tert-butyl-6-iodo-4-methylphenol (171) 
 
Aniline 171 (0.12 g, 0.67 mmol, 1 equiv.) in DMSO (1 cm3) was added to a solution of 
conc. H2SO4 (0.15 cm3) and H2O (1 cm3) at rt and the solution cooled using ice (1.5 g).  
NaNO2 (0.05 g, 0.74 mmol, 1.1 equiv.) dissolved in H2O (0.5 cm3) was added slowly to 
the solution of aniline sulfate and the aniline was left to diazotise for 40 min.  DMSO (2 
cm3) was added to the reaction mixture to redissolve the resultant precipitate.  KI (0.13 
g, 0.80 mmol, 1.2 equiv.) in H2O (0.5 cm3) was added and the reaction mixture heated to 
90 °C for 1 h. The reaction mixture was cooled to rt and diluted using EtOAc.  The 
organic phase was washed with water, brine, dried (MgSO4), and solvent removed under 
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reduced pressure. The crude product was purified by flash column chromatography (9:1 
petrol : EtOAc) to yield the product as a brown oil (0.04 g, 23%) 
Rf = 0.71 (4:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.43-7.41 (1H, m, H-2), 7.29 (1H, 
s, H-1), 2.42 (3H, s, H-3), 1.45 (9 H, s, H-4).; δC (100 MHz; CDCl3) 156.4, 135.5, 132.4, 
131.4, 127.4, 117.6, 34.7, 29.3, 21.3.; not visible by MS. 
 
 
 
2-(3-tert-butyl-2-hydroxy-5-methylphenylamino)benzene-1,3-dicarbonitrile (173) 
 
Phenol 170 (0.20 g,  1.12 mmol, 1.2 equiv.), K2CO3 (0.26 g, 1.86 mmol, 2 equiv.), 2-
Chloro-isophthalonitrile (0.15 g, 0.93 mmol, 1 equiv.), 3 Å molecular sieves (ca. 1 g) 
and anhydrous DMF (20 cm3) were treated as described in general procedure B. The 
crude product was purified by flash column chromatography (9:1 petrol : EtOAc) to 
yield the product as a light brown solid ( 0.088 g, 31 %). 
Rf = 0.59 (4:1 petrol:EtOAc). δH (400 MHz; CDCl3) 7.62 (2H, d, J 7.5, H-1), 7.03 (1H, 
s, H-3), 6.92 (2H, t, J 7.5, H-2), 6.68 (1H, s, H-4), 6.06 (1H, bs, H-5), 5.78 (1H, s, H-6), 
2.19 (3H, s, H-7)  and 1.36 (9H, s, H-8).; δC (100 MHz; CDCl3) 151.0, 150.0, 138.7, 
137.0, 136.0, 129.2, 128.1, 125.9, 124.9, 120.1, 115.1, 101.4, 34.7, 29.4 and 20.9.; ES- 
m/z 304 (M - H). 
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2-(2-tert-butylphenoxy)-1,3-bis(methoxymethyl)benzene (184) 
 
Diol 119b (0.4 g, 1.45 mmol, 1 equiv.), sodium hydride (60% dispersion in mineral oil) 
(0.35 g, 14.4 mmol, 6 equiv.), MeI (0.28 cm3, 4.34 mmol, 3 equiv.) and anhydrous THF 
(50 cm3) were treated as described in general procedure F.  The crude product was 
purified by flash column chromatography (2:1 petrol:EtOAc) to yield the product as a 
white solid (0.39 g, 79%).  
m.p  103-104 °C, Rf = 0.84 (9:1 petrol:EtOAc). δH (300 MHz; CDCl3) 7.50 (2H, d, J 7.5, 
H-1), 7.30-7.26 (2H, m, H-2 and H-3), 7.00-6.95 (2H, m, H-4 and H-5), 6.20 (1H, dd, J 
8 and 1.5, H-6), 4.4 – 4.2 (4H, CH AB m, H-7), 3.3 (6H, s, H-9) and 1.54 (9H, s, H-8).; 
δC (100 MHz; CDCl3) 156.9, 148.8, 136.8, 132.0, 128.6, 127.2, 126.5, 125.6, 121.4, 
112.6, 69.3, 58.4, 35.0 and 29.8.; ES+ m/z 337 (M + Na); HRMS found M + Na 
337.1776, C20H26O3Na requires 337.1775. 
 
 
 
2-(2-tert-butylphenoxy)-1,3-dimethylbenzene (187) 
 
Diol 119b (0.4 g, 1.45 mmol, 1 equiv.), dissolved in ethanol (20cm3) was placed under a 
hydrogen atmosphere through a continuous flow system over 10% Pd/C at a flow rate of 
1ml/min.  The solvent was removed under reduced pressure and the crude product was 
purified by flash column chromatography (15:1 petrol: EtOAc) to yield the products as a 
clear oil (0.15 g, 68%).  
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Rf = 0.54 (18:1 petrol:EtOAc); δH (300 MHz; CDCl3) 7.4 (1H, dd, J 7.5 and 1.5, H-3), 
7.08-7.18 (3H, m, H-4 and H-5 and H-2), 7.0 (1H, td, J 7.8 and 1.9, H-1), 6.9 (1H, td, J 
7.5 and 1.5, H-1), 6.3 (1H, dd, J 8 and 1.5, H-6), 2.16 (6H, s, H-8), 1.6 (9H, s, H-7). 
 
 
 
(2-(2-tert-butylphenoxy)-1,3-phenylene)bis(methylene) bis(diisopropylcarbamate) 
(194) 
 
Diol 119b (0.1 g, 0.35 mmol, 1 equiv.), NaH (60% dispersion in mineral oil) (0.08 g, 2.1 
mmol, 6 equiv.), 18-crown-6 ether (0.002 g, catalytic), and anhydrous ether (20 cm3) 
were charged to a flask at rt and stirred for 30 min. Diisopropyl carbamoyl chloride 
(0.24 g, 1.40 mmol, 4 equiv.). was added to the reaction mixture and the solution heated 
to reflux (35 °C) for 16 h. The reaction was quenched by adition of H2O and the organic 
phase was washed with water, brine, dried (MgSO4), and solvent removed under reduced 
pressure. The crude product was purified by flash column chromatography (9:1 petrol : 
EtOAc) to yield the product as a colourless oil turning into a white solid on standing 
(0.16 g, 87 %).  
m.p. 92 – 94 °C; Rf = 0.33 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.40 (2H, d, J 7.5, 
H-1), 7.26 (1H, dd, J 8 and 2, H-3), 7.22 (1H, t, J 7.5, H-2), 6.89-6.79 (2H, m, H-4 and 
H-5), 6.18 (1H, dd, J 8, and 2, H-6), 5.04 – 4.84 (4H AB m, H-8), 3.99 – 3.50 (4H br m, 
H-9) 1.45 (9H, s, H-7) and 1.15 – 1.00 (24H, br m, H-10); δC (100MHz; CDCl3) 156.9, 
155.1, 149.9, 137, 131.1, 129.8, 127.3, 127.1, 125.4, 121.6, 112.7, 61.6, 45.9 (br), 35, 
29.9, 21.3 and 20.70 (br).; ES+ m/z 563.4 (M + Na+); HRMS found: M + Na+ 541.3633, 
C32H48N2O5 requires 541.3636. 
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(2-(2-tert-butyl-6-methylphenoxy)-1,3-phenylene)bis(methylene) bis 
(diisopropylcarbamate) (195) 
 
Diol 119d (1.0 g, 3.73 mmol, 1 equiv.), NaH (60% dispersion in mineral oil) (0.90 g, 
22.35 mmol, 6 equiv.), 18-crown-6 ether (0.02 g, catalytic), and anhydrous ether (200 
cm3) were charged to a flask at rt and stirred for 30 min. Diisopropyl carbamoyl chloride 
(1.76 g, 14.9 mmol, 4 equiv.) was added to the reaction mixture and the solution heated 
to reflux (35 °C) for 16 h. The reaction was quenched by adition of water and the 
organic phase was washed with water, brine, dried (MgSO4), and solvent removed under 
reduced pressure. The crude product was purified by flash column chromatography (9:1 
petrol : EtOAc) to yield the product as a colourless oil turning into a white solid on 
standing (1.50 g g, 72 %).  
m.p. 96 – 98 °C. Rf = 0.38 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.26 (2H, d, J 7.6, 
H-1), 7.17 (1H, dd, J 7.5 and 1.5, H-3), 7.02 (1H, t, J 7.5, H-2), 6.89 (1H, t, J 7.5, H-4), 
6.84 (1H, dd, J 7.5 and 1.5, H-5), 4.96 – 4.82 (4H AB m, H-8), 3.95 – 3.65 (4H br m, H-
9) 1.73 (3H, s, H-6), 1.37 (9H, s, H-7) and 1.15 – 1.05 (24H, bd, J 6, H-10); δC 
(100MHz; CDCl3) 155.1, 154.5, 152.1, 139.7, 130.5, 129.5, 127.5, 126.9, 125.5, 123.7, 
122.6, 61.5, 45.9 (br), 35.3, 30.4, 21.2 (br) and 18.1.; ES+ m/z 577 (M + Na+); HRMS 
found M + Na 577.3618, C33H50N2O5 Na requires 577.3612; EA found C, 71.12; H, 
9.56; N; 5.08, C33H50N2O5 requires C 73.57; H, 9.35; N, 5.20%. 
 
 
 
 
 
 
     
 
 
O
O ON
O O
N
1 1
2
3 4
5
7
7
7
8 8 9
99
9
10
10
1010
10
10
1010
6
 196
Diisopropyl-carbamicacid 1-{2-(2-tert-butyl-phenoxy)-3-[(diisopropylcarb 
amoyloxy)-methyl]-phenyl}-2-hydroxy-2-methyl-propyl ester (198) 
 
Carbamate 194 (0.14 g, 0.25 mmol, 1.0 equiv.), sec-BuLi (1.3 M in hexanes) (0.31 cm3, 
0.41 mmol, 1.6 equiv.), acetone (1 cm3, excess) and anhydrous ether (14 cm3) were 
treated as described in general procedure G.  The crude product was purified by flash 
column chromatography (9:1 Petrol : EtOAc) to yield the product as a light yellow oil 
(0.095 g, 63 %).  
Rf = 0.10 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.55 (1H, dd, J 8 and 1.5, H-1), 
7.40 (1H, dd, J 8 and 1.5, H-1), 7.30-7.20 (2H, m, H-2 and H-3), 6.81 (2H, dd, J 6 and 
1.5 H-4 and H-5), 6.13 (1H, dd, J 6, and 1.5, H-6), 5.80 (1H, br s, H-11), 4.99–4.75 (2H 
AB m, H-8), 4.00-3.45 (4H, br m, H-9) 1.49 (9H, s, H-7), 1.18 (6H, br s, H-12) and 
1.12–1.00 (24H, bm, H-10); δC (100MHz; CDCl3) 157.0, 155.4, 155.1, 150.1, 136.8, 
132.5, 130.7, 130.0, 128.9, 127.4, 126.9, 125.1, 121.9, 114.0, 76.5, 73.6, 61.9, 45.4 (br), 
34.9, 30.1, 27.1, 25.4, and 20.5 (br).; ES+ m/z 621.5 (M + Na+); HRMS found M + H+ 
599.4048, C35H55N2O6 requires 599.4055. 
 
 
 
Di-isopropyl-carbamic acid 1-{2-(2-tert-butyl-6-methyl-phenoxy)-3-[(diisopropyl 
carbamoyloxy)-methyl]-phenyl}-2-hydroxy-2-methyl-propyl ester (199) 
 
Carbamate 195 (0.13 g, 0.23 mmol, 1.0 equiv.), sec-BuLi (1.3 M in hexanes) (0.28 cm3, 
0.37 mmol, 1.6 equiv.), acetone (1 cm3, excess) and anhydrous ether (13 cm3) were 
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treated as described in general procedure G.  The crude product was purified by flash 
column chromatography (9:1 Petrol : EtOAc) to yield the product as a light yellow oil 
(0.1 g, 75 %).  
Also synthesised by treatment of carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi 
(0.22 cm3, 0.29 mmol, 1.6 equiv.), (–)-sparteine (0.07 cm3, 0. 29mmol, 1.6 equiv), 
acetone (1 cm3, excess) and anhydrous ether (10 cm3) as described in general procedure 
G.  The crude product was purified by flash column chromatography (9:1 Petrol : 
EtOAc) to yield the product as a light yellow oil (0.12 g, 86 %).  
HPLC: (R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 1.0 ml/min; retention times 
14.04 min (major) and 15.85 min (minor). 
Material of 50% ee had [α]D22 = +28 (c = 1.000,  chloroform). 
Also synthesised by treatment of stannane 203 (0.05 g, 0.09 mmol, 1.0 equiv.), n-BuLi 
(2.4 M in hexanes) (0.06 cm3, 0.14 mmol, 1.5 equiv.), acetone (0.5 cm3, excess) and 
anhydrous ether (5 cm3) as described in general procedure I.  The crude product was 
purified by flash column chromatography (9:1 Petrol : EtOAc) to yield the product as a 
light yellow oil (0.02 g, 27 %).  
Rf = 0.13 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.49 (1H, dd, J 8 and 1.5, H-1), 
7.21-7.15 (2H, m, H-1 and H-3), 7.05 (1H, t, J 8, H-4), 6.86 (1H, t, J 7.5, H-2), 6.78 
(1H, dd, J 7.5, and 1, H-5), 6.51 (1H, s, H-11) 4.62 – 4.32 (2H AB m, H-8), 3.93–3.50 
(4H br m, H-9), 1.6 (3H, s, H-6), 1.41 (9H, s, H-7), 1.24 (6H, d, J 4, H-12), and 1.10 
(24H, dd, J 21 and 7, H-10); δC (100MHz; CDCl3) 155.2, 155.0, 152.4, 139.3, 130.9, 
130.2, 129.7, 129.1, 127.8, 126.4, 125.4, 123.6, 122.5, 75.5, 73.8, 60.8, 46.0 (br), 35.4, 
30.3, 26.9, 26.0, 21.4 (br) and 18.2.; ES+ m/z 635 (M + Na+), HRMS found M + H+ 
613.4229,  C36H57N2O6 requires 613.4212. 
 
 
 
 
 
 
 198
Diisopropyl-carbamic acid {2-(2-tert-butyl-6-methyl-phenoxy)-3-[(diisopro 
pylcarbamoyloxy)-methyl]-phenyl}-(1-hydroxy-cyclobutyl)-methyl ester (200) 
 
Carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi (1.3 M in hexanes) (0.22 cm3, 
0.29 mmol, 1.6 equiv.), cyclobutanone (1 cm3, excess) and anhydrous ether (10 cm3) 
were treated as described in general procedure G.  The crude product was purified by 
flash column chromatography (9:1 Petrol : EtOAc) to yield the product as a clear gum 
(0.06 g, 56 %).  
Also synthesised by treatment of carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi 
(0.22 cm3, 0.29 mmol, 1.6 equiv.), (–)-sparteine (0.07 cm3, 0. 29mmol, 1.6 equiv), 
cyclobutanone (1 cm3, excess) and anhydrous ether (10 cm3) as described in general 
procedure G.  The crude product was purified by flash column chromatography (9:1 
Petrol : EtOAc) to yield the product as a clear gum (0.028 g, 26 %).  
HPLC: (R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 1.0 ml/min; retention times 
14.79 min (major) and 16.89 min (minor). 
Material of 46% ee had [α]D22 = +9 (c = 0.100,  chloroform). 
Rf = 0.10 (9:1 petrol:EtOAc); δH (500 MHz; CDCl3) 7.66 (1H dd, J 7.5 and 1.5, H-
1), 7.30 (1Η, dd, J 8 and 1, H-1), 7.24 (1H, br d, J 7, H-3), 7.15 (1H, t, J 7.5, H-2), 6.94 
(1H, t, J 7.5, H-4), 6.87 (1H, br d, J 7, H-5), 6.67 (1H, br s, H-11), 4.73-4.45 (2H, AB m, 
H-8), 4.05-3.60 (4H, br m, H-9), 3.22 (1H, s, H-14), 2.55-2.50 (1H, br m, H-12), 2.35-
2.28 (1H, br m, H-12), 2.17-1.95 (4H, br m, H-12 and H-13), 1.70 (3H, s, H-6), 1.26 
(9H, s, H-7), 1.22-1.15 (24 H, br m, H-10).;  δC (100MHz; CDCl3) 155.1, 155.0, 152.2, 
139.3, 130.95, 130.0, 129.0, 127.8, 126.5, 125.4, 123.6, 122.6, 78.0, 73.9, 60.8, 45.9 
(br), 35.4, 33.4, 320, 30.4, 21.1 (br), 18.3 and 12.5.; ES+ m/z 647 (M + Na+); HRMS 
found M + Na 647.4028,  C37H56N2O6 Na requires 647.4036. 
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Diisopropyl-carbamic acid {2-(2-tert-butyl-6-methyl-phenoxy)-3-[(diisopro 
pylcarbamoyloxy)-methyl]-phenyl}-trimethylsilanyl-methyl ester (201) 
 
Carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi (1.3 M in hexanes) (0.22 cm3, 
0.29 mmol, 1.6 equiv.), TMSCl (1 cm3, excess) and anhydrous ether (10 cm3) were 
treated as described in general procedure G.  The crude product was purified by flash 
column chromatography (9:1 Petrol : EtOAc) to yield the product as a light yellow oil 
(0.079 g, 70 %).  
Also synthesised by treatment of carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi 
(0.22 cm3, 0.29 mmol, 1.6 equiv.), (–)-sparteine (0.07 cm3, 0. 29mmol, 1.6 equiv), 
TMSCl (1 cm3, excess) and anhydrous ether (10 cm3) as described in general procedure 
G.  The crude product was purified by flash column chromatography (9:1 Petrol : 
EtOAc) to yield the product as a light yellow oil (0.08 g, 72 %).  
HPLC: (R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 1.0 ml/min; retention times 
9.54 min (major) and 10.81 min (minor). 
Material of 56% ee had [α]D22 = +52 (c = 1.000,  chloroform). 
Also synthesised by treatment of stannane 203 (0.05 g, 0.09 mmol, 1.0 equiv.), n-BuLi 
(2.4 M in hexanes) (0.06 cm3, 0.14 mmol, 1.5 equiv.), TMSCl (0.5 cm3, excess) and 
anhydrous ether (5 cm3) as described in general procedure I.  The crude product was 
purified by flash column chromatography (9:1 Petrol : EtOAc) to yield the product as a 
light yellow oil (0.037 g, 33 %).  
Rf = 0.60 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.31 (1H, dd, J 8 and 2, H-1), 7.20 
(1H, dd, J 8 and 2, H-1), 7.16 (1H, dd, J 8 and 2, H-3), 7.08 (1H, t, J 8, H-2 or H-4), 
6.90 (1H, t, J 8, H-2 or H-4), 6.84 (1H, br dd, J 7.5 and 1, H-5), 6.28 (1H, s, H-11), 4.63-
4.35 (2H, AB m, H-8), 3.90-3.76 (4H, br m, H-9), 1.64 (3H, s, H-6), 1.36 (9H, s, H-7) 
1.11 (12H, br d, J 4, H-10), 1.04 (12H, br d, J 4, H-10) and 0.00 (9H, s, H-12).; δC 
(100MHz; CDCl3) 153.7, 153.5, 149.1, 137.3, 131.5, 129.6, 126.7, 126.3, 125.0, 123.6, 
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121.6, 121.2, 64.3, 59.5, 44.6 (br), 33.9, 28.8, 19.7 (br), 16.8 and -4.2.; ES+ m/z 649 (M 
+ Na+), HMRS Found M + Na 649.3996 C36H58N2O5Si Na requires 649.4008. 
 
 
 
Diisopropyl-carbamic acid 1-{2-(2-#tert!-butyl-6-methyl-phenoxy)-3-[(diisop= 
ropylcarbamoyloxy)-methyl]-phenyl}-2-oxo-propyl ester (202) 
 
Carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi (1.3 M in hexanes) (0.22 cm3, 
0.29 mmol, 1.6 equiv.), acetic anhydride (1 cm3, excess) and anhydrous ether (10 cm3) 
were treated as described in general procedure G.  The crude product was purified by 
flash column chromatography (9:1 Petrol : EtOAc) to yield the product as a light yellow 
oil (0.11 g, 69 %).  
Also synthesised by treatment of carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi 
(0.22 cm3, 0.29 mmol, 1.6 equiv.), (–)-sparteine (0.07 cm3, 0. 29mmol, 1.6 equiv), 
TMSCl (1 cm3, excess) and acetic anhydride (10 cm3) as described in general procedure 
G.  The crude product was purified by flash column chromatography (9:1 Petrol : 
EtOAc) to yield the product as a light yellow oil (0.10 g, 66 %).  
HPLC: (R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 1.0 ml/min; retention times 
11.89 min (major) and 16.11 min (minor). 
Material of 60% ee had [α]D22 = +102 (c = 0.9,  chloroform). 
Rf = 0.29 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.38 (1H, dd, J 7.5 and 2, H-1), 
7.33-7.29 (2H, m, H-1 and H-3), 7.13 (1H, t, J 7.5, H-2), 6.98 (1H, t, J 8, H-4), 6.88 
(1H, dd, J 7.5 and 1, H-5), 6.54 (1H, s, H-11), 4.92-4.70 (2H, AB m, H-8), 4.05-3.75 
(4H, br m, H-9), 2.14 (3H, s, H-12), 1.74 (3H, s, H-6), 1.52 (9H, s, H-7), 1.35-1.15 
(24H, br m, H-10).; δC (100MHz; CDCl3) 202.8, 154.5, 154.3, 152.7, 139.4, 131.2, 
130.7, 129.6, 127.6, 127.4, 125.7, 124.0, 123.3, 74.1, 61.1, 45.6 (br), 35.4, 30.5, 26.8, 
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20.9 (br), and 18.3.; ES+ m/z 619 (M + Na+), HMRS Found M + H 597.3889, 
C35H53N2O6 requires 597.3899. 
 
 
 
Diisopropyl-carbamic acid {2-(2-tert-butyl-6-methyl-phenoxy)-3-[(diisopro 
pylcarbamoyloxy)-methyl]-phenyl}-tributylstannanyl-methyl ester (203) 
 
Carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi (1.3 M in hexanes) (0.22 cm3, 
0.29 mmol, 1.6 equiv.), SnBu3Cl (0.5 cm3, excess) and anhydrous ether (10 cm3) were 
treated as described in general procedure G.  The crude product was purified by flash 
column chromatography (9:1 Petrol : EtOAc) to yield the product as a light yellow oil 
(0.088 g, 58 %) and as a mixture of diastereomers in the ratio 9:1 
HPLC: minor diastereomer elutes first, (R,R-Whelk-O1), eluting with hexane:IPA 97:3 
at 1.0 ml/min; retention times 3.13 min and 6.29 min; major diastereomer elutes second, 
(R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 1.0 ml/min; retention times 5.84 min 
and 6.63 min; 
 
Also synthesised by treatment of carbamate 195 (0.1 g, 0.18 mmol, 1.0 equiv.), sec-BuLi 
(0.22 cm3, 0.29 mmol, 1.6 equiv.), (–)-sparteine (0.07 cm3, 0. 29mmol, 1.6 equiv), 
TMSCl (1 cm3, excess) and anhydrous ether (10 cm3) as described in general procedure 
G.  The crude product was purified by flash column chromatography (9:1 Petrol : 
EtOAc) to yield the product as a light yellow oil (0.094 g, 62 %).  
HPLC: (R,R-Whelk-O1), eluting with hexane:IPA 97:3 at 1.0 ml/min; retention times 
5.84 min (minor) and 6.63 min (minor). 
Material of 50% ee had [α]D22 = –21 (c = 1.000,  chloroform). 
Rf = 0.29 (9:1 petrol:EtOAc); δH (400 MHz; CDCl3) 7.27-7.16 (3H, m, H-1 and H-3), 
7.07 (1H, t, J 7.5, H-2 or H-4), 6.97 (1H, t, J 7.5, H-2 or H-4), 6.91 (1H, dd, J 7.5 and 
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1.5, H-5), 5.92 (1H, s, H-11MINOR), 5.50 (1H, s, H-11MAJOR), 5.10-4.98 (2H, AB m, H-
8MAJOR), 4.75-4.55 (2H, s, H-8MINOR), 4.10-3.85 (3H, br m, H-9), 3.70 – 3.60 (1H, br m, 
H-9), 1.80 (3H, s, H-6), 1.41 (9H, s, H-7), 1.40-1.27 (9H, m, H-14), 1.22-1.14 (24H, br 
m, H-10), 1.02 (3H, br m, H-12), 0.84 (9H, t, J 7.5, H-12), 0.72 (6H, q, J 8, H-13).; δC 
(100MHz; CDCl3) 155.4, 155.2, 151.2, 139.4, 130.6, 130.5, 127.3, 126.8, 125.7, 123.6, 
122.5, 123.3, 74.1, 62.0, 58.08, 46.1 (br), 35.4, 30.4, 29.1, 27.6, 21.5 (br), 20.5, 18.6, 
13.7 and 10.7.; ES+ m/z 867 (M + Na+). 
 
 
 
2-(2-tert-butyl-6-methylphenoxy)-3-(methoxymethyl)benzaldehyde (243) 
 
Monoaldehyde 140 (1.46 g, 4.9 mmol, 1 equiv.), NaH (60% dispersion in mineral oil)  
(0.29 g, 5.88 mmol, 1.2 equiv.), MeI (0.37 cm3, 5.22 mmol, 1.2 equiv) and anhydrous 
THF (200 cm3) were treated as described in general procedure F.  The crude product was 
purified by flash column chromatography (9:1 Petrol : EtOAc) to yield the product as a 
light yellow solid (1.17 g, 76 %).  
m.p. 79 – 81 °C. Rf = 0.56 (9:1 petrol:EtOAc); vmax(film/cm-1) 1679 (CHO); δH (500 
MHz; CDCl3) 9.53 (1H, s, H-8), 7.68 (1H, dd, J 7.5 and 2, H-3), 7.64 (1H, dt, J 7.5 and 
1, H-1), 7.23 (1H, dd, J 8 and 1.5, 1, H-4), 7.07 (1H, t, J 7.5, H-2), 7.00 (1H, t, J 8, H-5), 
6.94 (1H, ddd, J 8, 2 and 0.5, H-6), 4.46-4.39 (2H, AB m, H-9), 3.33 (3H, s, H-11), 1.77 
(3H, s, H-7) and 1.38 (9H, s, H-10).; δC (100MHz; CDCl3) 188.7, 156.8, 155.8, 140.4, 
135.0, 131.0, 129.1, 128.6, 127.7, 126.1, 125.9, 124.9, 122.4, 58.7, 35.3, 30.4, and 17.6.; 
ES+ m/z 335 (M + Na); HRMS  found: M + Na 335.1629, C20H24O3 Na requires 
335.1618. 
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1-(2-(2-tert-butyl-6-methylphenoxy)-3-(methoxymethyl)phenyl)ethanol (244) 
 
MeMgBr (1.4 M solution in THF) (0.82 cm3, 1.15 mmol, 1.2 equiv.), aldehyde 243 (0.30 
g, 1.15 mmol, 1 equiv.) and anhydrous THF (10 cm3) were treated as described in 
general procedure J.  The crude product was purified by flash column chromatography 
(9:1 Petrol : EtOAc) to yield the product as a light yellow gum (0.25 g, 80 %) and as a 
mixture of diastereomers (29:71) by 1H NMR. 
Rf = 0.2 (9:1 petrol:EtOAc); δH (500 MHz; CDCl3) Mixture of diastereoisomers in the 
ratio of 29:71. 7.44 (1H, dd, J 7.5 and 1.5 H-1major or H-3major), 7.39 (1H, dd, J 7.5 and 
1.5, H-1minor or H-3minor) 7.29 (1H, td, J 8 and 1.5, H-1m or H-3), 7.21-7.18 (1H, m, H-2), 
7.10-7.03 (1H, m, H-4), 6.92 (1H, t, J 7.5 H-5), 6.87 (1H, br d, J 7.5 H-6), 5.16 (2H, q, 
H-8major), 4.96 (2H, q, H-8minor), 4.15-3.86 (2H, AB m, H-9), 3.14 (3H, s, H-11minor), 3.06 
(3H, s, H-11major), 1.72 (3H, s, H-7major), 1.69 (3H, s, H-7minor),  1.41 (3H, d, J 6.5, H-
12major), 1.39 (9H, s, H-10minor), 1.38 (9H, s, H-10major)  and 1.26 (3H, d, J 6.5, H-
12minor).; δC (100 MHz; CDCl3) 155.0, 154.8, 151.1, 150.8, 139.8, 139.7, 135.9, 135.7, 
135.0, 134.9, 130.6, 129.9, 128.9, 128.6, 127.7, 127.6, 127.5, 126.7, 126, 125.4, 123.6, 
123.5, 123.3, 123.2, 69.4, 64.5, 58.3, 35.4, 30.4, 24.4, 23.0 and 18.2.; ES+ m/z 351 (M + 
Na); HRMS found 351.1933, C21H28O3 Na requires 351.1931. 
Also synthesised by treatment of ketone 246 (0.057 g, 0.17 mmol, 1 equiv.) with L-
Selectride (1 M solution in THF) (0.2 cm3, 0.18 mmol, 1.1 equiv.) and THF (10 cm3) at 
0 °C as described in general procedure K.  The crude product (0.055 g, 98 %) was taken 
unpurified. Crude 1H NMR shows mixture of diastereomers in the ratio of 88:12. 
HPLC: Sphereclone,  hexane:IPA 97:03, 1.0 ml/min, retention times 5.4 min (major) and 
5.9 min (minor). 
Also synthesised by treatment of ketone 246 (0.08 g, 0.24 mmol, 1 equiv.) with Super-
Hydride® (1 M solution in hexane) (0.30 cm3, 0.27 mmol, 1.1 equiv.) and THF (10 cm3) 
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at 0 °C as described in general procedure K.  The crude product (0.078 g, 98%) was 
taken unpurified. Crude 1H NMR shows mixture of diastereomers in the ratio of 57:43. 
HPLC: Sphereclone,  hexane:IPA 97:03, 1.0 ml/min, retention times 5.4 min (major) and 
5.9 min (minor). 
 
 
 
(2-(2-tert-butyl-6-methylphenoxy)-3-(methoxymethyl)phenyl)(phenyl)methanol 
(245) 
 
PhMgBr (1M solution in THF) (0.5 cm3, 0.5 mmol, 1.2 equiv.), monoaldehyde 31 (0.13 
g, 0.42 mmol, 1 equiv.) and anhydrous THF (10 cm3) were treated as described in 
general procedure J.  The crude product was purified by flash column chromatography 
(9:1 Petrol : EtOAc) to yield the product as a light yellow oil (0.10 g, 63 %), and as 
seperable mixture of 2 diastereomers (55:45) by 1H crude NMR. 
Diastereomer 1 (first eluted): white solid, m.p. 120 – 123 °C; Rf = 0.33 (9:1 
petrol:EtOAc); δH (300 MHz; CDCl3) 7.51 (1H, d, J 7.5 H-1 or H-3), 7.28-7.22 (3H, m, 
H-12 and H-1 or H-3), 7.22-7.11 (4H, m, H-4 and H-13 and H-14), 7.06 (1H, t, J 7.5, H-
2), 6.89 (1H, t, J 8, H-5), 6.72 (1H, br d, J 8, H-6), 6.16 (1H, s, H-8), 3.81 - 3.60 (2H, 
AB m, H-9), 2.95 (3H, s, H-11), 1.38 (9H, s, H-10) and 1.18 (3H, s, H-7).; δC (75 MHz; 
CDCl3) 154.2, 151.2, 142.7, 140.2, 130.3, 129.1, 128.7, 128.4, 127.6, 127.3, 127.1, 
126.5, 125.1, 123.7, 122.7, 72.0, 69.0, 58.1, 35.3, 30.7 and 17.2; ES+ m/z 413 (M + Na); 
HRMS found M + Na 413.2084, C26H30O3 Na requires 413.2088. 
Diastereomer 2 (second eluted): light yellow oil; Rf = 0.27 (9:1 petrol:EtOAc); δH (300 
MHz; CDCl3) 7.4-7.16 (8H, m, H-1, H-3, H-12, H-13, H-14 and H-4), 7.27 (1H, d, J 8, 
H-3), 7.06 (1H, t, J 7.5, H-2), 6.98-6.93 (2H, m, H-5 and H-6), 6.17 (1H, s,  H-8), 4.04 - 
3.83 (2H, AB m, H-9), 3.05 (3H, s, H-11), 1.74 (3H, s, H-7) and 1.19 (9H, s, H-10).; δC 
O
O
OH
1
2
3
4 5
6
7
8 9
10
10
10
11
12
12
13
13
14
 205 
(75 MHz; CDCl3) 154.9, 151.7, 143.3, 140.1, 133.4, 130.4, 129.2, 128.5, 128.3, 128.1, 
127.4, 127.3, 127.0, 125.4, 123.7, 123.0, 70.6, 69.3, 58.3, 35.2, 30.6 and 18.1.; ES+ m/z 
413 (M + Na); HRMS found M + Na 413.2084, C26H30O3 Na requires 413.2088. 
Also synthesised by treatment of ketone 247 (0.064 g, 0.16 mmol, 1 equiv.) with L-
Selectride (1 M solution in THF) (0.2 cm3, 0.18 mmol, 1.1 equiv.) and THF (10 cm3) at 
0 °C as described in general procedure K.  The crude product (0.062 g, 98%) was taken 
unpurified.  Crude 1H NMR shows mixture of diastereomers in the ratio of >95:5. 
HPLC: Sphereclone,  hexane:IPA 97:03, 1.0 ml/min, retention times 4.4 min (major) and 
4.7 min (minor). 
 
Also synthesised by treatment of ketone 247 (0.068 g, 0.18 mmol, 1 equiv.) with Super-
Hydride® (1 M solution in hexane) (0.22 cm3, 0.19 mmol, 1.1 equiv.) and THF (10 cm3) 
at 0 °C as described in general procedure K.  The crude product (0.062 g, 92 %) was 
taken unpurified. .  Crude 1H NMR shows mixture of diastereomers in the ratio of >95:5. 
HPLC: Sphereclone,  hexane:IPA 97:03, 1.0 ml/min, retention times 4.4 min (major) and 
4.7 min (minor),  >99:1 dr. 
 
 
 
1-(2-(2-tert-butyl-6-methylphenoxy)-3-(methoxymethyl)phenyl)ethanone (246) 
 
Dess-martin periodinane (15 wt % solution in DCM) (1.7 cm3, 0.76 mmol, 1 equiv.), 
alcohol 32 (0.25 g, 0.76 mmol, 1 equiv.) and anhydrous DCM (20 cm3) were treated as 
described in general procedure L.  The crude product was purified by flash column 
chromatography (9:1 Petrol : EtOAc) to yield the product as a light yellow oil (0.24 g, 
97 %).  
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Rf = 0.41 (9:1 petrol:EtOAc); δH (300 MHz; CDCl3) 7.6 (1H, d, J 7.5, H-3), 7.51 (1H, 
dd, J 7.5 and 1.5, H-1), 7.32 (1H, d, J 8, H-4), 7.15 (1H, t, J 7.5, H-2), 7.06 (1H, t, J 8, 
H-5), 7.0 (1H, d, J 8, H-6), 4.13 - 3.92 (2H, AB m, H-8), 3.17 (3H, s, H-9), 2.56 (3H, s, 
H-11), 1.94 (3H, s, H-7) and 1.48 (9H, s, H-10).; δC (75MHz; CDCl3) 201.2, 154.1, 
152.4, 140.8, 132.9, 132.0, 130.7, 129.1, 128.2, 125.9, 124.5, 122.7, 58.5, 53.7, 35.7, 
30.9 and 18.8.; ES+ m/z 349 (M + Na); HRMS found M + Na 349.1777, C21H26O3 
requires 349.1775. 
 
 
 
(2-(2-tert-butyl-6-methylphenoxy)-3-(methoxymethyl)phenyl)(phenyl)methanone 
(247) 
 
Dess-martin periodinane (15 wt % solution in DCM) (0.56 cm3, 0.26 mmol, 1 equiv.), 
alcohol 245 (0.1 g, 0.26 mmol, 1 equiv.) and anhydrous DCM (20 cm3) were treated as 
described in general procedure L.  The crude product was purified by flash column 
chromatography (9:1 Petrol : EtOAc) to yield the product as a light yellow oil (0.09 g, 
90 %).  
Rf = 0.44 (9:1 petrol:EtOAc); δH (300 MHz; CDCl3) 7.81 (2H, dd, J 8 and 1.5, H-1 and 
H-3), 7.64-7.55 (2H, m, H-11), 7.44 (2H, t, J 7.5, H-12 or H-13), 7.28 (1H, dd, J 7.5 and 
2, H-4), 7.23-7.15 (2H, m, H-13 and H-12), 6.94 (1H, t, J 7.5, H-5), 6.79 (1H, dd, J 7.5 
and 1, H-6), 4.15 - 3.92 (2H, AB m, H-8), 3.2 (3H, s, H-10) and 1.2 (9H, s, H-9).; δC 
(75MHz; CDCl3) 196.3, 154.2, 151.8, 140.8, 137.8, 133.5, 130.9, 130.2, 128.6, 128.4, 
128.0, 127.4, 127.0, 125.3, 124.3, 122.3, 58.6, 53.7, 35.4, 30.4 and 18.2.; ES+ m/z 411 
(M + Na); HRMS found M + Na 411.1946, C26H28O3Na requires 411.1931. 
 
 
 
O
O
O
1
2
3
4 5
6
7
8
9
9
9
10
11
11
12
12
13
 207 
(2,4-di-tert-butyl-6-bromophenyl)(2,4-di-tert-butyl-6-methylphenyl)sulfane (250) 
 
Following a modified procedure reported by Buchwald,143 solid reagents: thiophenol 256 
(0.57 g, 2.4 mmol, 1.2 equiv.), copper(I) iodide (0.46 g, 2.4 mmol, 1.2 equiv.) and 
potassium carbonate (560 mg, 4.0 mmol, 2 equiv.) were charged to a flask fitted with a 
reflux condenser and evacuated / back filled with nitrogen × 3. A solution of iodide 258 
(0.8 g, 2.0 mmol, 1 equiv.) and ethylene glycol (0.23 cm3) in tert-amyl alcohol (6 mL) 
was added via syringe and the reaction mixture heated to reflux for 24 h.  The reaction 
mixture was allowed to cool to RT, diluted with ethyl acetate (40 cm3) and filtered 
through a glass sinter.  Organics were washed with water (3 × 50 cm3) and brine (50 
cm3) dried over MgSO4 and solvents removed under reduced pressure.  The crude 
product was purified by flash chromatography (petrol) to yield the title compound as a 
white solid that was then recrystalised from acetone (1.07 g, 64%).  
m.p 125-129 ˚C (acetone). Rf = 0.69 (petrol); δH (400 MHz, CDCl3) 7.45 (1H, d, J 2, H-
1), 7.36 (1H, d, J 2, H-1), 7.33 (1H, d, J 2, H-1), 6.93 (1H, d, J 2, H-1), 1.75 (3H, s, H-
3), 1.65 (9H, s, H-4), 1.64 (9H, s, H-2), 1.30 (9H, s, H-2) and 1.28 (9H, s, H-2).; δC (100 
MHz, CDCl3) 150.8, 150.2, 149.0, 148.5, 139.0, 133.1, 131.8, 129.7, 127.0, 126.1, 
123.6, 122.5, 38.3, 37.5, 34.7, 34.5, 31.3, 31.3, 31.1, 30.9 and 23.0.; m/z CI 502 (40 %, 
[79Br M]+), 504 (40 %, [81Br M]+) 503 (50 %, [79BrM+H]+), 505 (50 %, 81BrM+H]+) 
HRMS found 502.2264, C29H43BrS requires 502.2263. 
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2-bromo-1,5-di-tert-butyl-3-methylbenzene (254)165 
 
Using a modified procedure reported by Wieghardt.152 A solution of bromine (12.6 cm3, 
480 mmol, 2 equiv.) in chloroform (100 cm3) was added via syringe pump to a 
suspension of iron powder (4.1 g, 73.4 mmol, 0.3 equiv.) in a solution of 3,5-di-tert-
butyl toluene (50 g, 240 mol, 1 equiv.) in chloroform (400 cm3) at 0 ˚C over 2 hours.  
The reaction mixture was stirred for a further 2 hours at 0 ˚C.  The reaction was 
quenched by addition of saturated Na2O3S2 solution (150 cm3).  The organic phases were 
washed with Na2O3S2 solution (3 × 100 cm3), water (2 × 100 cm3) and brine (100 cm3), 
dried over MgSO4 and solvents removed under reduced pressure.  The resultant oil was 
purified by distillation under reduced pressure to yield the product as a colourless oil (40 
g, 55 %).  
b.p. 100-104 ˚C (1 mmHg); δH (200 MHz; CDCl3) 7.42 (1H, d, J 2.5, H-1), 7.22 (1H, d, 
J 2.5, H-2), 2.52 (3H, s, H-3), 1.63 (9H, s, H-4) and 1.38 (9H, s, H-4).; Analyses 
matched the reported data. 
 
 
 
(2,4-di-tert-butyl-6-methylphenyl)(methyl)sulfane (255) 
 
A flame dried flask was evacuated / back filled with nitrogen × 3.  Bromide 254 (6 g, 
21.2 mmol, 1 equiv.) was charged to the flask and dissolved in anhydrous THF (150 
cm3) and the solution cooled to –78 ˚C.  t-BuLi solution (2.2 M in hexanes) (46.6 cm3, 
46.6 mmol, 2.2 equiv.) was added over 5 mins and stirred for a further 5 mins.  Dimethyl 
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disulfide (4.79 cm3,  53 mmol,  2.5 equiv.) was added dropwise and the reaction stirred 
and allowed to warm to RT over 16 h.   The reaction was quenched by addition of 
saturated NH4Cl solution (35 cm3) and  diluted with with ether (200 cm3).  The organic 
phase was washed with water (2 × 200 cm3) and brine (100 cm3), dried over MgSO4 and 
solvents removed under reduced pressure to yield the product as a colourless oil which 
slowly crystallised on standing (4.95 g, 93 %).  
m.p 32-34 ˚C; δH (400 MHz, CDCl3) 7.26 (1H, s, H-1), 7.05 (1H, s, H-2), 2.97 (3H, s, H-
5), 2.37 (3H, s, H-3) and 1.34 (18H, s, H-4).; δC (100 MHz, CDCl3) 152.8, 150.4, 144.1, 
131.8, 125.8, 121.8, 37.5, 34.6, 31.5, 31.3, 22.1 and 19.9.; CI m/z 250 (100 %, [M]+); 
HRMS found 250.1757, C16H26S requires 250.1750. 
 
 
 
2,4-di-tert-butyl-6-methylbenzenethiol166 (256) 
 
Sulfide 255 (4.47 g, 17.8 mmol, 1 equiv.) was added to a solution of Sodium 2-methyl-
2-propanethiolate (10 g, 89.2 mmol, 5 equiv.) in DMF (85 cm3) under an atmosphere of 
nitrogen.  The reaction was heated to reflux for 18 h.  The reaction mixture was cooled 
in ice for 20 mins.  3 M HCl solution (100 m cm3) was added and a stream of nitrogen 
blown over the reaction mixture for 10 mins.  The reaction mixture was poured into a 
conical flask containing 3 M HCl solution (500 cm3) and stirred for 15 mins, and diluted 
with DCM.  Organic phase was washed with water (300 cm3), dried over MgSO4 and 
solvent evaporated by blowing a stream of nitrogen over the solution.  The crude product 
was purified by column chromatography (petrol) to yield the title compound as a waxy 
white solid (3.65 g, 87%).   
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Rf = 0.34 (petrol); δH (500 MHz, CDCl3) 7.34 (1H, d, J 1.5, H-1),  
7.14 (1H, d, J 1.5, H-2), 3.28 (1H, s, SH), 3.42 (3H, s, H-3), 1.54 (9H, s, H-4) and 1.30 
(9H, s, H-4).; Analyses matched the reported data.153 
 
 
 
1,5-di-tert-butyl-3-bromo-2-iodobenzene (258) 
 
Following a modified procedure reported by Stavber138, 1-Bromo-3,5-di-tert-butyl 
benzene (11.2 g, 41.6 mmol, 1 equiv.) and selectfluor® (16.3 g, 45.9 mmol, 1.1 equiv.) 
were charged to a flask and dissolved in acetonitrile (300 cm3).  The reaction mixture 
was heated to reflux for 5 hours.  The reaction was allowed to cool to room temperature 
and quenched by addition solid Na2O3S2 (~10 g) and water (~30 cm3) and stirred for 10 
min.  Solvents were removed under reduced pressure and the resultant residue dissolved 
in dichloromethane (200 cm3), washed with water (3 × 150 cm3), saturated Na2O3S2 
solution (100 cm3L) and brine (100 cm3), dried over MgSO4 and solvents removed under 
reduced pressure.  The crude product was purified by distillation under reduced pressure 
yielding 1-bromo-3,5-di-tert-butyl benzene (bp 85-95 ˚C (1 mmHg) and the title 
compound as a yellow oil (6.9 g, 42 %),   
bp 125-130 ˚C (1 mmHg); δH (300 MHz, CDCl3) 7.59 (1H, d, J 2.5, H-1), 7.37 (1H, d, J 
2.5, H-2), 1.58 (9H, s, H-3) and 1.29 (9H, s, H-3).; δC (125 MHz, CDCl3) 153.4, 152.0, 
134.4, 128.0, 123.5, 99.1, 38.5, 31.3, 31.0 and 30.2.; EI m/z 394 (30 %, [79BrM+H]+), 
396 (30 %, [81BrM+H]+); HRMS found 393.9793, C14H20BrI requires 393.9788. 
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1-(3,5-di-tert-butyl-2-(2,4-di-tert-butyl-6-methylphenylthio)phenyl)ethanol (259) 
 
Bromide 150 (0.08 g, 0.16 mmol, 1 equiv.), n-BuLi (2.1 M in hexanes) (0.08 cm3, 0.16 
mmol, 1 equiv.) and acetaldehyde (0.03 cm3, 0.4 mmol, 2.5 equiv.) were treated as 
described in general procedure L. Reaction mixture was diluted using ether and the 
organic phase washed with water (3 × 20 cm3) and brine (20 cm3), dried over MgSO4 
and solvent evaporated under reduced pressure.  The crude product was purified by flash 
chromatography (25:1 petrol:ethyl acetate) to yield the title compound as a colourless oil 
(13 mg, 18%) and as a mixture of diastereomers: crude 1H NMR shows the ratio as 2:1. 
Major diastereomer: Rf = 0.40 (9:1 petrol:EtOAc); δH (400 MHz, CDCl3) 7.41-7.35 (2H, 
m, H-1), 7.31 (1H, d, J 2, H-1), 6.94 (1H, d, J 2, H-1), 4.94 (1H, dq, J 6.5 and 2.5, H-4),  
1.66 (9H, s, H-2), 1.65 (9H, s, H-2), 1.64 (3H, s, H-3), 1.32 (9H, s, H-2), 1.29 (9H, s, H-
2) and 1.16 (3H, d, J 6.5, H-5).; ES+ m/z 491.5 (M + Na);  
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1-(3,5-di-tert-butyl-2-(2,4-di-tert-butyl-6-methylphenylthio)phenyl)propan-1-ol 
(260) 
 
Bromide 250 (0.8 g, 0.16 mmol, 1 equiv.), n-BuLi (2.1 M in hexanes) (0.08 cm3, 0.16 
mmol, 1 equiv.) and propionaldehyde (0.03 cm3, 0.4 mmol, 2.5 equiv.) were treated as 
described in general procedure L. Reaction mixture was diluted using ether and the 
organic phase washed with water (3 × 20 cm3) and brine (20 cm3), dried over MgSO4 
and solvent evaporated under reduced pressure.  The crude product was purified by flash 
chromatography (25:1 petrol:ethyl acetate) to yield the title compound as a colourless oil 
(18 mg, 23%) and as a mixture of diastereomers; Crude 1H NMR shows the ratio as 2:1. 
First eluted diastereomer (major diastereomer) (11mg, 14%); Rf = 0.6 (4:1 
petrol:EtOAc); δH (400 MHz, CDCl3) 7.45 (1H, d, J 2, H-1), 7.39 (1H, d, J 2, H-1), 7.24 
(1H, d, J 2, H-1), 6.90 (1H, d, J 2, H-1), 4.77 (1H, dd, J 10 and 2, H-4,  
1.69 (9H, s, H-2), 1.68 (3H, s, H-3), 1.66 (9H, s, H-2), 1.42-1.40 (2H, m, H-5), 1.30 (9H, 
s, H-2), 1.29 (9H, s, H-2) and 0.41 (3H, t, J 7, H-6).; ES+ m/z 505.5 (M + Na).  
Second eluted diastereomer (minor diastereomer): (7 mg, 9%); Rf = 0.55 (4:1 
petrol:EtOAc); δH (400 MHz, CDCl3) 7.41 (1H, d, J 2, H-1), 7.38 (1H, d, J 2, H-1), 7.22 
(1H, d, J 2, H-1), 6.92 (1H, d, J 2, H-1), 4.63 (1H, dt, J 7 and 3, H-4,  
1.67 (9H, s, H-2), 1.65 (9H, s, H-2), 1.60 (3H, s, H-3), 1.40-1.37 (2H, m, H-5), 1.30 (9H, 
s, H-2), 1.28 (9H, s, H-2) and 0.60 (3H, t, J 7, H-6).; ES+ m/z 505.5 (M + Na). 
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1-(3,5-di-tert-butyl-2-(2,4-di-tert-butyl-6-methylphenylthio)phenyl)-2-
methylpropan-1-ol (261) 
 
Bromide 250 (0.08 g, 0.16 mmol, 1 equiv.), n-BuLi (2.1 M in hexanes) (0.08 cm3, 0.16 
mmol, 1 equiv.) and isobutryaldehyde (0.04 cm3, 0.4 mmol, 2.5 equiv.) were treated as 
described in general procedure L. Reaction mixture was diluted using ether and the 
organic phase washed with water (3 × 20 cm3) and brine (20 cm3), dried over MgSO4 
and solvent evaporated under reduced pressure .The crude product was purified by flash 
chromatography (25:1 petrol:ethyl acetate) to yield the title compound as a colourless oil 
(30 mg, 38%) and as a mixture of diastereomers; Crude 1H NMR shows the ratio as 6:1. 
Major diastereomer: Rf = 0.48 (9:1 petrol:EtOAc); δH (400 MHz, CDCl3) 7.4 (1H, d, J 2, 
H-1), 7.37 (1H, d, J 2, H-1), 7.18 (1H, d, J 2, H-1), 6.9 (1H, d, J 2, H-1), 4.23 (1H, dd, J 
9.8 and 3.3, H-4),  
1.67 (9H, s, H-2), 1.64 (9H, s, H-2), 1.56 (3H, s, H-3), 1.30 (9H, s, H-2, 1.28 (9H, s, H-
2), 0.90 (3H, d, J 6.5, H-6), 0.75-0.73 (1H, m, H-5) and 0.37 (3H, d, J 6.5, H-6).; ES+ 
m/z 519.6 (M+ Na). 
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(3,5-di-tert-butyl-2-(2,4-di-tert-butyl-6- ethylphenylthio)phenyl)(phenyl)methanol 
(262) 
 
Bromide 250 (0.03 g, 0.06 mmol, 1 equiv.), n-BuLi (2.1 M in hexanes) (0.03 cm3, 0.06 
mmol, 1 equiv.) and benzaldehyde (0.015 cm3, 0.15 mmol, 2.5 equiv.)  were treated as 
described in general procedure L.  Reaction mixture was diluted using ether and the 
organic phase washed with water (3 × 20 cm3) and brine (20 cm3), dried over MgSO4 
and solvent evaporated under reduced pressure. The crude product was purified by flash 
chromatography (25:1 petrol:EtOAc) to yield the title compound as a white foam (21 
mg, 68%).  
Rf = 0.71 (4:1 petrol:ethyl acetate); δH (400 MHz, CDCl3) 7.41 (1H, d, J 2, H-1), 7.36 
(1H, d, J 2, H-1), 7.21-7.17 (2H, m, H-2), 7.14-7.07 (3H, m, H-2), 7.00 (1H, d, J 2, H-1), 
6.93 (1H, d, J 2, H-1), 5.97 (1H, d, J 4, H-4,  
1.72 (3H, s, H-5), 1.68 (9H, s, H-3), 1.63 (9H, s, H-3), 1.30 (9H, s, H-3) and 1.15 (9H, s, 
H-3).; δC (100 MHz, CDCl3) 150.0, 149.7, 149.6, 148.7, 145.3, 144.8, 139.7, 135.3, 
133.14, 127.7, 127.1, 126.0, 125.8, 125.3, 123.6, 122.9, 72.5, 37.7, 37.7, 34.6, 34.6, 
31.3, 31.2, 31.1, 30.9 and 22.5.; CI m/z 513 (20 %, [M-OH]+), 530 (30 %, [M]+); HRMS 
found 530.3578, C36H50OS requires 530.3577. 
 
 
 
 
 
 
 
S OH
1
1
11
2
2
2
2
2
3
3
3
3
3
33
3
3
3
3
3
 215 
N-benzyl-2-iodo-N-phenylbenzamide (272) 
 
2-iodobenzoylchloride (0.29 g, 1.09 mmol, 1 equiv) was dissolved in DCM (10 cm3) and 
a solution of N-phenylbenzylamine (0.20 g, 1.09 mmol, 1.0 equiv) and triethylamine (1 
cm3) in DCM (6 cm3) added dropwise at RT and stirred for 16 hours.  The organic phase 
was washed with water and brine, dried over MgSO4 and the solvent removed under 
reduced pressure.  The crude product was purified by flash column chromatography (9:1 
petrol:EtOAc) to yield the amide as light yellow oil (0.02 g, 5%). 
Rf = 0.32 (4:1 petrol:EtOAc); νmax (film/cm-1) 1646 (amide C=O).; δH (400 MHz; CDCl3) 
7.70 (1H, d, J 8, H-1), 7.40-7.34 (3H, m, H-1), 7.32-7.25 (3H, m, H-1), 7.12-6.99 (6H, 
m, H-1), 6.80 (1H, dt, J = 8 and 1.5, H-1), and 5.14 (2H, s, H-2, H-2).; ES+ m/z 436 
(M+Na).  VT NMR; In CDCl3 run from -50 to 40 °C, modeling benzylic protons 
decoalescence observed at 0 and -20 °C. 
 
 
 
bis(2-isopropylphenyl)sulfane135,167 (289a) 
 
Following the procedure reported by Buchwald135 2-i-propyl thiophenol (1 g, 5.5 mmol, 
1.2 equiv.), 2-i-propyl iodobenzene (1.21 g, 4.6 mol, 1.0 equiv.), copper(I) iodide (1.05 
g,  5.5 mmol, 1.2 equiv.), ethylene glycol (0.55 cm3) and tert-amyl alcohol (6 cm3) were 
charged to a flask fitted with a reflux condenser and stirred at 120 ºC under an 
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atmosphere of nitrogen for 18 h.  The reaction was allowed to cool to RT and diluted 
with EtOAc (20 cm3).  Organic phase was washed with water (3 × 20 cm3) and brine (20 
cm3) dried over MgSO4 and solvents removed under reduced pressure.  The crude 
product was purified by flash chromatography (petrol) to yield the title compound as a 
colourless oil (1.13 g, 85%).  
δH (500 MHz, CDCl3) 7.21 (2H, d, 8, H-1), 7.13-7.10 (2H, m, H-1), 6.96-6.95 (4H, m, 
H-1), 3.41 (2H, sept, J 6.5, H-2) and 1.13 (12H, d, J 6.5, H-3).; δC (125 MHz, CDCl3) 
149.0, 134.1, 131.9, 127.4, 126.5, 125.7, 30.5, 23.4; Analyses matched the reported 
data.135 
 
 
 
1-tert-butyl-2-iodobenzene168 
 
Following the procedure reported by Howell et al.155 t-butyl aniline (25 g, 0.17 mol, 1 
equiv.) was slowly added to 3 M H2SO4 solution (250 cm3) at -15 °C with overhead 
mechanical stirring.  A saturated solution of sodium nitrite (12.1 g, 0.18 mol, 1.05 
equiv.) was added dropwise over 30 min with vigorous stirring.  The reaction mixture 
was rapidly added to a solution of potassium iodide (75 g) in water (100 cm3) at 0 ˚C 
and stirred for 2 h.  Reaction mixture was diluted using ether and the organic phase 
washed with water (2 × 100 cm3) and brine (100 cm3), dried over MgSO4 and solvents 
removed under reduced pressure.  The crude product was purified by flash 
chromatography (petrol) to yield the title compound as a colourless oil (8.8 g, 20 %).  
δH (500 MHz, CDCl3) 8.09 (1H, d, J 7.5, H-1), 7.53 (1H, d, J 7.5, H-1), 7.36 (1H, t, J 
7.5, AH-1), 6.89 (1H, t, J 7.5, H-1) and 1.65 (9H, s, H-2).; Analyses matched the 
reported data.168 
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bis(2-tert-butylphenyl)sulfane (189b) 
 
Following a modified procedure reported by Buchwald135 2-t-Butyl thiophenol (1 g, 5.1 
mmol, 1.2 equiv.), 2-t-Butyl iodobenzene (1.30 g, 4.24 mmol, 1 equiv.), copper(I) iodide 
(0.23 g, 5.1 mmol, 1.2 equiv.), ethylene glycol (0.67 cm3) and tert-amyl alcohol (6 cm3) 
were charged to a flask fitted with a reflux condenser and stirred at 120 ºC under an 
atmosphere of nitrogen for 18 h.  The reaction mixture was allowed to cool to RT and 
diluted with ethyl acetate (20 cm3).  Organic phase was washed with water (3 × 20 cm3) 
and brine (20 cm3), dried over MgSO4 and solvents removed under reduced pressure.  
The crude product was purified by flash chromatography (petrol) to yield the title 
compound as a colourless oil (1.31 g, 88%).  
Rf = 0.37 (petrol); δH (500 MHz, CDCl3) 7.54 (2H, d, 8, H-1), 7.28-7.20 (2H, m, H-1), 
7.16-7.10 (4H, m, H-1) and 1.68 (18H, s, H-2).; δC (125 MHz, CDCl3) 150.0, 137.0, 
135.1, 126.7, 126.6, 126.5, 36.5 and 30.5; EI m/z 298 (70 %, [M]+); HRMS found 
298.1751, C20H26S requires 298.1750. 
 
 
 
Dinaphthalen-1-ylsulfane169(289c) 
 
Following a modified procedure reported by Buchwald135 naphthalene-1-thiol (1.0 g, 
6.24 mmol, 1.2 equiv.), 1-iodonaphthalene (1.0 cm3, 5.2 mmol, 1 equiv.), copper(I) 
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iodide (0.24 g, 6.24 mmol, 1.2 equiv.), ethylene glycol (0.70 cm3) and tert-amyl alcohol 
(6.5 cm3) were charged to a flask fitted with a reflux condenser and stirred at 120 ºC 
under an atmosphere of nitrogen for 18 h.  The reaction was allowed to cool to RT and 
diluted with EtOAc (20 cm3).  Organic phase was washed with water (3 × 20 cm3) and 
brine (20 cm3) dried over MgSO4 and solvents removed under reduced pressure.  The 
crude product was purified by flash chromatography (petrol) to yield the title compound 
as a white solid (1.60 g, 90 %).  
m.p. found 108-111 ˚C, lit. 110 ˚C;169 δH (400 MHz, CDCl3) 8.42-8.39 (2H, m, H-1), 
7.90-7.86 (2H, m, H-1), 7.54-7.48 (4H, m, H-1), and 7.33-7.27 (4H, m, H-1).; δC (100 
MHz, CDCl3) 129.9, 128.6, 128.0, 126.8, 126.4, 125.9 and 125.1.  Analyses matched the 
published data.169 
 
 
 
2,2'-sulfinylbis(isopropylbenzene (190a) 
 
Sulfide 189a (0.09 g, 0.33 mmol, 1 equiv.), mCPBA (0.057 g, 0.33 mmol, 1 equiv.) and 
DCM were treated as described in general procedure N for 2 hours.  The crude product 
was purified by flash column chromatography (9:1 petrol:EtOAc) to yield the title 
compound as a clear film (0.089 g, 95%).  
Rf = 0.15 (9:1 petrol:EtOAc); δH (400 MHz, CDCl3) 7.67 (2H, dd, J 8 and 1, H-1), 7.45 
(2H, dd J 8 and 1, H-1), 7.32-7.28 (4H, m, H-1), 3.44 (2H, sept, J 6.5, H-2),  
1.33 (6H, d, J 6.5, H-3) and 1.00 (6H, d, J 6.5, H-3).; δC (100 MHz, CDCl3)147.3, 133.5, 
131.6, 127.2, 126.3, 126.2, 29.4, 24.5 and 22.7.; ES+ m/z 309.2 (M + Na); HRMS found 
M 287.1467, C18H23OS requires 287.1465. 
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2,2'-sulfinylbis(tert-butylbenzene) (190b) 
 
Sulfide 189b (0.19 g, 0.65 mmol, 1 equiv.) mCPBA (0.11 g, 0.65 mmol, 1 equiv.) and 
DCM were treated as described in general procedure N for 2 hours.  The crude product 
was purified by flash column chromatography (9:1 petrol:EtOAc) to yield the title 
compound as a white solid (0.19 g, 93%).  
m.p. 150 – 152 °C; Rf = 0.20 (9:1 petrol:EtOAc); δH (400 MHz, CDCl3) 7.79 (2H, d, J 8, 
H-1), 7.59-7.54 (2H, m, H-1), 7.46-7.41 (2H, m, H-1), 7.35-7.31 (2H, m, H-1) and  
1.54 (18H, s, H-2).; δC (100 MHz, CDCl3) 149.7, 142.2, 133.6, 128.9, 127.9, 37.0 and 
32.5.; ES+ m/z 315.2 (M) and 337.2 (M + Na); HRMS found M 315.1772, C20H26OS 
requires 315.1778. 
 
 
 
1,1'-sulfinyldinaphthalene (190c) 
 
Sulfide 189c (0.10 g, 0.35 mmol, 1 equiv.), mCPBA (0.06 g, 0.35 mmol, 1 equiv.) and 
DCM were treated as described in general procedure N for 2 hours.  The crude product 
was purified by flash column chromatography (9:1 petrol:EtOAc) to yield the title 
compound as a white solid (95 mg, 90%).  
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m.p. 162 – 164 °C; Rf = 0.19 (9:1 petrol:EtOAc); δH (400 MHz, CDCl3) 8.36-8.33 (2H, 
m, H-1), 8.07 (2H, dd, J 8 and 1, H-1), 7.97 (2H, d, J 8, H-1), 7.90-7.88 (2H, m, H-1) 
and 7.60-7.50 (6H, m, H-1 ).; δC (100 MHz, CDCl3) 139.5, 133.7, 132.1, 129.9, 129.0, 
127.7, 126.8, 125.7, 125.6 and 122.6.; ES+ m/z 303.1 (M + Na); HRMS found M 
303.0837, C20H14OS requires 303.0839. 
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5.3 Biocatalysis Procedures 
Galactose oxidase (GOase) expression and purification 
Cultures of 800 ml LB media (containing 100 µg/ml ampicillin) were inoculated with 5 
ml preculture (OD = 0.5-0.6) containing the GOase M3-5 Escherichia coli clone. The 
cells were harvested after overnight incubation at 26 °C and lysed by sonification. The 
Ni-NTA purification and subsequent copper activation of the proteins were performed as 
previously described.101 From SDS-PAGE analysis and subsequent Coomassie staining 
more than 95% pure protein was acquired with a molecular mass of approximately 71 
KDa, identical to the theoretical mass of the histidine-tagged GOase variants. Protein 
concentrations were determined by measuring the absorbance at 280 nm (ε = 1.05 x 105 
M-1). Yields of approximately 7-8 mg pure protein/L culture were obtained.  
 
 
Determination of GOase activity for diols 119a-d 
The specific activity, kinetics constants and conversion rates of the purified enzymes 
were measured using a ABTS-HRP coupled assay.170 For the initial activity 
measurements, 20 µl protein (12.5 nM final concentration) were mixed with 50 mM 
substrate in 250 mM NaP (pH 7.0) that contained 0.5 U HRP (Sigma Aldrich) and 0.1 
mg ABTS (Pierce) in a 96-well plate (200 µl total volume). Product formation was 
measured at 420 nm in a SpectraMax M2 (Molecular Devices) plate reader at 30°C in 
triplicate in at least three independent experiments. 
Cu2+ preincubation: 
Cu2+ preincubation of old M3-5 sample:  Galactose oxidase is a copper dependent 
oxidase. The enzyme needs to be preincubated with copper prior to the assay: 
6.06 µL GaoAM3-5 (5.69 mg/mL) + 994 µL water + 0.62 µL CuSO4 80 mM 
→ GaoAM3-5 final concentration: 34.5 µg/mL ↔ 0.5 µM (MW = 68000 Da) 
→ Cu2+ final concentration: 50 µM 
The mixture was vortexed for 30 min at room temperature and then diluted 5 times with 
water (final concentration: 6.9 µg/mL ↔ 0.1 µM) 
Colorimetric assay protocol: 
The enzymatic assay is based on the oxidase-catalysed H2O2 formation; H2O2 release is 
then coupled with a peroxidase-based assay (peroxidase + peroxidase substrate ↔ 
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ABTS) producing a coloured pigment (green colour using ABTS as peroxidase 
substrate). The kinetics can be measured by following the absorbance increase at 420 nm 
when ABTS is used. 
Since the 4 compounds 119a-d are not soluble in water, a 0.4 M stock solution in DMSO 
was prepared. 
Assay components Assay Control – GaoA Control - substrate 
ABTS solution 100 µL 100 µL 100 µL 
water 74 µL 94 µL 74 µL 
DMSO - - 5 µL 
Peroxidase (1 mg/mL) 1 µL 1 µL 1 µL 
Substrate (0.4 M in DMSO) 5 µL 5 µL - 
GaoAM3-5 (6.9 µg/mL) 20 µL - 20 µL 
 
For each substrate, solution corresponding to 5 assays prepared and aliquoted in wells (3 
x 175 µL or 3 x 195 µL for control - GaoA), then 5 µL of substrate added to the assay 
mixture and 20 µL of GaoA protein added to initiate the reaction using a multi-channel 
pipetman. 
Measurement and rate calculation 
- λ = 420 nm, length: 0-3600 sec 
- Plate and GaoA samples preincubated at 30˚C for 15 min before assay  
- Rate calculation:  
Vimax = Vimax-obs – control without GaoA – control without Substrate 
Then average on the triplicate 
 
 
GOase catalysed oxidation of diaryl ethers 119d and 140 
For the desymmetrisation of diol 119d and kinetic resolution of monoaldehyde 140, the 
following components were placed in a glass tube; substrate (10 mM), DMSO (30% 
v/v), horse radish peroxidase (1mg), catalase (0.1mg), in sodium phosphate buffer 
(100mM, pH 7.0) total volume = 1mL. Oxygen was bubbled through the solution for 5 
min prior to the addition of purified GOase M3-5 variant (2mg). Parafilm was wrapped 
around the rubber septum of the tube in order to reduce leakage of oxygen. The reaction 
was shaken at 30 °C and 250 rpm.  The desymmetrisation reactions were monitored by 
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normal phase HPLC; 50 µl of sample were taken and 200 µl of MTBE was added. The 
sample was then thoroughly mixed in an Eppendorf tube and the upper-layer was 
transferred to another Eppendorf tube, volatiles were removed under reduced pressure 
and 100µl of ethanol was added. The solution was then transferred into a 2 mL HPLC 
vial with 0.2 mL insert and both conversion and ee determined. 
The kinetic resolution reactions were monitored by both reverse phase HPLC 
(conversion) and normal phase HPLC (ee) analysis; For reverse phase analysis, 50 µl of 
sample was taken and 50 µl of acetonitrile was added. The sample was then thoroughly 
mixed in an Eppendorf tube and centrifuged for 2 minutes. The supernatant was taken 
and transferred to a 2 ml HPLC vial with a 0.45 µm filter and analysed by reverse phase 
HPLC. 
 
Reduction of dialdehyde 118d using ketoreductases (KREDs) 
For the reduction of the dialdehyde 118d using ketoreductases the following components 
were placed in a glass tube; substrate 118d (5mg, 17 mM), DMSO (30% v/v), KRED 
enzyme (5mg), glucose dehydrogenase (CDX-901, 1mg), NADP+ (1mg), glucose (3.8 
mg, 1.25 mol excess relative to substrate), in potassium phosphate buffer (100 mM, pH 
7.0), total volume = 1 ml.  The reaction mixture was shaken at 30 °C and 250 rpm.  Both 
conversion and ee were monitored by normal phase HPLC. 
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5.4  X-Ray Crystal Data and structure refinement for 245  
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